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ABSTRACT
LIFE COURSE HEALTH EFFECTS OF EARLY LIFE TRAUMA
by
Jennifer M.P. Woo

The University of Wisconsin-Milwaukee, 2020
Under the Supervision of Professor Helen C.S. Meier, Ph.D., M.P.H.
The experience of trauma and psychosocial stress over the life course can have lasting
impacts on health. Childhood and adolescence may serve as a particularly sensitive period during
which trauma may become biologically embedded and affect adult health. Evaluating the
pathways through which early life trauma can affect biological mechanisms of disease
development provides insight into the early origins and etiology of adverse health outcomes in
adulthood and provides potential targets to help mitigate their effects.
Using data from the Sister Study, a large prospective cohort study of women residing in
the U.S. or Puerto Rico aged 35 to 74 with a sister previously diagnosed with breast cancer, we
examined the relationship between early life trauma and three indicators of adult health—1)
incident breast cancer risk, 2) DNA methylation of the glucocorticoid receptor gene (NR3C1),
and 3) leukocyte telomere length. Much of the previous literature has depended upon summative
trauma scores, traditional trauma domains (e.g., sexual trauma, physical trauma, household
dysfunction), or single traumatic events to represent early life adversity. However, early life
traumatic experiences rarely occur in isolation and the experience of trauma in early life is a risk
factor for future revictimization. This dissertation utilizes a latent class approach to evaluate the
effect of specific profiles of early profiles on the three measures of adult health and biological
embedding of trauma, as well as uses a sensitive period life course model to examine whether
ii

early life trauma impacts 1) NR3C1 methylation and 2) leukocyte telomere length in adulthood
independent of later life trauma or if adult trauma mediates these associations.
The findings from this dissertation suggest that the relationship between early life trauma
and these three indicators of adult health are complex. There were no associations between
traditional measures of early life trauma (e.g., summative scores or trauma domains) and incident
breast cancer risk; however, compared to women who were classified in the latent class of early
life trauma consisting of low early life trauma (i.e., the average probability of reporting any type
of early life trauma was less than 2% across all possible traumatic events), the rate of incident
breast cancer overall, as well as pre- and post- menopausal breast cancer, appeared higher among
women belonging to the latent class of early life trauma consisting of both sexual trauma and
family drug, alcohol, and/or mental health issues. This latent class of early life trauma was also
associated with hypomethylation of cytosine-phosphate-guanine (CpG) sites located in the gene
body of NR3C1. This association was also observed in a sensitive period life course model
whereby the direct effect of early life trauma on decreased methylation was independent of
trauma in adulthood. Finally, leukocyte telomere length was statistically significantly shorter in
women classified in the latent class consisting of high early life trauma experience (i.e., the
average probability of reporting each early life traumatic event was approximately 32%)
compared to women classified in the latent class of low early life trauma experience independent
of any indirect effect through trauma in adulthood.
The findings from this dissertation emphasize that the effect of early life trauma on
incident breast cancer risk, NR3C1 methylation, and leukocyte telomere length in adulthood may
be more nuanced than what is captured via a cumulative trauma score, assessment of a single
traumatic event, or traditional trauma domains can capture. Traumatic experiences differ in
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duration and intensity and various traumatic experiences tend to cluster and cooccur, likely
contributing to unique patterns of biological embedding, behavioral responses, and
socioenvironmental trajectories that may further differentiate how early life trauma affects adult
health. Measures that capture the unique combinations of concomitant early life trauma profiles
are needed to fully elucidate the effects of different experiences of early life trauma on adult
health. Doing so can assist in designing programs and early life interventions to address those
trauma profiles that are most detrimental to future health. Furthermore, the experience of trauma
can occur across the life course. Utilizing life course models can help to better understand the
relationship between the experience of early life trauma and adult manifestations of the
biological embedding of stress and trauma. The findings from this dissertation contribute to a
more robust understanding of the relationship between early life trauma and incident breast
cancer risk, adult circulating NR3C1 methylation, and leukocyte telomere length in adulthood
and support the need to identify opportunistic windows for interventions over the life course in
order to minimize these negative health outcomes and their impacts. Future research will need to
continue to utilize complex measures of early life trauma and a life course framework before a
unified picture of the association between the nuanced roles of early life trauma in shaping these
health outcomes can be fully elucidated.
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CHAPTER 1
Introduction
1.1 Introduction
The experience of trauma and psychosocial stress over the life course has the potential to
impact current as well as future health outcomes1, 2. Childhood trauma and adversity,
experienced before age 18, have been associated with health risk behaviors3-6, mental health
conditions7-10, chronic disease11-16, and overall poor health17, 18. Life course theory posits that
early life environments may affect later health outcomes by “getting under the skin” and acting
during developmentally sensitive periods or by contributing damage to biological systems that
accrue over time. In a sensitive period model, early life trauma and adversity have lasting effects
on biological structures and functions and long-term health outcomes, independent of subsequent
adverse exposures19. Alternatively, in accumulation models, early life trauma and adversity may
take part in a web of risk factors that span the life course and contribute to the accrual of
biological damage or they may serve as early links in a chain of risk factors that lead to a final
risk factor (i.e., adult trauma) that ultimately triggers the health outcome of interest19, 20.
Evaluation of the pathways through which early life trauma acts on biological mechanisms of
disease development and cellular aging provides insight into the early life origins and etiology of
adverse health outcomes.
Three indicators of adult health that may be accelerated by the biological embedding of
psychosocial stress over the life course are 1) breast cancer tumorigenesis, 2) epigenetic
modification of stress management pathway genes, and 3) cellular aging. These three
mechanisms are ongoing biological processes and may, therefore, be more susceptible to the
influence of chronic stress. First, psychosocial stress experienced over the life course has been
1

associated with the development of breast cancer21-23, which is one of the most commonly
diagnosed cancers among women in the U.S.24, 25, affecting approximately 12% of women during
their lifetime26, and stress experienced at potentially vulnerable periods of breast development27
(i.e., childhood and adolescence) may differentially affect breast cancer risk via various
behavioral and biological pathways. Second, both DNA methylation and telomere length have
been linked to disease development via biological embedding of trauma28, 29. DNA methylation
is a form of epigenetic modification that can alter gene expression by interrupting gene
transcription without modifying the underlying genetic code30. Methylation of genes on the
hypothalamus-pituitary-adrenal (HPA) axis, the primary stress management pathway, contributes
to modified expression of genes related to immune response, inflammatory pathways, DNA
repair, and cell apoptosis, contributing to disease risk and negative health impacts31. Finally,
telomere length is a marker of cellular division and aging32. Telomeres are repeating DNA
protein complexes found at the end of chromosomes that shorten with subsequent cell divisions
until a critical length is reached and cellular senescence occurs33. Telomere length is sensitive to
perceived and chronic stress via increased exposure to stress response-related oxidative stress
and lowered telomerase activity34.
Research in the impact of childhood adversity and early life trauma on adult health
gained traction in the 1990’s with the seminal Adverse Childhood Experience (ACE) Study
conducted by Felitti et al., which identified a core set of seven domains of trauma that were
linked to the leading causes of adult mortality35. Since then, researchers have not only expanded
the field of study to assess this relationship in other adult health outcomes, but have also begun
to study the mechanisms contributing to the biological embedding of these early life exposures.
These studies have primarily utilized summative trauma scores36-40, distinct traumatic events
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(e.g., death of a parent)41-45, or singular domains of trauma (e.g., sexual trauma)46-49 to study the
effects of early life trauma and adversity. Due to the heterogeneity of these methods, findings
reported on the association between early life trauma and the measures of adult health that are
investigated in this dissertation have been mixed23, 36, 37, 40, 47, 50-59. While traumatic experiences
rarely occur in isolation, with about 80 percent of individuals who report one adverse experience
also reporting at least one additional adverse experience35, few studies have investigated how
specific combinations of early life traumatic events (not just the total number of events or
individual domains) may interact and differentially impact mechanisms of stress embodiment
and adult health outcomes.
Using data from the Sister Study, a large prospective cohort study of women residing in
the U.S. and Puerto Rico free of breast cancer at baseline but with a biological sister diagnosed
with breast cancer, the objectives of this dissertation are: to investigate the association between
early life trauma and 1) incident breast cancer risk, 2) DNA methylation of the HPA axis gene,
nuclear receptor subfamily 3, group C, member 1 (NR3C1), and 3) leukocyte telomere length.
1.2 Specific Aims and Hypotheses
Aim 1: Investigate the association between early life trauma and incident breast cancer.
Hypothesis 1a: Traditional measures of early life trauma (e.g., summative trauma scores
or singular events) will be positively associated with breast cancer incidence among women
enrolled in the Sister Study.
Hypothesis 1b: The association between early life trauma and incident breast cancer will
vary based on latent models of concomitant early life traumas (i.e. the substantive nature of a
cluster of experienced traumatic experiences may be more nuanced than the actual number of
experienced traumas).
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Aim 2: Examine the relationship between early life trauma and DNA methylation of the HPA
axis gene, NR3C1.
Hypothesis 2a: The effect of early life trauma on levels of adult DNA methylation of
NR3C1 in peripheral blood will differ based on latent class of early life trauma.
Hypothesis 2b: Early life trauma will directly affect adult NR3C1 levels independent of
potential mediating pathways via adult trauma and other adult health and lifestyle factors.
Aim 3: Assess the relationship between early life trauma and leukocyte telomere length.
Hypothesis 3a: The association between early life trauma and adult leukocyte telomere
length will differ based on latent classes of early life trauma.
Hypothesis 3b: Early life trauma will directly affect adult leukocyte telomere length
independent of potential mediating pathways via adult trauma and other adult health and lifestyle
factors.
1.3 Background
Approximately 50% of women in the U.S. report experiencing at least one trauma in their
lifetime47, 60, including physical, sexual, or emotional abuse, household dysfunction, and
experience of natural disasters or major accidents. The first formal study of early life trauma, the
Adverse Childhood Experiences Study, identified a core set of seven domains or categories of
trauma (e.g., emotional, physical, and sexual abuse, physical and emotional neglect, and
household challenges associated with substance abuse, mental illness, violent treatment of a
female care giver, parental separation or divorce, or imprisonment of a member of the
household) that were linked to the leading causes of adult mortality35.
Since the seminal ACE Study, numerous studies have reported associations between
ACEs and health risk behaviors3-6 (e.g., alcohol use, drug abuse, smoking, physical inactivity,
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and poor diet), mental health conditions7-10, chronic disease11, 12 (e.g. heart disease12,
autoimmune disease13, and different cancers14-16), and overall poor health17, 18. Research has also
begun to assess the biological mechanisms through which psychosocial stress may become
embodied and link the exposure of early life stress to these health outcomes. Early life trauma
has the potential to impact adult health through the process of biological embedding61 during
which initial regulatory homeostatic functions related to neural, immune, inflammatory, and
metabolic processes negatively alter physiology with prolonged activation62. These processes can
be driven by epigenetic modification, which include DNA methylation, histone modification,
and telomere regulation.
1.4 Life Course Perspective
The life course perspective posits that physical and social exposures during gestation and
early life through adulthood can have long term effects on the development of chronic disease
later in life, such as breast cancer19. This framework highlights the fallacy of assessing social and
biological pathways independently63 and instead promotes the integration of multiple
psychosocial and biological pathways over the life course to identify causal pathways of disease
development19.
The critical or sensitive period model is one of the primary theoretical frameworks used
in the life course perspective. Critical or sensitive period models (known as latency models) posit
that there are windows of vulnerability throughout the life course that correspond to periods of
growth or disease susceptibility during which pertinent exposures have greater effect on adult
health19, 64. Critical periods represent timeframes during which a given exposure must occur in
order trigger a specific health outcome; if the exposure occurs outside this window, then the
health outcome does not manifest in relation to the exposure. Conversely, sensitive periods
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represent timeframes during which a given exposure will have a greater impact on disease risk; if
the exposure occurs outside the sensitive period then the effect of the exposure may persist, but
the impact is lessened. Figure 1.1 outlines a sensitive period model for the potential life course
health effects of early life trauma. It proposes a sensitive period in early life, such that exposure
to early life trauma has a direct effect on adult measures of health, independent of other periods
(dashed line), but also allows for early life trauma to have downstream effects on health
outcomes through mediating pathways via adult SEP, trauma, and behavioral and lifestyle factors
outside of the sensitive period (solid black lines).
1.5 Early Life Trauma and Breast Cancer Incidence
Breast cancer pathogenesis and tumorigenesis
Invasive breast cancer is a heterogeneous disease and different molecular subtype milieus
have been associated with different populations, disease pathogenesis, and response to
treatment65. Breast cancer tumors are often classified by the presence or absence of cellular
receptors, the most common of these being receptors for estrogen (ER), progesterone (PR), and
human epidermal growth factor receptor 2 (HER2). Tumors that lack receptors for one or more
of these ligands (i.e., triple negative tumors) respond poorly to current breast cancer therapies
and are associated with the worst outcomes66. In addition to the subtype classification, breast
cancer severity is classified using additional clinical manifestations to determine tumor stage.
Tumor stage is primarily determined using the system developed by the American Joint
Committee on Cancer67, which can range from stage 0 (in situ tumors) to stage IV with stage 0
representing non-invasive tumors, stage I representing the earliest invasive breast cancer where
tumor cells have just started to invade normal surrounding tissue, and stage IV representing
tumors that have metastasized to distant tissues in the body. Further classification within each
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tumor stage is determined by the size of the primary tumor, involvement of the lymphatic system
(a common conduit that allows for tumor cells to travel to distal tissues), metastatic status, and
cellular grade (similarity in appearance of cancer cells compared to normal cells).
The development of breast cancer is thought to stem from the interaction of genetic and
environmental factors; however, breast cancer etiology and the mechanisms through which risk
factors contribute to differential pathology are still largely unknown. Less than 25% of risk for
breast cancer is thought to be attributable to genetic risk associated with highly penetrant genetic
mutations or intermediate risk-low frequency genetic variants68. A substantial portion of the
unknown non-genetic risk for breast cancer is likely attributable to the exposure to and the
embodiment of the spectrum of social determinants of health, including neighborhood context,
SEP, and psychosocial stress experienced over the life course69-72.
Childhood/adolescence as a sensitive period for breast cancer risk
Childhood and adolescence represent potential sensitive periods associated with later
breast cancer risk due to ongoing breast development, characterized by rapid proliferation of
undifferentiated mammary cells and heightened susceptibility to tumorigenic changes73, 74.
Premature thelarche75 (onset of breast development) and younger age at menarche (age at first
menses)76, both indicators of accelerated breast development, have both been associated with
increased breast cancer risk. The period of breast duct development may serve as a sensitive
period for carcinogenesis due to a prolonged period of cellular differentiation in the breast ducts.
National trends indicate that although age at menarche has remained fairly constant over the past
two decades, age at thelarche has experienced a downward trend, suggesting a lengthening of
this inherent period of vulnerability at a population level77. Age at menarche has also been
associated with the timing of a woman’s first pregnancy; late onset of menarche is associated
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with slightly increased risk for subfecundity and/or infertility78. Delayed age at first birth, parity,
and time since last pregnancy are all known risk factors for breast cancer in young women79, 80.
Early age at first birth and increased parity are associated with decreased long-term breast cancer
risk79, 81, 82, whereas pregnancy itself is associated with a transient increase in breast cancer risk
within 5 years of delivery83-85. Although earlier age at menarche may serve as a predictor for
additional breast cancer risk factors later in life, early life exposure to stress-related factors may
also contribute to premature menarche and alter baseline breast cancer risk independent of future
pregnancy-related breast cancer risk factors75.
Early life trauma may affect breast cancer risk by contributing to high risk phenotypes of
early life breast cancer risk factors, including early onset thelarche and menarche. Premature
thelarche and menarche are patterned in the U.S. by adverse childhood experiences, such as food
and resource insecurity86, childhood sexual abuse87, the presence of family conflict, and
perception of environmental instability88, which have all been associated with early age at
menarche and fecundity89. Taken together with their potential impact on the timing of breast
development, trauma experienced during childhood and adolescence may be relevant for
understanding breast cancer etiology.
1.6 Early Life Trauma and Glucocorticoid Receptor Gene (NR3C1) Methylation
The hypothalamus-pituitary-adrenal axis and the glucocorticoid receptor
The hypothalamic-pituitary-adrenal (HPA) axis is one of the primary stress response
mechanisms in the body and functions via a series of biochemical feedback pathways between
the hypothalamus, anterior pituitary gland, and adrenal glands. Glucocorticoids are one of the
key hormone signals utilized in the HPA axis in stress reactivity. They are released from the
adrenal glands and serve as the primary negative feedback mechanism to discontinue stress
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response along the HPA axis90. Glucocorticoid regulation, which is managed by genes within the
HPA axis, modulates the impact of socioenvironmental stress on biologic pathways (e.g., growth
and development, metabolism, immune function and inflammatory processes)91. Persistent
activation of the HPA access due to exposure to chronic stress can decrease the functionality of
the glucocorticoid negative feedback loop contributing to greater allostatic load and disease
susceptibility90, 92.
The glucocorticoid receptor is a member of the nuclear receptor superfamily and is
commonly found in the cytoplasm before binding to glucocorticoids (forming a glucocorticoid
receptor complex) and translocating to the cell nucleus93. While in the cell nucleus, the
glucocorticoid receptor complex can act as a transcription factor by binding to glucocorticoid
response elements of genes responsive to glucocorticoid signaling, upregulating the synthesis of
immune- and metabolic-related proteins, or can interact with transcription factors necessary for
additional gene expression to downregulate the synthesis of immunosuppressive and proinflammatory proteins93-95. Glucocorticoid receptors are present in all tissue types (including
healthy breast tissue) and is the primary vehicle for glucocorticoid signaling, which regulates
mammary physiology and development96 in addition to stress-induced inflammatory and immune
responses and cellular proliferation and apoptosis97.
Epigenetics, DNA methylation, and glucocorticoid receptor gene (NR3C1)
Epigenetic modifications are durable characteristics that alter gene expression without
changing underlying genetic code, thus disrupting DNA transcription and preventing gene
expression. Genes are read through the process of transcription, during which DNA uncoils and
the protein RNA polymerase scans each DNA base pair to create messenger RNA and eventually
proteins that terminate in phenotypic manifestations.
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One of the primary mechanisms of epigenetic modification is DNA methylation, in which
a methyl group is added to the 5 position of a cytosine (C) base to create 5-methylcytosine. DNA
methylation frequently occurs at cytosine-guanine (G) dinucleotides, which consist of a cytosine
nucleotide (C:G) followed by a guanine nucleotide (G:C) separated by a single phosphate group
in the 5’ to 3’ direction of the sequence of base pairs, also known as CpG sites31. CpG islands are
areas that are rich in CpG sites and are commonly found in gene promotor regions. When the
CpG islands are methylated, RNA polymerase is unable to bind to the DNA, preventing
messenger RNA (mRNA) production and subsequent gene expression, thus silencing the gene
and prohibiting any physiological functions to which it may contribute. Conversely, when CpG
islands located in the gene promoter region are unmethylated, RNA polymerase can bind to the
DNA and proceed with mRNA production and gene expression. Abnormal methylation patterns
can result in the expression or silencing of genes responsible for vital biological mechanisms
(e.g. immune response, inflammatory pathways, DNA repair, cell apoptosis, etc.), contributing to
disease risk and negative health impacts31.
The glucocorticoid receptor gene, (i.e., nuclear receptor subfamily 3, group C, member 1
(NR3C1)), is located on chromosome 5q31-q32 and is composed of eight coding exons (2-9) and
9 tissue-specific alternative first exons (1A-1J, excluding G), which each have their own
promoter immediately upstream (Figure 1.2). The promotor region consists of the distal
promotor (exons 1A and 1I) and the proximal promotor (exons 1D, 1J, 1E, 1B, 1F, 1C, and 1H);
the latter of which is located in a 3 kilobase pairs (kbp) CpG island located 5kbp upstream from
the translation start site98. NR3C1 regulates genes associated with development, metabolism,
inflammation and immune function as well as glucocorticoid receptor expression across multiple
tissues94. The single glucocorticoid receptor gene is responsible for generating multiple
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glucocorticoid receptor isoforms, which are differentially distributed within different tissues, via
alternative splicing and alternative translation initiation99.
Trauma and NR3C1 methylation
Early life trauma has been associated with lower NR3C1 expression in leukocytes100 and
hippocampal tissue101; differential methylation may contribute to this association by altering
NR3C1 gene transcription. Methylation of genes within the HPA axis has been hypothesized to
serve as potential markers of stress embodiment and disease risk29. Negative socioenvironmental
conditions, such as low childhood SEP102 and childhood adversity (e.g., trauma, neglect, and
abuse)103, 104 have been associated with modified hormonal exposures74 and earlier pubertal
onset102, as well as methylation of genes within the HPA axis105-107.
One of the HPA genes commonly studied is NR3C1, due to the prominent role of
glucocorticoid receptors in the stress response process. Methylation of NR3C1 has been
attributed to altered stress management and inflammatory response and has been associated with
increased childhood adversity38, 39, 108, as well as tissue-specific glucocorticoid receptor
expression94, contributing to increased disease susceptibility29, 107, 109. Hypermethylation of
NR3C1 fundamentally results in decreased glucocorticoid receptor expression and down
regulates glucocorticoid receptor-regulated pathways related to stress management, development,
metabolism, inflammation and immune function, and cell differentiation, and increasing the
potential to alter risk for psychopathologies, immune dysfunction, and tumorigenesis29, 110.
Much of the existing literature studying NR3C1 methylation has focused on methylation
of CpG sites within the 3kpb CpG island that houses the proximal promotor, due to its potential
to affect NR3C1 transcription, with less research conducted on the tissue-specific first exons and
whose functional roles are currently unknown111. However, findings from much of the previous
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literature have been mixed. Hypermethylation of exon 1F and its promotor, located within the
NR3C1 proximal promoter CpG island, in peripheral blood has been associated with increased
childhood adversity and adult mental health outcomes (e.g., post-traumatic stress disorder,
depression, and borderline personality disorder)106, 111, 112. Additional studies have reported
increased levels of NR3C1 methylation overall and within promoter regions associated with
number of traumas38, 39 or specific domains of childhood/adolescent adversity (e.g., physical
abuse and emotional neglect)113, 114, while other studies have reported decreased methylation
around promoter regions and at individual CpG sites associated with different measures early life
trauma42, 114, 115. Still other studies report no association between early life adversity and NR3C1
methylation43, 116, 117. The variation in these results may be in part to the heterogeneity of
measures used to assess childhood and/adolescent trauma, the period during which trauma data
were ascertained, the NR3C1 CpG sites included in the analyses, the method used to capture
NR3C1 methylation data, whether the studies corrected for multiple testing, as well as the study
populations represented in previous studies, which have differed by age, sex, and proportion of
participants selected for known psychiatric and mental health disorders. In a recent review article
by Palma-Gudiel et al., the authors call for methodological consensus and a more methodical
selection of CpG methylation sites in studies of early life trauma59.
1.7 Early Life Trauma and Adult Leukocyte Telomere Length
Telomere length and cellular aging
Telomeres are repeating DNA protein complexes consisting of tandem 5’-TTAGGG-3’
sequences found at the end of chromosomes that range from about 10 to 15 kb118 and protect
chromosomal stability and integrity28. Telomeres gradually shorten by approximately 50 to 200
bp with each cell replication119 and continues until cell cycle arrest occurs, leading to apoptotic

12

cell death or cellular senescence-the state in which telomeres reach a critical length and no
longer have the capacity to divide33. Telomeres can also shorten due to direct DNA damage as a
result of oxidative stress related negative health behaviors such as high BMI or smoking120, 121.
Although telomere shortening can be reversed with the addition of new repeats on chromosome
ends by telomerase proteins, this process is only observed in progenitor cells of tissues with high
turnover rates, with most tissues characterized by shortening telomeres with age122-124. Therefore,
telomeres can serve as mitotic clocks or an indicator of potential cellular division and aging.
Leukocyte telomere length reflects the telomere length of hematopoietic stem cells125 and
is often studied due to its accessibility. Due to the constant proliferation of leukocytes, leukocyte
telomere length may not be reflective of other tissues that are less proliferative (e.g., neurons,
skeletal muscle, etc.)126-128. However, leukocyte telomere length is strongly correlated with
telomere lengths in other somatic tissues, such that an individual with shortened telomeres in one
tissues will also have shortened telomeres in another tissue129. Shortened leukocyte telomere
length has been associated with age-dependent processes130, the development of chronic
diseases131 including cancer132-135, obesity136, 137, diabetes138, 139, and cardiovascular disease138, 140,
and mortality141.
Trauma and telomere length
Due to the growing evidence linking telomere length and disease development, telomeres
have been proposed as a pathway to describe how trauma and other adversities are biologically
embodied to influence adverse health outcomes28. In 2010, Tyrka et al. first reported that
childhood maltreatment related to physical neglect and emotional neglect was associated with
significantly shorter telomeres in adults after controlling for age, sex, smoking, BMI, and other
demographic characteristics142. Since then, research has supported the association between
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childhood and adolescent trauma and shorter telomeres in both children55, 58 and adults54, 55, 57.
The type of traumatic adversity55, 56, 143, 144, number of traumatic exposures52, 58, 145, and timing of
exposure143, 145 have been shown to have differential or compounding effects on telomere length
with increased trauma severity or chronic exposures contributing to shorter telomere length.
Recent life course research has further suggested that exposure during early life may be
particularly damaging, revealing cumulative adversity during early life predicted shorter
telomere length in adulthood57 in addition to shorter baseline adult telomere length and greater
telomere attrition in mid-life145. Only one study at the time of this dissertation, has used
structural equation modeling to evaluate different life course models of childhood stressful life
events before 18 years, and was conducted by evaluating telomere length in saliva146. Using
financial and social/traumatic adversity to create an adversity score first constructed in Puterman
et al.57, Wallis et al. reported that there was no direct effect of childhood stressful life events on
adult telomere length, with all effects mediated through adult stressful life events146.
Despite these findings, other studies have reported more complex results, suggesting
temporal impacts of stress on telomere length. Studies have suggested that the timing between
the exposure and measurement of telomere length may play a role in the observed association
between early life stress and adult telomere length. McFarland et al. reported that the association
between exposure to stressful life events in early life and shortened telomere length was only
observed in adults aged 22 to 44 years, but not in adults over the age of 45 years52. Results from
Verhoeven et al. did not find an association between psychosocial stress that occurred more than
six years prior to telomere length measurement53. Conversely, a study by Parks et al. reported
that current perceived stress was not significantly associated with shorter telomere length, but
telomeres were significantly shorter with higher perceived stress in women over 55 years147.
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These studies fail to report how the occurrence of different early life traumatic events may
differentially impact telomere length in adulthood.
1.8 Measurement of Early Life Trauma
There is currently no consensus on how early life psychosocial stress is measured. Early
life stress is commonly described using terms such as “stressful life events” or “adverse events”
(i.e., circumstances that may negatively impact physical or psychological well-being)148,
“childhood adversity” (i.e., “experiences that are likely to required significant adaptation by an
average child and that represent a deviation from the expectable environment”)149, “adverse
childhood experiences” (i.e., often limited to those experiences identified in the ACE Study)35,
“maltreatment” (i.e., all forms of physical and/or emotional ill-treatment that result in “actual or
potential harm to the child’s health, survival, development or dignity in the context of a
relationship of responsibility, trust or power”)150, and “trauma” (i.e., circumstances that are
perceived as extremely threatening or harmful to the physical and/or psychological safety of the
individual or individuals close to them; often times it is inclusive of ACEs, but is not limited to
those experiences)149. The nuances between these terms are not often addressed when describing
the relationship between early life stress and adult health outcomes149, 151. The use of one term
over another is based on the measure that is used to capture psychosocial stress, such as the ACE
Questionnaire35, a lifetime trauma survey152, Brief Betrayal Trauma Survey153, childhood trauma
questionnaire154, as well as the abstraction of individual events such as death of a parent or
experience of a specific natural disaster.
Most studies assessing the relationship between early life adversity and breast cancer,
HPA axis gene methylation, and leukocyte telomere length have relied on summative
measures36-40, 155, distinct traumatic events (e.g., loss of a parent) 41, 42, 44, 156, or trauma domains43,

15

46-49

as measures for early life adversity. However, early life trauma does not occur in isolation.

Dong et al. reported that between 81-98% of individuals who reported experiencing at least one
ACE reported at least one additional ACE and the report of one ACE increased the odds of
reporting additional ACEs from 2 to 17.2 times when compared to individuals who did not report
any ACEs157. Furthermore, early life trauma may also influence the adoption of health risk
behaviors, additional stress or trauma in adulthood, or future socioeconomic environments and
opportunities, which may mediate the pathway to poor health158, 159. Life course models that
assess different profiles of early life trauma are therefore needed in order to better understand the
relationship between the cooccurrence of different early life traumatic events and adult health
outcomes and measures of biological embedding.
1.9 The Sister Study
The Sister Study is a prospective cohort study of women residing in the U.S. or Puerto
Rico (ages 35 to 74 years old; N = 50,884 overall; n = 42,558 non-Hispanic White) identified
between 2003-2009160. All participants had a sister who had been diagnosed with breast cancer
but had not been diagnosed with breast cancer themselves at baseline. Participants completed a
telephone interview, as well as anthropometric measurements and blood sample collection at
baseline and continue to complete annual health updates and detailed follow-up visits every 2-3
years.
The Sister Study serves as a unique resource available to address the paucity of research
examining epigenetic pathways by which childhood adversity and socioeconomic disadvantage
influence incident breast cancer risk. The cohort design and the intentional enrichment of the
cohort allows one to more easily explore breast cancer incidence among this population. The
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robust collection of traumatic events independent of SEP data over the life course allows one to
evaluate the effects of adversity and SEP during potential sensitive periods, such as childhood.
1.10 Social patterning of trauma
Socioeconomic position (SEP) and the experience of trauma over the life course are
highly correlated; as such, early life trauma may impact health through adult SEP, which can
serve as an intermediate confounder. The experience of early life trauma is socially patterned
with higher rates of reported early life trauma and child maltreatment associated with low
childhood SEP161, 162, including receipt of public assistance163, poverty164, homelessness165, and
neighborhood disadvantage166. On an ecological level, counties in the U.S. with higher income
inequality were also reported as having higher county rates of child maltreatment167. Although
rates of child maltreatment are higher among children of racial and ethnic minorities, these
differences disappear after controlling for individual, family, or environmental factors168-170.
Early life SEP has also been associated with chronic disease171 and poor health outcomes172-174,
and therefore serves as an important confounder in our assessment of the relationship between
early life trauma and adult health. Adult SEP may exacerbate or buffer the effects of early life
trauma on chronic illness. Mock and Arai reported that cumulative disadvantage following early
life trauma was associated with greater risk of chronic illness175. Furthermore, Turner et al. found
that the relationships between childhood adversity and adult health were mostly mediated by
adult SEP and stress, except for the association between childhood adversity and allostatic load,
which was not attenuated based on adult SEP and adult stress exposures158.
Psychosocial theory of disease distribution posits that socially patterned stressors (e.g.,
environmental or neighborhood factors, social structures—such as race and gender, and SEP) can
become internalized and embodied to negatively affect health, contributing to pathophysiological
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and behavioral coping mechanisms in the form of altered neuroendocrine functioning and/or
promoting the development of negative health behaviors176. The distribution of social and
structural stressors are socially and economically patterned; persons with low SEP are not only
more likely to experience social stressors and adverse events, but may also be more vulnerable to
social stress and adversity over the life course due to restricted access to physical resources that
would normally aid in developing healthy coping methods177, 178.
1.11 Public Health Significance
Approximately half of women in the U.S. report experiencing at least one early life
trauma in their lifetime47, 60, and up to 98% of those women are likely to report at least one
additional early life trauma157. The impacts of early life trauma on adult health are estimated to
cost between $448 billion to over $1 trillion in North America annually (approximately 2.134.90% of the gross domestic product), mostly attributable to costs related to long term mental
illness and chronic disease179. Early life trauma has the potential to affect adult health through
the process of biological embedding during which the experience of traumatic events can get
“under the skin” to disrupt normal physiologic processes and contribute to poor health1, 2. Adult
health outcomes, such as breast cancer, or adult measures of biological embedding, such as DNA
methylation of HPA axis genes (e.g., NR3C1) and leukocyte telomere length, can be used to
assess potential pathways through which early life trauma can affect health. The research linking
early life trauma and these outcomes have been mixed23, 36, 37, 40, 47, 50-59. The heterogeneity of
these results may stem in part from the lack of consistency regarding how early life trauma is
measured and assessed in adulthood. Previous studies have failed to evaluate the impact of
potential clusters of co-occurring early life traumatic experiences, instead assessing summative
scores, individual trauma domains, or specific traumatic events. Furthermore, they often fail to
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incorporate a life course perspective in their analyses and address the ways in which adult
stress/trauma, adult SEP, and adult health and lifestyle factors may mediate the relationship
between early life trauma and adult measures of biological embedding and health outcomes. As
such, it is unclear whether early life trauma independently affects adult health or if its impact lies
solely through mediating pathways.
This dissertation proposes three aims to assess the relationship between early life trauma
and adult health. The first aim of this dissertation investigates the association between early life
trauma and incident breast cancer, using both traditional and latent variable measures of early
life trauma. The second aim of this dissertation uses a life course approach to examine the
association between early life trauma measures identified in Aim 1 and patterns of DNA
methylation of the HPA axis gene, nuclear receptor subfamily 3, group C, member 1 (NR3C1)
and to assess whether adult trauma mediates the relationship between early life trauma and
NR3C1 methylation. The third aim of this dissertation also uses a life course approach assess the
relationship between early life trauma, using measures identified in Aim 1, and leukocyte
telomere length, a biomarker of cellular aging. The results from this research will benefit public
health by clarifying how various patterns of early life trauma may affect different measures of
adult health and stress embodiment and how subsequent trauma may impact those outcomes. If
certain clusters of early life traumatic experiences exacerbate risk for incident breast cancer or
mechanisms of biological embedding of stress, then targeted programs and policies that may be
more feasible than wide-sweeping policies can be implemented to reduce adult morbidity.
Furthermore, identification of direct or mediating pathways between early life trauma and adult
outcomes can support timing of interventions to best mitigate the effects of early life trauma over
the life course. For example, if early life trauma primarily affects adult health via direct
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pathways, then prevention strategies implemented to address youths will be necessary to fully
negate the effects of early life trauma. Conversely, if the effect of early life trauma is largely
mediated through adult stress/trauma, SEP, or health and lifestyle factors, then interventions in
adulthood that target these factors may be most important in limiting the effect of early life
trauma on adult health. Thus, this work has important implications for how early life trauma
should be studied and addressed in order to limit the burden of early life trauma on adult health.
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1.12 Figures
Figure 1.1 Life course model of early life trauma on adult measures of biological embedding and
health outcomes. Dashed line represents direct effects of early life trauma on adult measures of
biological embedding or health outcomes independent of mediating pathways.

Figure 1.2 Nuclear receptor subfamily 3, group C, member 1 (NR3C1) gene structure. The
NR3C1 gene is located on chromosome 5 and spans approximately one half mega base pairs. It
is composed of eight coding exons (numbered 2-9) and nine alternative first exons (A-J,
excluding G). A 3kbp CpG island located in the proximal promotor spans exons 1B-1H (green
bar).

21

1.13 References
1.

McFarlane AC. The long-term costs of traumatic stress: intertwined physical and
psychological consequences. World Psychiatry. 2010;9(1):3-10. Epub 2010/02/12. doi:
10.1002/j.2051-5545.2010.tb00254.x. PubMed PMID: 20148146; PMCID:
PMC2816923.

2.

Thoits PA. Stress and health: major findings and policy implications. J Health Soc Behav.
2010;51 Suppl:S41-53. Epub 2010/12/22. doi: 10.1177/0022146510383499. PubMed
PMID: 20943582.

3.

Campbell JA, Walker RJ, Egede LE. Associations Between Adverse Childhood
Experiences, High-Risk Behaviors, and Morbidity in Adulthood. Am J Prev Med.
2016;50(3):344-52. Epub 2015/10/18. doi: 10.1016/j.amepre.2015.07.022. PubMed
PMID: 26474668; PMCID: PMC4762720.

4.

Loudermilk E, Loudermilk K, Obenauer J, Quinn MA. Impact of adverse childhood
experiences (ACEs) on adult alcohol consumption behaviors. Child Abuse Negl.
2018;86:368-74. Epub 2018/09/23. doi: 10.1016/j.chiabu.2018.08.006. PubMed PMID:
30241703.

5.

Rehkopf DH, Headen I, Hubbard A, Deardorff J, Kesavan Y, Cohen AK, Patil D, Ritchie
LD, Abrams B. Adverse childhood experiences and later life adult obesity and smoking
in the United States. Annals of epidemiology. 2016;26(7):488-92.e5. Epub 2016/07/28.
doi: 10.1016/j.annepidem.2016.06.003. PubMed PMID: 27449570; PMCID:
PMC4966898.

6.

Windle M, Haardorfer R, Getachew B, Shah J, Payne J, Pillai D, Berg CJ. A multivariate
analysis of adverse childhood experiences and health behaviors and outcomes among
college students. J Am Coll Health. 2018;66(4):246-51. Epub 2018/02/07. doi:
10.1080/07448481.2018.1431892. PubMed PMID: 29405856; PMCID: PMC5948167.

7.

Merrick MT, Ports KA, Ford DC, Afifi TO, Gershoff ET, Grogan-Kaylor A. Unpacking
the impact of adverse childhood experiences on adult mental health. Child Abuse Negl.
2017;69:10-9. Epub 2017/04/19. doi: 10.1016/j.chiabu.2017.03.016. PubMed PMID:
28419887; PMCID: PMC6007802.

8.

Sachs-Ericsson NJ, Sheffler JL, Stanley IH, Piazza JR, Preacher KJ. When Emotional
Pain Becomes Physical: Adverse Childhood Experiences, Pain, and the Role of Mood
and Anxiety Disorders. J Clin Psychol. 2017;73(10):1403-28. Epub 2017/03/23. doi:
10.1002/jclp.22444. PubMed PMID: 28328011; PMCID: PMC6098699.

9.

Stern KR, Thayer ZM. Adversity in childhood and young adulthood predicts young adult
depression. Int J Public Health. 2019;64(7):1069-74. Epub 2019/06/30. doi:
10.1007/s00038-019-01273-6. PubMed PMID: 31253994.

10.

Thompson MP, Kingree JB, Lamis D. Associations of adverse childhood experiences and
suicidal behaviors in adulthood in a U.S. nationally representative sample. Child Care
22

Health Dev. 2019;45(1):121-8. Epub 2018/09/04. doi: 10.1111/cch.12617. PubMed
PMID: 30175459.
11.

Gilbert LK, Breiding MJ, Merrick MT, Thompson WW, Ford DC, Dhingra SS, Parks SE.
Childhood adversity and adult chronic disease: an update from ten states and the District
of Columbia, 2010. Am J Prev Med. 2015;48(3):345-9. doi:
10.1016/j.amepre.2014.09.006. PubMed PMID: 25300735.

12.

Cubbin C, Kim Y, Panisch LS. Familial Childhood Adversity is Associated with Chronic
Disease Among Women: Data from the Geographic Research on Wellbeing (GROW)
Study. Matern Child Health J. 2019;23(8):1117-29. Epub 2019/06/17. doi:
10.1007/s10995-019-02758-9. PubMed PMID: 31203522.

13.

Dube SR, Fairweather D, Pearson WS, Felitti VJ, Anda RF, Croft JB. Cumulative
childhood stress and autoimmune diseases in adults. Psychosom Med. 2009;71(2):24350. Epub 2009/02/04. doi: 10.1097/PSY.0b013e3181907888. PubMed PMID: 19188532;
PMCID: PMC3318917.

14.

Holman DM, Ports KA, Buchanan ND, Hawkins NA, Merrick MT, Metzler M, Trivers
KF. The Association Between Adverse Childhood Experiences and Risk of Cancer in
Adulthood: A Systematic Review of the Literature. Pediatrics. 2016;138(Suppl 1):S81S91. Epub 2016/12/13. doi: 10.1542/peds.2015-4268L. PubMed PMID: 27940981;
PMCID: PMC5892430.

15.

Brown MJ, Thacker LR, Cohen SA. Association between adverse childhood experiences
and diagnosis of cancer. PLoS One. 2013;8(6):e65524. doi:
10.1371/journal.pone.0065524. PubMed PMID: 23776494; PMCID: PMC3679131.

16.

Chen CC, David AS, Nunnerley H, Michell M, Dawson JL, Berry H, Dobbs J, Fahy T.
Adverse life events and breast cancer: case-control study. BMJ. 1995;311(7019):1527-30.
Epub 1995/12/09. doi: 10.1136/bmj.311.7019.1527. PubMed PMID: 8520393; PMCID:
PMC2548223.

17.

Hughes K, Bellis MA, Hardcastle KA, Sethi D, Butchart A, Mikton C, Jones L, Dunne
MP. The effect of multiple adverse childhood experiences on health: a systematic review
and meta-analysis. Lancet Public Health. 2017;2(8):e356-e66. Epub 2017/12/19. doi:
10.1016/s2468-2667(17)30118-4. PubMed PMID: 29253477.

18.

Thompson R, Flaherty EG, English DJ, Litrownik AJ, Dubowitz H, Kotch JB, Runyan
DK. Trajectories of Adverse Childhood Experiences and Self-Reported Health at Age 18.
Acad Pediatr. 2015;15(5):503-9. Epub 2014/12/03. doi: 10.1016/j.acap.2014.09.010.
PubMed PMID: 25441654; PMCID: PMC4409920.

19.

Ben-Shlomo Y, Kuh D. A Life Course Approach to Chronic Disease Epidemiology:
Conceptual Models, Empirical Challenges and Interdisciplinary Perspectives.
International journal of epidemiology. 2002;31(2). PubMed PMID: 11980781.

23

20.

Pollitt RA, Rose KM, Kaufman JS. Evaluating the evidence for models of life course
socioeconomic factors and cardiovascular outcomes: a systematic review. BMC public
health. 2005;5:7. Epub 2005/01/22. doi: 10.1186/1471-2458-5-7. PubMed PMID:
15661071; PMCID: PMC548689.

21.

Fischer A, Ziogas A, Anton-Culver H. Negative Valence Life Events Promote Breast
Cancer Development. Clin Breast Cancer. 2017. doi: 10.1016/j.clbc.2017.10.017.
PubMed PMID: 29170032.

22.

Kricker A, Price M, Butow P, Goumas C, Armes JE, Armstrong BK. Effects of life event
stress and social support on the odds of a >or= 2 cm breast cancer. Cancer causes &
control : CCC. 2009;20(4):437-47. doi: 10.1007/s10552-008-9257-z. PubMed PMID:
18998218.

23.

Michael YL, Carlson NE, Chlebowski RT, Aickin M, Weihs KL, Ockene JK, Bowen DJ,
Ritenbaugh C. Influence of stressors on breast cancer incidence in the Women's Health
Initiative. Health Psychol. 2009;28(2):137-46. doi: 10.1037/a0012982. PubMed PMID:
19290705; PMCID: PMC2657917.

24.

U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011
Incidence and Mortality Web-based Report. Atlanta, GA: U.S. Department of Health and
Human Services, Centers for Disease Control and Prevention and National Cancer
Institute, 2014.

25.

Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, Mariotto A, Lake AJ,
Wilson R, Sherman RL, Anderson RN, Henley SJ, Kohler BA, Penberthy L, Feuer EJ,
Weir HK. Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring
Survival. Journal of the National Cancer Institute. 2017;109(9). doi: 10.1093/jnci/djx030.
PubMed PMID: 28376154; PMCID: PMC5409140.

26.

American Cancer Society. Breast Cancer Facts & Figures 2015-2016. Atlanta: American
Cancer Society, Inc., 2015.

27.

Terry MB, Michels KB, Brody JG, Byrne C, Chen S, Jerry DJ, Malecki KMC, Martin
MB, Miller RL, Neuhausen SL, Silk K, Trentham-Dietz A, McDonald J, Oskar S, Knight
J, Toro-Campos R, Cai X, Rising CJ, Afanaseva D, Mullis MD, Berry MP, Bird J,
Bradfield C, Gangnon R, Gould M, Hampton J, Lindberg S, Luongo S, Malecki K,
Rolland B, Shull J, Gaudet M, Thornquist M, Aupperlee MD, Haslam SZ, Hoshyar R,
Kariagina A, Lopes JR, Miller KJ, Morozova O, Newkirk CJ, Schwartz RC, Thomas B,
Totzkay D, Xie F, Silk KJ, Biro FM, Fassler CS, Giannini CM, Pinney S, Troester MA,
Burke K, Herbstman J, Kehm R, Lilge L, Miller R, Perera F, Sahay D, Tehranifar P,
Terry MB, Walker D, Zeinomar N, de Hoz M, Shepard P, Binder A, Michels K,
Bessonneau V, Brody J, De La Rosa V, Ohayon J, Rudel R, Corvalan C, Pereira A,
Pereira J, Russo J, Yanrong S, Shepherd J, Adams-Campbell L, Dash C, Haddad B,
Hamilton R, Martin MB, Richardson B, Byrne C, Denic-Roberts H, Chang G, Chen S,
Ding YC, Kanaya N, Neuhausen S, Rakoff M, Saeki K, Serrano M, Reynolds P, Dunphy
K, Jerry J, Symington A, Vandenberg L, Schneider S, Adams SA, Brandt HM, Friedman
24

D, Lead JR, Kreps G, Wright K, Burke-Garcia A, Fisher C, on behalf of Breast C, the
Environment Research P. Environmental exposures during windows of susceptibility for
breast cancer: a framework for prevention research. Breast Cancer Research.
2019;21(1):96. doi: 10.1186/s13058-019-1168-2.
28.

Epel ES, Prather AA. Stress, Telomeres, and Psychopathology: Toward a Deeper
Understanding of a Triad of Early Aging. Annu Rev Clin Psychol. 2018;14:371-97. Epub
2018/03/02. doi: 10.1146/annurev-clinpsy-032816-045054. PubMed PMID: 29494257;
PMCID: PMC7039047.

29.

Argentieri MA, Nagarajan S, Seddighzadeh B, Baccarelli AA, Shields AE. Epigenetic
Pathways in Human Disease: The Impact of DNA Methylation on Stress-Related
Pathogenesis and Current Challenges in Biomarker Development. EBioMedicine.
2017;18:327-50. doi: 10.1016/j.ebiom.2017.03.044. PubMed PMID: 28434943; PMCID:
PMC5405197.

30.

Whitelaw N, Whitelaw E. How Lifetimes Shape Epigenotype Within and Across
Generations. Human molecular genetics. 2006;15 Spec No 2. doi: 10.1093/hmg/ddl200.
PubMed PMID: 16987876.

31.

Moore LD, Le T, Fan G. DNA methylation and its basic function.
Neuropsychopharmacology. 2013;38(1):23-38. Epub 2012/07/12. doi:
10.1038/npp.2012.112. PubMed PMID: 22781841; PMCID: PMC3521964.

32.

Sanders JL, Newman AB. Telomere length in epidemiology: a biomarker of aging, agerelated disease, both, or neither? Epidemiol Rev. 2013;35:112-31. Epub 2013/01/11. doi:
10.1093/epirev/mxs008. PubMed PMID: 23302541; PMCID: PMC4707879.

33.

Armanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet. 2012;13(10):693704. doi: 10.1038/nrg3246. PubMed PMID: 22965356; PMCID: 3548426.

34.

Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, Cawthon RM.
Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A.
2004;101(49):17312-5. Epub 2004/12/03. doi: 10.1073/pnas.0407162101. PubMed
PMID: 15574496; PMCID: PMC534658.

35.

Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, Koss MP,
Marks JS. Relationship of childhood abuse and household dysfunction to many of the
leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am
J Prev Med. 1998;14(4):245-58. Epub 1998/06/23. doi: 10.1016/s0749-3797(98)00017-8.
PubMed PMID: 9635069.

36.

Lillberg K, Verkasalo PK, Kaprio J, Teppo L, Helenius H, Koskenvuo M. Stressful life
events and risk of breast cancer in 10,808 women: a cohort study. American journal of
epidemiology. 2003;157(5):415-23. Epub 2003/03/05. doi: 10.1093/aje/kwg002. PubMed
PMID: 12615606.

25

37.

Surtees PG, Wainwright NW, Luben RN, Khaw KT, Bingham SA. No evidence that
social stress is associated with breast cancer incidence. Breast cancer research and
treatment. 2010;120(1):169-74. Epub 2009/07/03. doi: 10.1007/s10549-009-0454-6.
PubMed PMID: 19572196.

38.

Perroud N, Paoloni-Giacobino A, Prada P, Olie E, Salzmann A, Nicastro R, Guillaume S,
Mouthon D, Stouder C, Dieben K, Huguelet P, Courtet P, Malafosse A. Increased
methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of
childhood maltreatment: a link with the severity and type of trauma. Transl Psychiatry.
2011;1:e59. doi: 10.1038/tp.2011.60. PubMed PMID: 22832351; PMCID: PMC3309499.

39.

Bustamante AC, Aiello AE, Galea S, Ratanatharathorn A, Noronha C, Wildman DE,
Uddin M. Glucocorticoid receptor DNA methylation, childhood maltreatment and major
depression. J Affect Disord. 2016;206:181-8. doi: 10.1016/j.jad.2016.07.038. PubMed
PMID: 27475889; PMCID: PMC5077661.

40.

Willis M, Reid SN, Calvo E, Staudinger UM, Factor-Litvak P. A scoping systematic
review of social stressors and various measures of telomere length across the life course.
Ageing Res Rev. 2018;47:89-104. Epub 2018/07/27. doi: 10.1016/j.arr.2018.07.006.
PubMed PMID: 30048807; PMCID: PMC6195444.

41.

Kennedy B, Valdimarsdottir U, Sundstrom K, Sparen P, Lambe M, Fall K, Fang F. Loss
of a parent and the risk of cancer in early life: a nationwide cohort study. Cancer causes
& control : CCC. 2014;25(4):499-506. Epub 2014/02/07. doi: 10.1007/s10552-014-0352z. PubMed PMID: 24500176.

42.

Tyrka A, Parade S, Welch E, Ridout K, Price L, Marsit C, Philip N, Carpenter L.
Methylation of the Leukocyte Glucocorticoid Receptor Gene Promoter in Adults:
Associations With Early Adversity and Depressive, Anxiety and Substance-Use
Disorders. Translational psychiatry. 2016;6(7). doi: 10.1038/tp.2016.112. PubMed
PMID: 27378548.

43.

Vangeel E, Kempke S, Bakusic J, Godderis L, Luyten P, Van Heddegem L, Compernolle
V, Persoons P, Lambrechts D, Izzi B, Freson K, Claes S. Glucocorticoid Receptor DNA
Methylation and Childhood Trauma in Chronic Fatigue Syndrome Patients. Journal of
psychosomatic research. 2018;104. doi: 10.1016/j.jpsychores.2017.11.011. PubMed
PMID: 29275786.

44.

Rotar O, Moguchaia E, Boyarinova M, Kolesova E, Khromova N, Freylikhman O,
Smolina N, Solntsev V, Kostareva A, Konradi A, Shlyakhto E. Seventy years after the
siege of Leningrad: does early life famine still affect cardiovascular risk and aging? J
Hypertens. 2015;33(9):1772-9; discussion 9. Epub 2015/07/03. doi:
10.1097/hjh.0000000000000640. PubMed PMID: 26136204.

45.

Savolainen K, Eriksson JG, Kananen L, Kajantie E, Pesonen AK, Heinonen K,
Raikkonen K. Associations between early life stress, self-reported traumatic experiences
across the lifespan and leukocyte telomere length in elderly adults. Biol Psychol.
26

2014;97:35-42. Epub 2014/02/18. doi: 10.1016/j.biopsycho.2014.02.002. PubMed PMID:
24530884.
46.

Modesitt SC, Gambrell AC, Cottrill HM, Hays LR, Walker R, Shelton BJ, Jordan CE,
Ferguson JE, 2nd. Adverse impact of a history of violence for women with breast,
cervical, endometrial, or ovarian cancer. Obstet Gynecol. 2006;107(6):1330-6. Epub
2006/06/02. doi: 10.1097/01.aog.0000217694.18062.91. PubMed PMID: 16738160.

47.

Wise LA, Palmer JR, Boggs DA, Adams-Campbell LL, Rosenberg L. Abuse
victimization and risk of breast cancer in the Black Women's Health Study [corrected].
Cancer causes & control : CCC. 2011;22(4):659-69. doi: 10.1007/s10552-011-9738-3.
PubMed PMID: 21327459; PMCID: PMC3153377.

48.

Jodczyk S, Fergusson DM, Horwood LJ, Pearson JF, Kennedy MA. No Association
between Mean Telomere Length and Life Stress Observed in a 30 Year Birth Cohort.
PLoS One. 2014;9(5). doi: 10.1371/journal.pone.0097102. PubMed PMID: 24816913.

49.

Mason SM, Prescott J, Tworoger SS, De Vivo I, Rich-Edwards JW. Childhood Physical
and Sexual Abuse History and Leukocyte Telomere Length among Women in Middle
Adulthood. PLoS One. 2015;10(6):e0124493. Epub 2015/06/09. doi:
10.1371/journal.pone.0124493. PubMed PMID: 26053088; PMCID: PMC4459951.

50.

Eskelinen M, Ollonen P. Life stress due to losses and deficit in childhood and
adolescence as breast cancer risk factor: a prospective case-control study in Kuopio,
Finland. Anticancer Res. 2010;30(10):4303-8. Epub 2010/11/03. PubMed PMID:
21036756.

51.

Nielsen NR, Zhang ZF, Kristensen TS, Netterstrom B, Schnohr P, Gronbaek M. Self
reported stress and risk of breast cancer: prospective cohort study. Bmj.
2005;331(7516):548. Epub 2005/08/17. doi: 10.1136/bmj.38547.638183.06. PubMed
PMID: 16103031; PMCID: PMC1200588.

52.

McFarland MJ, Taylor J, Hill TD, Friedman KL. Stressful life events in early life and
leukocyte telomere length in adulthood. Advances in Life Course Research. 2018;35:3745. doi: https://doi.org/10.1016/j.alcr.2017.12.002.

53.

Verhoeven JE, van Oppen P, Puterman E, Elzinga B, Penninx BW. The Association of
Early and Recent Psychosocial Life Stress With Leukocyte Telomere Length. Psychosom
Med. 2015;77(8):882-91. Epub 2015/09/17. doi: 10.1097/PSY.0000000000000226.
PubMed PMID: 26374947.

54.

Edmonds GW, Hampson SE, Cote HC, Hill PL, Klest B. Childhood Personality, Betrayal
Trauma, and Leukocyte Telomere Length in Adulthood: A Lifespan Perspective on
Conscientiousness and Betrayal Traumas as Predictors of a Biomarker of Cellular Aging.
Eur J Pers. 2016;30(5):426-37. Epub 2016/12/27. doi: 10.1002/per.2051. PubMed PMID:
28018048; PMCID: PMC5172594.

27

55.

Li Z, He Y, Wang D, Tang J, Chen X. Association between childhood trauma and
accelerated telomere erosion in adulthood: A meta-analytic study. J Psychiatr Res.
2017;93:64-71. Epub 2017/06/12. doi: 10.1016/j.jpsychires.2017.06.002. PubMed PMID:
28601667.

56.

Mitchell C, McLanahan S, Schneper L, Garfinkel I, Brooks-Gunn J, Notterman D. Father
Loss and Child Telomere Length. Pediatrics. 2017;140(2). Epub 2017/07/19. doi:
10.1542/peds.2016-3245. PubMed PMID: 28716823; PMCID: PMC5527665 conflicts of
interest to disclose.

57.

Puterman E, Gemmill A, Karasek D, Weir D, Adler NE, Prather AA, Epel ES. Lifespan
adversity and later adulthood telomere length in the nationally representative US Health
and Retirement Study. Proc Natl Acad Sci U S A. 2016;113(42):E6335-E42. Epub
2016/10/30. doi: 10.1073/pnas.1525602113. PubMed PMID: 27698131; PMCID:
PMC5081642.

58.

Shalev I, Moffitt TE, Sugden K, Williams B, Houts RM, Danese A, Mill J, Arseneault L,
Caspi A. Exposure to violence during childhood is associated with telomere erosion from
5 to 10 years of age: a longitudinal study. Mol Psychiatry. 2013;18(5):576-81. Epub
2012/04/25. doi: 10.1038/mp.2012.32. PubMed PMID: 22525489; PMCID:
PMC3616159.

59.

Palma-Gudiel H, Cordova-Palomera A, Leza JC, Fananas L. Glucocorticoid receptor
gene (NR3C1) methylation processes as mediators of early adversity in stress-related
disorders causality: A critical review. Neurosci Biobehav Rev. 2015;55:520-35. doi:
10.1016/j.neubiorev.2015.05.016. PubMed PMID: 26073068.

60.

Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder
in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52(12):1048-60. Epub
1995/12/01. doi: 10.1001/archpsyc.1995.03950240066012. PubMed PMID: 7492257.

61.

Berens AE, Jensen SK, Nelson CA. Biological embedding of childhood adversity: from
physiological mechanisms to clinical implications. BMC medicine. 2017;15(1):135.

62.

Hertzman C. Putting the concept of biological embedding in historical perspective.
Proceedings of the National Academy of Sciences. 2012;109(Supplement 2):17160-7.

63.

Krieger N. Theories for social epidemiology in the 21st century: an ecosocial perspective.
Int J Epidemiol. 2001;30(4):668-77. PubMed PMID: 11511581.

64.

Colen CG. Addressing racial disparities in health using life course perspectives: Toward
a Constructive Criticism. Du Bois Review: Social Science Research on Race.
2011;8(1):79-94. Epub 04/15. doi: 10.1017/S1742058X11000075.

65.

Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen
receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative
invasive breast cancer, the so-called triple-negative phenotype: a population-based study

28

from the California cancer Registry. Cancer. 2007;109(9):1721-8. doi:
10.1002/cncr.22618. PubMed PMID: 17387718.
66.

Parise CA, Bauer KR, Brown MM, Caggiano V. Breast cancer subtypes as defined by the
estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth
factor receptor 2 (HER2) among women with invasive breast cancer in California, 19992004. The breast journal. 2009;15(6):593-602. doi: 10.1111/j.1524-4741.2009.00822.x.
PubMed PMID: 19764994.

67.

Hortobagyi GN, Connolly JL, D'Orsi CJ, Edge SB, Mittendorf EA, Rugo HS, Solin LJ,
Weaver DL, Winchester DJ, Guilano A. Breast. AJCC Cancer Staging Manual. 8th ed.
Chicago, IL: American College of Surgeons (ACS); 2018.

68.

Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q,
Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, Nordestgaard BG,
Nielsen SF, Flyger H, Czene K, Darabi H, Eriksson M, Peto J, Dos-Santos-Silva I,
Dudbridge F, Johnson N, Schmidt MK, Broeks A, Verhoef S, Rutgers EJ, Swerdlow A,
Ashworth A, Orr N, Schoemaker MJ, Figueroa J, Chanock SJ, Brinton L, Lissowska J,
Couch FJ, Olson JE, Vachon C, Pankratz VS, Lambrechts D, Wildiers H, Van Ongeval
C, van Limbergen E, Kristensen V, Grenaker Alnaes G, Nord S, Borresen-Dale AL,
Nevanlinna H, Muranen TA, Aittomaki K, Blomqvist C, Chang-Claude J, Rudolph A,
Seibold P, Flesch-Janys D, Fasching PA, Haeberle L, Ekici AB, Beckmann MW,
Burwinkel B, Marme F, Schneeweiss A, Sohn C, Trentham-Dietz A, Newcomb P, Titus
L, Egan KM, Hunter DJ, Lindstrom S, Tamimi RM, Kraft P, Rahman N, Turnbull C,
Renwick A, Seal S, Li J, Liu J, Humphreys K, Benitez J, Pilar Zamora M, Arias Perez JI,
Menendez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Bogdanova NV,
Antonenkova NN, Dork T, Anton-Culver H, Neuhausen SL, Ziogas A, Bernstein L,
Devilee P, Tollenaar RA, Seynaeve C, van Asperen CJ, Cox A, Cross SS, Reed MW,
Khusnutdinova E, Bermisheva M, Prokofyeva D, Takhirova Z, Meindl A, Schmutzler
RK, Sutter C, Yang R, Schurmann P, Bremer M, Christiansen H, Park-Simon TW,
Hillemanns P, Guenel P, Truong T, Menegaux F, Sanchez M, Radice P, Peterlongo P,
Manoukian S, Pensotti V, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Brauch H,
Bruning T, Ko YD, Sigurdson AJ, Doody MM, Hamann U, Torres D, Ulmer HU, Forsti
A, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Andrulis IL, Knight JA, Glendon G,
Marie Mulligan A, Chenevix-Trench G, Balleine R, Giles GG, Milne RL, McLean C,
Lindblom A, Margolin S, Haiman CA, Henderson BE, Schumacher F, Le Marchand L,
Eilber U, Wang-Gohrke S, Hooning MJ, Hollestelle A, van den Ouweland AM, Koppert
LB, Carpenter J, Clarke C, Scott R, Mannermaa A, Kataja V, Kosma VM, Hartikainen
JM, Brenner H, Arndt V, Stegmaier C, Karina Dieffenbach A, Winqvist R, Pylkas K,
Jukkola-Vuorinen A, Grip M, Offit K, Vijai J, Robson M, Rau-Murthy R, Dwek M,
Swann R, Annie Perkins K, Goldberg MS, Labreche F, Dumont M, Eccles DM, Tapper
WJ, Rafiq S, John EM, Whittemore AS, Slager S, Yannoukakos D, Toland AE, Yao S,
Zheng W, Halverson SL, Gonzalez-Neira A, Pita G, Rosario Alonso M, Alvarez N,
Herrero D, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Ahmed S, Maranian
M, Healey CS, Simard J, Hall P, Easton DF, Garcia-Closas M. Prediction of breast cancer
risk based on profiling with common genetic variants. Journal of the National Cancer

29

Institute. 2015;107(5). doi: 10.1093/jnci/djv036. PubMed PMID: 25855707; PMCID:
PMC4754625.
69.

Krieger N, Williams DR, Moss NE. Measuring social class in US public health research:
concepts, methodologies, and guidelines. Annu Rev Public Health. 1997;18:341-78. doi:
10.1146/annurev.publhealth.18.1.341. PubMed PMID: 9143723.

70.

Chen E, Martin AD, Matthews KA. Understanding health disparities: the role of race and
socioeconomic status in children's health. Am J Public Health. 2006;96(4):702-8. doi:
10.2105/AJPH.2004.048124. PubMed PMID: 16507739; PMCID: PMC1470539.

71.

Robert SA, Strombom I, Trentham-Dietz A, Hampton JM, McElroy JA, Newcomb PA,
Remington PL. Socioeconomic risk factors for breast cancer: distinguishing individualand community-level effects. Epidemiology. 2004;15(4):442-50. PubMed PMID:
15232405.

72.

Samiian L, Sharma P, Van Den Bruele AB, Smotherman C, Vincent M, Crandall M. The
Effect of Insurance and Race on Breast Cancer Tumor Biology and Short-Term
Outcomes. Am Surg. 2018;84(7):1223-8. Epub 2018/08/02. PubMed PMID: 30064593.

73.

Colditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early
life: prevention efforts must shift focus. Cancer epidemiology, biomarkers & prevention :
a publication of the American Association for Cancer Research, cosponsored by the
American Society of Preventive Oncology. 1995;4(5):567-71. PubMed PMID: 7549816.

74.

Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to
carcinogenesis. Breast cancer research and treatment. 1982;2(1):5-73. PubMed PMID:
6216933.

75.

Bodicoat DH, Schoemaker MJ, Jones ME, McFadden E, Griffin J, Ashworth A,
Swerdlow AJ. Timing of pubertal stages and breast cancer risk: the Breakthrough
Generations Study. Breast cancer research : BCR. 2014;16(1):R18. doi: 10.1186/bcr3613.
PubMed PMID: 24495528; PMCID: PMC3978643.

76.

Bertrand KA, Gerlovin H, Bethea TN, Palmer JR. Pubertal growth and adult height in
relation to breast cancer risk in African American women. International journal of cancer
Journal international du cancer. 2017;141(12):2462-70. doi: 10.1002/ijc.31019. PubMed
PMID: 28845597; PMCID: PMC5654671.

77.

Cabrera SM, Bright GM, Frane JW, Blethen SL, Lee PA. Age of thelarche and menarche
in contemporary US females: a cross-sectional analysis. J Pediatr Endocrinol Metab.
2014;27(1-2):47-51. doi: 10.1515/jpem-2013-0286. PubMed PMID: 23959659; PMCID:
PMC4137967.

78.

Guldbrandsen K, Hakonsen LB, Ernst A, Toft G, Lyngso J, Olsen J, Ramlau-Hansen CH.
Age of menarche and time to pregnancy. Hum Reprod. 2014;29(9):2058-64. doi:
10.1093/humrep/deu153. PubMed PMID: 25061027.

30

79.

Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV,
Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS,
Perou CM. Epidemiology of basal-like breast cancer. Breast cancer research and
treatment. 2008;109(1):123-39. doi: 10.1007/s10549-007-9632-6. PubMed PMID:
17578664; PMCID: 2443103.

80.

Palmer JR, Viscidi E, Troester MA, Hong CC, Schedin P, Bethea TN, Bandera EV,
Borges V, McKinnon C, Haiman CA, Lunetta K, Kolonel LN, Rosenberg L, Olshan AF,
Ambrosone CB. Parity, lactation, and breast cancer subtypes in African American
women: results from the AMBER Consortium. Journal of the National Cancer Institute.
2014;106(10). doi: 10.1093/jnci/dju237. PubMed PMID: 25224496; PMCID:
PMC4271113.

81.

Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol
Rev. 1993;15(1):36-47. PubMed PMID: 8405211.

82.

Russo J, Moral R, Balogh GA, Mailo D, Russo IH. The protective role of pregnancy in
breast cancer. Breast cancer research : BCR. 2005;7(3):131-42. doi: 10.1186/bcr1029.
PubMed PMID: 15987443; PMCID: PMC1143568.

83.

Bruzzi P, Negri E, La Vecchia C, Decarli A, Palli D, Parazzini F, Del Turco MR. Short
term increase in risk of breast cancer after full term pregnancy. BMJ.
1988;297(6656):1096-8. PubMed PMID: 3143438; PMCID: PMC1834877.

84.

Hsieh C, Pavia M, Lambe M, Lan SJ, Colditz GA, Ekbom A, Adami HO, Trichopoulos
D, Willett WC. Dual effect of parity on breast cancer risk. Eur J Cancer.
1994;30A(7):969-73. PubMed PMID: 7946593.

85.

Palmer JR, Wise LA, Horton NJ, Adams-Campbell LL, Rosenberg L. Dual effect of
parity on breast cancer risk in African-American women. Journal of the National Cancer
Institute. 2003;95(6):478-83. PubMed PMID: 12644541.

86.

Moffitt TE, Caspi A, Belsky J, Silva PA. Childhood experience and the onset of
menarche: a test of a sociobiological model. Child Dev. 1992;63(1):47-58. PubMed
PMID: 1551329.

87.

Boynton-Jarrett R, Wright RJ, Putnam FW, Lividoti Hibert E, Michels KB, Forman MR,
Rich-Edwards J. Childhood abuse and age at menarche. J Adolesc Health.
2013;52(2):241-7. doi: 10.1016/j.jadohealth.2012.06.006. PubMed PMID: 23332491;
PMCID: PMC3950206.

88.

Clutterbuck S, Adams J, Nettle D. Frequent Residential Relocations Cumulatively
Accelerate Menarcheal Timing in a Sample of English Adolescent Girls. J Biosoc Sci.
2015;47(2):188-202. doi: 10.1017/S0021932014000157. PubMed PMID: 24784148.

89.

Amir D, Jordan MR, Bribiescas RG. A Longitudinal Assessment of Associations between
Adolescent Environment, Adversity Perception, and Economic Status on Fertility and

31

Age of Menarche. PLoS One. 2016;11(6):e0155883. doi: 10.1371/journal.pone.0155883.
PubMed PMID: 27249338; PMCID: PMC4889152.
90.

McEwen BS. Protective and damaging effects of stress mediators. The New England
journal of medicine. 1998;338(3):171-9. Epub 1998/01/15. doi:
10.1056/NEJM199801153380307. PubMed PMID: 9428819.

91.

Moisiadis VG, Matthews SG. Glucocorticoids and fetal programming part 1: Outcomes.
Nat Rev Endocrinol. 2014;10(7):391-402. doi: 10.1038/nrendo.2014.73. PubMed PMID:
24863382.

92.

McEwen BS, Seeman T. Protective and damaging effects of mediators of stress.
Elaborating and testing the concepts of allostasis and allostatic load. Ann N Y Acad Sci.
1999;896:30-47. Epub 2000/02/22. PubMed PMID: 10681886.

93.

van der Goes MC, Jacobs JW, Bijlsma JW. The value of glucocorticoid co-therapy in
different rheumatic diseases--positive and adverse effects. Arthritis Res Ther. 2014;16
Suppl 2:S2. Epub 2015/01/23. doi: 10.1186/ar4686. PubMed PMID: 25608693; PMCID:
PMC4249491.

94.

Lu NZ, Cidlowski JA. Translational regulatory mechanisms generate N-terminal
glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell.
2005;18(3):331-42. Epub 2005/05/04. doi: 10.1016/j.molcel.2005.03.025. PubMed
PMID: 15866175.

95.

Fryer CJ, Archer TK. Chromatin remodelling by the glucocorticoid receptor requires the
BRG1 complex. Nature. 1998;393(6680):88-91. Epub 1998/05/20. doi: 10.1038/30032.
PubMed PMID: 9590696.

96.

Wintermantel TM, Bock D, Fleig V, Greiner EF, Schutz G. The epithelial glucocorticoid
receptor is required for the normal timing of cell proliferation during mammary
lobuloalveolar development but is dispensable for milk production. Mol Endocrinol.
2005;19(2):340-9. Epub 2004/10/09. doi: 10.1210/me.2004-0068. PubMed PMID:
15471946.

97.

Baschant U, Tuckermann J. The role of the glucocorticoid receptor in inflammation and
immunity. J Steroid Biochem Mol Biol. 2010;120(2-3):69-75. Epub 2010/03/30. doi:
10.1016/j.jsbmb.2010.03.058. PubMed PMID: 20346397.

98.

Turner JD, Alt SR, Cao L, Vernocchi S, Trifonova S, Battello N, Muller CP.
Transcriptional control of the glucocorticoid receptor: CpG islands, epigenetics and more.
Biochem Pharmacol. 2010;80(12):1860-8. doi: 10.1016/j.bcp.2010.06.037. PubMed
PMID: 20599772.

99.

Lu NZ, Cidlowski JA. Glucocorticoid receptor isoforms generate transcription
specificity. Trends Cell Biol. 2006;16(6):301-7. Epub 2006/05/16. doi:
10.1016/j.tcb.2006.04.005. PubMed PMID: 16697199.

32

100.

Light AE, Holt-Lunstad J, Porter CL, Light KC. Early life trauma: An exploratory study
of effects on OXTR and NR3C1 gene expression and nurturing self-efficacy in mothers
of infants. Int J Psychophysiol. 2019;136:64-72. Epub 2018/03/28. doi:
10.1016/j.ijpsycho.2018.03.018. PubMed PMID: 29580902.

101.

Labonte B, Yerko V, Gross J, Mechawar N, Meaney MJ, Szyf M, Turecki G. Differential
glucocorticoid receptor exon 1(B), 1(C), and 1(H) expression and methylation in suicide
completers with a history of childhood abuse. Biol Psychiatry. 2012;72(1):41-8. Epub
2012/03/27. doi: 10.1016/j.biopsych.2012.01.034. PubMed PMID: 22444201.

102.

Hiatt RA, Stewart SL, Hoeft KS, Kushi LH, Windham GC, Biro FM, Pinney SM, Wolff
MS, Teitelbaum SL, Braithwaite D. Childhood Socioeconomic Position and Pubertal
Onset in a Cohort of Multiethnic Girls: Implications for Breast Cancer. Cancer
epidemiology, biomarkers & prevention : a publication of the American Association for
Cancer Research, cosponsored by the American Society of Preventive Oncology.
2017;26(12):1714-21. doi: 10.1158/1055-9965.EPI-17-0496. PubMed PMID: 28939588;
PMCID: PMC5712280.

103.

Belsky J, Ruttle PL, Boyce WT, Armstrong JM, Essex MJ. Early adversity, elevated
stress physiology, accelerated sexual maturation, and poor health in females. Dev
Psychol. 2015;51(6):816-22. doi: 10.1037/dev0000017. PubMed PMID: 25915592;
PMCID: PMC4446150.

104.

Bleil ME, Adler NE, Appelhans BM, Gregorich SE, Sternfeld B, Cedars MI. Childhood
adversity and pubertal timing: understanding the origins of adulthood cardiovascular risk.
Biol Psychol. 2013;93(1):213-9. doi: 10.1016/j.biopsycho.2013.02.005. PubMed PMID:
23428374; PMCID: PMC3709571.

105.

Huang JY, Gavin AR, Richardson TS, Rowhani-Rahbar A, Siscovick DS, Hochner H,
Friedlander Y, Enquobahrie DA. Accounting for Life-Course Exposures in Epigenetic
Biomarker Association Studies: Early Life Socioeconomic Position, Candidate Gene
DNA Methylation, and Adult Cardiometabolic Risk. American journal of epidemiology.
2016;184(7):520-31. doi: 10.1093/aje/kww014. PubMed PMID: 27651384; PMCID:
PMC5044807.

106.

Melas PA, Wei Y, Wong CC, Sjoholm LK, Aberg E, Mill J, Schalling M, Forsell Y,
Lavebratt C. Genetic and epigenetic associations of MAOA and NR3C1 with depression
and childhood adversities. Int J Neuropsychopharmacol. 2013;16(7):1513-28. doi:
10.1017/S1461145713000102. PubMed PMID: 23449091.

107.

Needham BL, Smith JA, Zhao W, Wang X, Mukherjee B, Kardia SL, Shively CA,
Seeman TE, Liu Y, Diez Roux AV. Life course socioeconomic status and DNA
methylation in genes related to stress reactivity and inflammation: The multi-ethnic study
of atherosclerosis. Epigenetics. 2015;10(10):958-69. doi:
10.1080/15592294.2015.1085139. PubMed PMID: 26295359; PMCID: PMC4844216.

108.

Tyrka AR, Price LH, Marsit C, Walters OC, Carpenter LL. Childhood adversity and
epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in
33

healthy adults. PLoS One. 2012;7(1):e30148. doi: 10.1371/journal.pone.0030148.
PubMed PMID: 22295073; PMCID: PMC3266256.
109.

Smith JA, Zhao W, Wang X, Ratliff SM, Mukherjee B, Kardia SLR, Liu Y, Diez Roux
AV, Needham BL. Neighborhood characteristics influence DNA methylation of genes
involved in stress response and inflammation: The Multi-Ethnic Study of Atherosclerosis.
Epigenetics. 2017:0. doi: 10.1080/15592294.2017.1341026. PubMed PMID: 28678593.

110.

Matthews LC, Berry AA, Morgan DJ, Poolman TM, Bauer K, Kramer F, Spiller DG,
Richardson RV, Chapman KE, Farrow SN, Norman MR, Williamson AJ, Whetton AD,
Taylor SS, Tuckermann JP, White MR, Ray DW. Glucocorticoid receptor regulates
accurate chromosome segregation and is associated with malignancy. Proc Natl Acad Sci
U S A. 2015;112(17):5479-84. Epub 2015/04/08. doi: 10.1073/pnas.1411356112.
PubMed PMID: 25847991; PMCID: PMC4418855.

111.

Turner JD, Vernocchi S, Schmitz S, Muller CP. Role of the 5'-untranslated regions in
post-transcriptional regulation of the human glucocorticoid receptor. Biochim Biophys
Acta. 2014;1839(11):1051-61. doi: 10.1016/j.bbagrm.2014.08.010. PubMed PMID:
25150144.

112.

Vangeel E, Van Den Eede F, Hompes T, Izzi B, Del Favero J, Moorkens G, Lambrechts
D, Freson K, Claes S. Chronic Fatigue Syndrome and DNA Hypomethylation of the
Glucocorticoid Receptor Gene Promoter 1F Region: Associations With HPA Axis
Hypofunction and Childhood Trauma. Psychosom Med. 2015;77(8):853-62. doi:
10.1097/PSY.0000000000000224. PubMed PMID: 26230484.

113.

Martín-Blanco A, Ferrer M, Soler J, Salazar J, Vega D, Andión O, Sanchez-Mora C,
Arranz M, Ribases M, Feliu-Soler A, Pérez V, Pascual J. Association Between
Methylation of the Glucocorticoid Receptor Gene, Childhood Maltreatment, and Clinical
Severity in Borderline Personality Disorder. Journal of psychiatric research. 2014;57. doi:
10.1016/j.jpsychires.2014.06.011. PubMed PMID: 25048180.

114.

van der Knaap LJ, Riese H, Hudziak JJ, Verbiest MM, Verhulst FC, Oldehinkel AJ, van
Oort FV. Glucocorticoid receptor gene (NR3C1) methylation following stressful events
between birth and adolescence. The TRAILS study. Transl Psychiatry. 2014;4:e381. doi:
10.1038/tp.2014.22. PubMed PMID: 24713862; PMCID: PMC4012286.

115.

Marzi SJ, Sugden K, Arseneault L, Belsky DW, Burrage J, Corcoran DL, Danese A,
Fisher HL, Hannon E, Moffitt TE, Odgers CL, Pariante C, Poulton R, Williams BS,
Wong CC, Mill J, Caspi A. Analysis of DNA Methylation in Young People: Limited
Evidence for an Association Between Victimization Stress and Epigenetic Variation in
Blood. Am J Psychiatry. 2018;175(6):517-29. doi: 10.1176/appi.ajp.2017.17060693.
PubMed PMID: 29325449; PMCID: 5988939.

116.

Vangeel E, Van Den Eede F, Hompes T, Izzi B, Del Favero J, Moorkens G, Lambrechts
D, Freson K, Claes S. Chronic Fatigue Syndrome and DNA Hypomethylation of the
Glucocorticoid Receptor Gene Promoter 1F Region: Associations With HPA Axis
34

Hypofunction and Childhood Trauma. Psychosomatic medicine. 2015;77(8). doi:
10.1097/PSY.0000000000000224. PubMed PMID: 26230484.
117.

Cairney CJ, Keith WN. Telomerase redefined: integrated regulation of hTR and hTERT
for telomere maintenance and telomerase activity. Biochimie. 2008;90(1):13-23. Epub
2007/09/15. doi: 10.1016/j.biochi.2007.07.025. PubMed PMID: 17854971.

118.

Zhao Y, Sfeir AJ, Zou Y, Buseman CM, Chow TT, Shay JW, Wright WE. Telomere
extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer
cells. Cell. 2009;138(3):463-75. Epub 2009/08/12. doi: 10.1016/j.cell.2009.05.026.
PubMed PMID: 19665970; PMCID: PMC2726829.

119.

Richter T, von Zglinicki T. A continuous correlation between oxidative stress and
telomere shortening in fibroblasts. Exp Gerontol. 2007;42(11):1039-42. Epub
2007/09/18. doi: 10.1016/j.exger.2007.08.005. PubMed PMID: 17869047.

120.

von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci.
2002;27(7):339-44. Epub 2002/07/13. doi: 10.1016/s0968-0004(02)02110-2. PubMed
PMID: 12114022.

121.

Daniali L, Benetos A, Susser E, Kark JD, Labat C, Kimura M, Desai K, Granick M, Aviv
A. Telomeres shorten at equivalent rates in somatic tissues of adults. Nat Commun.
2013;4:1597. Epub 2013/03/21. doi: 10.1038/ncomms2602. PubMed PMID: 23511462;
PMCID: PMC3615479.

122.

Muezzinler A, Zaineddin AK, Brenner H. A systematic review of leukocyte telomere
length and age in adults. Ageing Res Rev. 2013;12(2):509-19. Epub 2013/01/22. doi:
10.1016/j.arr.2013.01.003. PubMed PMID: 23333817.

123.

Song S, Johnson FB. Epigenetic Mechanisms Impacting Aging: A Focus on Histone
Levels and Telomeres. Genes (Basel). 2018;9(4). Epub 2018/04/13. doi:
10.3390/genes9040201. PubMed PMID: 29642537; PMCID: PMC5924543.

124.

Kimura M, Gazitt Y, Cao X, Zhao X, Lansdorp PM, Aviv A. Synchrony of telomere
length among hematopoietic cells. Experimental hematology. 2010;38(10):854-9.

125.

Granick M, Kimura M, Kim S, Daniali L, Cao X, Herbig U, Aviv A. Telomere dynamics
in keloids. Eplasty. 2011;11:e15. Epub 2011/03/26. PubMed PMID: 21436892; PMCID:
PMC3060056.

126.

Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O,
Blomqvist L, Hoffstedt J, Naslund E, Britton T, Concha H, Hassan M, Ryden M, Frisen
J, Arner P. Dynamics of fat cell turnover in humans. Nature. 2008;453(7196):783-7.
Epub 2008/05/06. doi: 10.1038/nature06902. PubMed PMID: 18454136.

127.

Spalding KL, Bhardwaj RD, Buchholz BA, Druid H, Frisen J. Retrospective birth dating
of cells in humans. Cell. 2005;122(1):133-43. Epub 2005/07/13. doi:
10.1016/j.cell.2005.04.028. PubMed PMID: 16009139.
35

128.

Daniali L, Benetos A, Susser E, Kark JD, Labat C, Kimura M, Desai KK, Granick M,
Aviv A. Telomeres shorten at equivalent rates in somatic tissues of adults. Nature
Communications. 2013;4(1):1597. doi: 10.1038/ncomms2602.

129.

Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW,
Harley CB. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl
Acad Sci U S A. 1992;89(21):10114-8. PubMed PMID: 1438199; PMCID: 50288.

130.

Kong CM, Lee XW, Wang X. Telomere shortening in human diseases. Febs j.
2013;280(14):3180-93. Epub 2013/05/08. doi: 10.1111/febs.12326. PubMed PMID:
23647631.

131.

Campa D, Barrdahl M, Santoro A, Severi G, Baglietto L, Omichessan H, Tumino R,
Bueno-de-Mesquita HBA, Peeters PH, Weiderpass E, Chirlaque MD, RodriguezBarranco M, Agudo A, Gunter M, Dossus L, Krogh V, Matullo G, Trichopoulou A,
Travis RC, Canzian F, Kaaks R. Mitochondrial DNA copy number variation, leukocyte
telomere length, and breast cancer risk in the European Prospective Investigation into
Cancer and Nutrition (EPIC) study. Breast cancer research : BCR. 2018;20(1):29. Epub
2018/04/19. doi: 10.1186/s13058-018-0955-5. PubMed PMID: 29665866; PMCID:
PMC5905156.

132.

Karimi B, Yunesian M, Nabizadeh R, Mehdipour P, Aghaie A. Is Leukocyte Telomere
Length Related with Lung Cancer Risk?: A Meta-Analysis. Iran Biomed J.
2017;21(3):142-53. Epub 2016/11/23. doi: 10.18869/acadpub.ibj.21.3.142. PubMed
PMID: 27874106; PMCID: PMC5392217.

133.

Xu J, Chang WS, Tsai CW, Bau DT, Xu Y, Davis JW, Thompson TC, Logothetis CJ, Gu
J. Leukocyte telomere length is associated with aggressive prostate cancer in localized
prostate cancer patients. EBioMedicine. 2020;52:102616. Epub 2020/01/26. doi:
10.1016/j.ebiom.2019.102616. PubMed PMID: 31981976; PMCID: PMC6992931.

134.

Yang M, Prescott J, Poole EM, Rice MS, Kubzansky LD, Idahl A, Lundin E, De Vivo I,
Tworoger SS. Prediagnosis Leukocyte Telomere Length and Risk of Ovarian Cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American
Association for Cancer Research, cosponsored by the American Society of Preventive
Oncology. 2017;26(3):339-45. Epub 2017/02/18. doi: 10.1158/1055-9965.EPI-16-0466.
PubMed PMID: 28209595; PMCID: PMC5336400.

135.

Gielen M, Hageman GJ, Antoniou EE, Nordfjall K, Mangino M, Balasubramanyam M,
de Meyer T, Hendricks AE, Giltay EJ, Hunt SC, Nettleton JA, Salpea KD, Diaz VA,
Farzaneh-Far R, Atzmon G, Harris SE, Hou L, Gilley D, Hovatta I, Kark JD, Nassar H,
Kurz DJ, Mather KA, Willeit P, Zheng YL, Pavanello S, Demerath EW, Rode L, Bunout
D, Steptoe A, Boardman L, Marti A, Needham B, Zheng W, Ramsey-Goldman R, Pellatt
AJ, Kaprio J, Hofmann JN, Gieger C, Paolisso G, Hjelmborg JBH, Mirabello L, Seeman
T, Wong J, van der Harst P, Broer L, Kronenberg F, Kollerits B, Strandberg T, Eisenberg
DTA, Duggan C, Verhoeven JE, Schaakxs R, Zannolli R, Dos Reis RMR, Charchar FJ,
Tomaszewski M, Mons U, Demuth I, Iglesias Molli AE, Cheng G, Krasnienkov D,
36

D'Antono B, Kasielski M, McDonnell BJ, Ebstein RP, Sundquist K, Pare G, Chong M,
Zeegers MP, group T. Body mass index is negatively associated with telomere length: a
collaborative cross-sectional meta-analysis of 87 observational studies. Am J Clin Nutr.
2018;108(3):453-75. Epub 2018/12/12. doi: 10.1093/ajcn/nqy107. PubMed PMID:
30535086; PMCID: PMC6454526.
136.

Batsis JA, Mackenzie TA, Vasquez E, Germain CM, Emeny RT, Rippberger P, LopezJimenez F, Bartels SJ. Association of adiposity, telomere length and mortality: data from
the NHANES 1999-2002. Int J Obes (Lond). 2018;42(2):198-204. Epub 2017/08/18. doi:
10.1038/ijo.2017.202. PubMed PMID: 28816228; PMCID: PMC5858938.

137.

D'Mello MJ, Ross SA, Briel M, Anand SS, Gerstein H, Pare G. Association between
shortened leukocyte telomere length and cardiometabolic outcomes: systematic review
and meta-analysis. Circ Cardiovasc Genet. 2015;8(1):82-90. Epub 2014/11/20. doi:
10.1161/circgenetics.113.000485. PubMed PMID: 25406241.

138.

Wang J, Dong X, Cao L, Sun Y, Qiu Y, Zhang Y, Cao R, Covasa M, Zhong L.
Association between telomere length and diabetes mellitus: A meta-analysis. J Int Med
Res. 2016;44(6):1156-73. Epub 2016/01/01. doi: 10.1177/0300060516667132. PubMed
PMID: 28322101; PMCID: PMC5536737.

139.

Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P.
Leucocyte telomere length and risk of cardiovascular disease: systematic review and
meta-analysis. Bmj. 2014;349:g4227. Epub 2014/07/10. doi: 10.1136/bmj.g4227.
PubMed PMID: 25006006; PMCID: PMC4086028.

140.

Rode L, Nordestgaard BG, Bojesen SE. Peripheral blood leukocyte telomere length and
mortality among 64,637 individuals from the general population. Journal of the National
Cancer Institute. 2015;107(6):djv074. Epub 2015/04/12. doi: 10.1093/jnci/djv074.
PubMed PMID: 25862531.

141.

Tyrka AR, Price LH, Kao HT, Porton B, Marsella SA, Carpenter LL. Childhood
maltreatment and telomere shortening: preliminary support for an effect of early stress on
cellular aging. Biol Psychiatry. 2010;67(6):531-4. Epub 2009/10/16. doi:
10.1016/j.biopsych.2009.08.014. PubMed PMID: 19828140; PMCID: PMC2853238.

142.

Ridout KK, Levandowski M, Ridout SJ, Gantz L, Goonan K, Palermo D, Price LH,
Tyrka AR. Early life adversity and telomere length: a meta-analysis. Mol Psychiatry.
2018;23(4):858-71. Epub 2017/03/23. doi: 10.1038/mp.2017.26. PubMed PMID:
28322278; PMCID: PMC5608639.

143.

Vincent J, Hovatta I, Frissa S, Goodwin L, Hotopf M, Hatch SL, Breen G, Powell TR.
Assessing the contributions of childhood maltreatment subtypes and depression casecontrol status on telomere length reveals a specific role of physical neglect. J Affect
Disord. 2017;213:16-22. Epub 2017/02/12. doi: 10.1016/j.jad.2017.01.031. PubMed
PMID: 28187293; PMCID: PMC6191534.

37

144.

Mayer SE, Prather AA, Puterman E, Lin J, Arenander J, Coccia M, Shields GS, Slavich
GM, Epel ES. Cumulative lifetime stress exposure and leukocyte telomere length
attrition: The unique role of stressor duration and exposure timing.
Psychoneuroendocrinology. 2019;104:210-8. Epub 2019/03/19. doi:
10.1016/j.psyneuen.2019.03.002. PubMed PMID: 30884304; PMCID: PMC6518420.

145.

Willis M, Staudinger UM, Factor-Litvak P, Calvo E. Stress and salivary telomere length
in the second half of life: A comparison of life-course models. Advances in Life Course
Research. 2019;39:34-41. doi: https://doi.org/10.1016/j.alcr.2019.02.001.

146.

Parks C, Miller D, McCanlies E, Cawthon R, Andrew M, DeRoo L, Sandler D. Telomere
Length, Current Perceived Stress, and Urinary Stress Hormones in Women. Cancer
epidemiology, biomarkers & prevention : a publication of the American Association for
Cancer Research, cosponsored by the American Society of Preventive Oncology.
2009;18(2). doi: 10.1158/1055-9965.EPI-08-0614. PubMed PMID: 19190150.

147.

Tosevski DL, Milovancevic MP. Stressful life events and physical health. Curr Opin
Psychiatry. 2006;19(2):184-9. Epub 2006/04/14. doi:
10.1097/01.yco.0000214346.44625.57. PubMed PMID: 16612201.

148.

McLaughlin KA. Future Directions in Childhood Adversity and Youth Psychopathology.
J Clin Child Adolesc Psychol. 2016;45(3):361-82. Epub 2016/02/06. doi:
10.1080/15374416.2015.1110823. PubMed PMID: 26849071; PMCID: PMC4837019.

149.

Butchart A, Harvey AP, Mian M, Fürniss T, Kahane T. Preventing Child Maltreatment: a
Guide to Taking Action and Generating. France: World Health Organization and
International Society for Prevention of Child Abuse and Neglect, 2006.

150.

Krupnik V. Trauma or adversity? Traumatology. 2019;25(4):256-61. doi:
10.1037/trm0000169. PubMed PMID: 2018-37142-001.

151.

Turner RJ, Lloyd DA. Lifetime traumas and mental health: the significance of cumulative
adversity. J Health Soc Behav. 1995;36(4):360-76. Epub 1995/12/01. PubMed PMID:
8719054.

152.

Martin CG, Cromer LD, Deprince AP, Freyd JJ. The Role of Cumulative Trauma,
Betrayal, and Appraisals in Understanding Trauma Symptomatology. Psychol Trauma.
2013;52(2):110-8. Epub 2013/04/02. doi: 10.1037/a0025686. PubMed PMID: 23542882;
PMCID: PMC3608140.

153.

Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, Stokes J,
Handelsman L, Medrano M, Desmond D, Zule W. Development and validation of a brief
screening version of the Childhood Trauma Questionnaire. Child Abuse Negl.
2003;27(2):169-90. Epub 2003/03/05. doi: 10.1016/s0145-2134(02)00541-0. PubMed
PMID: 12615092.

38

154.

Danielson R, Sanders GF. An effective measure of childhood adversity that is valid with
older adults. Child Abuse Negl. 2018;82:156-67. Epub 2018/06/16. doi:
10.1016/j.chiabu.2018.05.028. PubMed PMID: 29906739.

155.

Savolainen K, Eriksson JG, Kananen L, Kajantie E, Pesonen A-K, Heinonen K,
Räikkönen K. Associations between early life stress, self-reported traumatic experiences
across the lifespan and leukocyte telomere length in elderly adults. Biological
Psychology. 2014;97:35-42. doi: https://doi.org/10.1016/j.biopsycho.2014.02.002.

156.

Dong M, Anda RF, Felitti VJ, Dube SR, Williamson DF, Thompson TJ, Loo CM, Giles
WH. The interrelatedness of multiple forms of childhood abuse, neglect, and household
dysfunction. Child abuse & neglect. 2004;28(7):771-84.

157.

Turner RJ, Thomas CS, Brown TH. Childhood adversity and adult health: Evaluating
intervening mechanisms. Soc Sci Med. 2016;156:114-24. Epub 2016/04/01. doi:
10.1016/j.socscimed.2016.02.026. PubMed PMID: 27030896.

158.

Duffy KA, McLaughlin KA, Green PA. Early life adversity and health-risk behaviors:
proposed psychological and neural mechanisms. Ann N Y Acad Sci. 2018;1428(1):15169. Epub 2018/07/17. doi: 10.1111/nyas.13928. PubMed PMID: 30011075; PMCID:
PMC6158062.

159.

Sandler DP, Hodgson ME, Deming-Halverson SL, Juras PS, D'Aloisio AA, Suarez LM,
Kleeberger CA, Shore DL, DeRoo LA, Taylor JA, Weinberg CR, Sister Study Research
T. The Sister Study Cohort: Baseline Methods and Participant Characteristics. Environ
Health Perspect. 2017;125(12):127003. Epub 2018/01/27. doi: 10.1289/EHP1923.
PubMed PMID: 29373861; PMCID: PMC5963586.

160.

Berger LM, Brooks-Gunn J. Socioeconomic status, parenting knowledge and behaviors,
and perceived maltreatment of young low-birth-weight children. Social Service Review.
2005;79(2):237-67.

161.

Herrenkohl TI, Herrenkohl RC. Examining the overlap and prediction of multiple forms
of child maltreatment, stressors, and socioeconomic status: A longitudinal analysis of
youth outcomes. Journal of Family Violence. 2007;22(7):553-62.

162.

Mersky JP, Berger LM, Reynolds AJ, Gromoske AN. Risk factors for child and
adolescent maltreatment: a longitudinal investigation of a cohort of inner-city youth.
Child Maltreat. 2009;14(1):73-88. Epub 2008/07/04. doi: 10.1177/1077559508318399.
PubMed PMID: 18596199; PMCID: PMC4545632.

163.

Lee BJ, Goerge RM. Poverty, early childbearing, and child maltreatment: A multinomial
analysis. Children and Youth Services Review. 1999;21(9-10):755-80.

164.

Roos LE, Mota N, Afifi TO, Katz LY, Distasio J, Sareen J. Relationship between adverse
childhood experiences and homelessness and the impact of axis I and II disorders. Am J
Public Health. 2013;103 Suppl 2:S275-81. Epub 2013/10/24. doi:
10.2105/AJPH.2013.301323. PubMed PMID: 24148049; PMCID: PMC3969113.
39

165.

Baglivio MT, Wolff KT, Epps N, Nelson R. Predicting adverse childhood experiences:
The importance of neighborhood context in youth trauma among delinquent youth. Crime
& Delinquency. 2017;63(2):166-88.

166.

Eckenrode J, Smith EG, McCarthy ME, Dineen M. Income inequality and child
maltreatment in the United States. Pediatrics. 2014;133(3):454-61. Epub 2014/02/12. doi:
10.1542/peds.2013-1707. PubMed PMID: 24515511.

167.

Freisthler B, Bruce E, Needell B. Understanding the geospatial relationship of
neighborhood characteristics and rates of maltreatment for black, hispanic, and white
children. Soc Work. 2007;52(1):7-16. Epub 2007/03/29. doi: 10.1093/sw/52.1.7. PubMed
PMID: 17388079.

168.

Ards SD, Myers SL, Jr., Chung C, Malkis A, Hagerty B. Decomposing Black-White
differences in child maltreatment. Child Maltreat. 2003;8(2):112-21. Epub 2003/05/09.
doi: 10.1177/1077559502250817. PubMed PMID: 12735713.

169.

Putnam-Hornstein E, Needell B, King B, Johnson-Motoyama M. Racial and ethnic
disparities: a population-based examination of risk factors for involvement with child
protective services. Child Abuse Negl. 2013;37(1):33-46. Epub 2013/01/16. doi:
10.1016/j.chiabu.2012.08.005. PubMed PMID: 23317921.

170.

Vohra J, Marmot MG, Bauld L, Hiatt RA. Socioeconomic position in childhood and
cancer in adulthood: a rapid-review. Journal of epidemiology and community health.
2016;70(6):629. doi: 10.1136/jech-2015-206274.

171.

Cohen S, Janicki-Deverts D, Chen E, Matthews KA. Childhood socioeconomic status and
adult health. Ann N Y Acad Sci. 2010;1186:37-55. doi: 10.1111/j.17496632.2009.05334.x. PubMed PMID: 20201867.

172.

Galobardes B, Lynch JW, Davey Smith G. Childhood socioeconomic circumstances and
cause-specific mortality in adulthood: systematic review and interpretation.
Epidemiology Reviews. 2004;26:7-21. doi: 10.1093/epirev/mxh008. PubMed PMID:
15234944.

173.

Glymour MM, Avendano M, Haas S, Berkman LF. Lifecourse social conditions and
racial disparities in incidence of first stroke. Annals of epidemiology. 2008;18(12):90412. doi: 10.1016/j.annepidem.2008.09.010. PubMed PMID: 19041589; PMCID:
PMC2796851.

174.

Mock SE, Arai SM. Childhood trauma and chronic illness in adulthood: mental health
and socioeconomic status as explanatory factors and buffers. Front Psychol. 2010;1:246.
Epub 2010/01/01. doi: 10.3389/fpsyg.2010.00246. PubMed PMID: 21833299; PMCID:
PMC3153850.

175.

Krieger N. A glossary for social epidemiology. Journal of epidemiology and community
health. 2001;55(10):693-700. PubMed PMID: 11553651; PMCID: PMC1731785.

40

176.

Matthews KA, Gallo LC. Psychological perspectives on pathways linking socioeconomic
status and physical health. Annu Rev Psychol. 2011;62:501-30. Epub 2010/07/20. doi:
10.1146/annurev.psych.031809.130711. PubMed PMID: 20636127; PMCID:
PMC3121154.

177.

Kristenson M, Eriksen HR, Sluiter JK, Starke D, Ursin H. Psychobiological mechanisms
of socioeconomic differences in health. Soc Sci Med. 2004;58(8):1511-22. Epub
2004/02/05. doi: 10.1016/S0277-9536(03)00353-8. PubMed PMID: 14759694.

178.

Bellis MA, Hughes K, Ford K, Ramos Rodriguez G, Sethi D, Passmore J. Life course
health consequences and associated annual costs of adverse childhood experiences across
Europe and North America: a systematic review and meta-analysis. The Lancet Public
Health. 2019;4(10):e517-e28. doi: 10.1016/S2468-2667(19)30145-8.

41

CHAPTER 2
Early Life Trauma and Incident Breast Cancer
2.1 Introduction
The experience of psychosocial stress over the life course has the potential to impact
current as well as future health outcomes. Adversity and trauma experienced during childhood
and adolescence is an example of one type of stress that can have a lasting impact on adult health
and well-being. Indeed, numerous studies have reported on the observed association between
adverse childhood experiences (ACE) and health risk behaviors1-4 (e.g., alcohol use, drug abuse,
smoking, physical inactivity, and poor diet), mental health conditions5-8, chronic disease9, 10 (e.g.
heart disease10, autoimmune disease11, and different cancers12-14), and overall poor health15, 16.
Breast cancer is one of the most commonly diagnosed cancers among women in the
U.S.17, 18, affecting approximately 12% of women during their lifetime19. Psychosocial stress
experienced over the life course has been associated with the development of breast cancer20-22
and stress experienced at potentially vulnerable periods may differentially affect breast cancer
risk via various behavioral and biological pathways. Both childhood and adolescence represent
potential sensitive periods of breast development during which breast tissue is more vulnerable
to pre-tumorigenic mechanisms compared to other life periods that are characterized by minimal
changes in the breast tissue23. Indicators of early life trauma (e.g., cumulative adverse childhood
experiences, childhood physical abuse, childhood sexual abuse, etc.) have been associated with
early menarche and onset of menopause24-27, obesity28, and alcohol use28, 29, all of which are
reported breast cancer risk factors30-32.
However, prior studies of stress and breast cancer risk have focused on either the years
proceeding a woman’s breast cancer diagnosis (i.e., 1 to 10 years)14, 21, 22, 33, 34 or cumulative
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adversity over the life course20. Stress is commonly measured by summary ACE scores33, 35,
singular events (e.g., death of a parent)36, or specific types of trauma-such as sexual or physical
abuse during childhood37, 38—as sole measures of early life adversity. There is a paucity of
research on whether the patterning of concurrent traumas in early life may differentially affect
breast cancer risk.
Using data collected from The Sister Study, a prospective cohort study of women free of
breast cancer but with a biological sister diagnosed with breast cancer, the current study aims to
investigate the relationship between early life trauma (childhood and adolescence) and incident
breast cancer. We assessed whether cumulative early life trauma and traditional domains of early
life trauma, were associated with increased risk for incident breast cancer during follow-up.
Furthermore, since adverse experiences and traumas do not commonly occur alone, we evaluated
whether the co-occurrence of different early life traumas is associated with breast cancer
incidence.
2.2 Methods
Study population
The Sister Study is a prospective cohort study was designed to assess environmental and
genetic risk factors for breast cancer and other conditions39. Participants are U.S. and Puerto
Rican women (ages 35 to 74 years old; N = 50,884) who have a biological sister previously
diagnosed with breast cancer and had not been diagnosed with breast cancer themselves by the
time of enrollment (2003-2009). During the baseline visit, participants completed a telephone
interview as well as anthropometric measurements and blood sample collection; annual health
updates and detailed follow-up visits are completed every 2-3 years. Data for the current study
used Sister Study data release 7.0, which included follow-up data collected through September
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15, 2017. Requests for Sister Study data can be submitted by following directions at
http://sisterstudy.niehs.nih.gov/English/coll-data.htm.
All participants provided written informed consent. The study was approved by the
Institutional Review Boards of the National Institute of Environmental Health Sciences and the
Copernicus Group. The current analysis using coded data was considered exempt from human
subject research by the Institutional Review Board at the University of Wisconsin-Milwaukee.
We excluded 65 participants who either had withdrawn from the study at the time of
analysis (n = 2), were missing date of breast cancer diagnosis (n = 6), or were diagnosed with
breast cancer prior to completing enrollment procedures (n = 57). An additional 4,221
participants were excluded who did not complete the stress and trauma questionnaire at the first
follow-up biennial interview. Thus, 45,973 participants were included in the present study.
Traumatic events during childhood and adolescence
Adverse experiences and traumatic events were collected during biennial follow-up study
interviews. Questions were based on the revised 14-item Brief Betrayal Trauma Survey40 and
included an additional 13 questions developed for The Sister Study, for a total of 26 items; of
these, 20 items were utilized to assess early life traumatic experiences. Participants were asked
whether they had ever experienced each traumatic event in their lifetime (Possible responses:
Yes, No, Don’t know, Refuse to answer). Participants who answered affirmatively, were asked if
they experienced the trauma before age 13 (childhood) and/or between the ages of 13 and 17
(adolescence). Due to the low reporting of some types of childhood trauma in this cohort
(Supplemental Table 1), cumulative trauma was assessed by the number of traumatic
experiences reported for childhood and/or adolescence. Trauma types not included in these
scores were: death of a child, death of a spouse, and witnessed or learned of a child’s experience
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of unwanted sexual contact, or sexual, physical, or psychological abuse; these experiences were
unlikely to be reported for early life. Summative trauma scores were calculated by summing the
number of early life experiences reported for childhood and/or adolescence. In addition, the 20
trauma types were classified into 7 domains: 1) natural disasters, 2) major accidents, 3)
household dysfunction, 4) sexual abuse, 5) physical abuse, 6) emotional or psychological abuse,
and 7) major illness before age 18 (Figure 2.1).
Incident breast cancer
Breast cancer status was assessed at baseline (women with positive breast cancer
diagnosis were excluded from the study) and during annual health updates. In addition, breast
cancer status was also obtained during the triennial detailed follow-up questionnaires or
communication with The Sister Study staff. Self-reported details about the participant’s
diagnosis was captured approximately six months after her diagnosis via a Breast Cancer
Follow-Up questionnaire, which was self-administered from a mailed survey or completed via
telephone with the Sister Study staff. Complementary information, such as estrogen receptor
(ER) status, was requested form the participant’s medical record and corresponding pathology
reports when permission was granted by the participant. Response rates for were more than 94%
for follow-up39; medical record-documented breast cancer diagnosis was available for 86% of
cases. A previous study reported a positive predictive value of 99% between medical records and
self-report among Sister Study participants with medical records41. There was also high
agreement between self-reported ER status and abstracted data from medical records (95%)42.
Covariates
Covariates were race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanic,
other) and measures of early life socioeconomic position (SEP): highest level of education in the
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household at age 13 (Less than high school, High school graduate, Some college, College degree
or higher), a subjective measure of family income while growing up (Poor, Low income, Middle
income, Well off), and as a child, whether there were times when the family did not have enough
food to eat (Yes, No). Due to the timing of the exposure of interest (early life trauma during
childhood and/or adolescence) and incident breast cancer risk, common breast cancer risk factors
(e.g., parity, age at menarche, thelarche, age at first birth, etc.), were not included as potential
confounders in the models, as they instead represent potential mediators along the early life
trauma – breast cancer pathway.
Statistical analysis
Descriptive statistics were calculated using means and standard deviations (SD) for
continuous variables and frequency counts for categorical variables.
Two latent class analyses were conducted to evaluate potential relationship between
combinations of 1) concurrent trauma types or 2) trauma domains and incident breast cancer.
This model assumes that there is a finite number of mutually exclusive latent clusters that
represent the associations between the set of categorical trauma types and domains. Latent class
analysis does not assume that the categorical indicators (i.e., traumatic experiences or trauma
domains) are independent; as some trauma types reflect different aspects of similar traumas (e.g.,
unwanted sexual contact by someone close or unwanted sexual contact by someone not close),
we would not expect these traumas to be independent. The number of clusters of individual
trauma types was determined by estimating models with two to six clusters. Models were
compared using model fit (Bayesian Information criterion - BIC)43, entropy, and substantive
groupings of trauma types and domains. There were no a priori assumptions made for the
number of latent classes and models with successive number of clusters were identified until
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further models were not justified by model fit criteria or substantive clusters. This process was
repeated with the seven trauma domains in models with two to five clusters.
Cox proportional hazards regression was used to calculate hazard ratios (HRs) and 95%
confidence intervals (CIs) for incident breast cancer risk; age was used as the time scale with
person-time accrued from age at enrollment until the age at which the woman received a breast
cancer diagnosis or the age on the date of completion of the last follow-up. Models were run
using cumulative trauma scores, individual traumas (separate model for each trauma), trauma
domains (separate models for each trauma domain), and the two latent class variables for early
life trauma (trauma type and trauma domains) as the primary exposures. Models were adjusted
for the noted covariates. In analyses of breast cancer subtypes based on ER status, women with
competing or missing ER status (i.e., ER negative breast cancer when assessing risk for ER
positive breast cancer) were censored from follow-up at time of breast cancer diagnosis
Test for the proportional hazard assumption was conducted by assessing the interaction
between age (i.e., time from age at baseline to age at end of follow-up) and the main exposure of
interest. For pre-menopausal breast cancer risk, Cox proportional hazards models were
conducting using time from age at baseline to age of onset of menopause, breast cancer onset, or
loss to follow-up, which ever occurred first. For post-menopausal breast cancer risk, Cox
proportional hazards models were conducted using time from age at baseline or onset of
menopause, which ever came second, until age of breast cancer onset or loss to follow-up.
Participants with missing data for any early life trauma variables or covariates were
excluded from the given analysis. Missing data was <5% for each covariate and 3.3% overall for
participants who had complete trauma data. All tests were two-sided with p < 0.05 considered
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statistically significant. Analyses were conducted using Mplus version 8.344 and SAS version 9.4
(SAS Institute Inc., Cary, NC)45.
2.3 Results
Characteristics of study participants
For this study, 45,973 women contributed 435,220.05 person-years of follow-up (mean
(SD): 9.47 (2.13) years), with 3,082 women developing incident invasive breast cancer (n =
2,397), in situ breast cancer (n = 681), or tumors of unknown stage (n = 4). Approximately 50%
of Sisters Study participants reported experiencing at least one early life trauma before age 18,
similar to other national surveys that reported between 48 - 51% of women reporting the
experience of at least one lifetime trauma37, 46. Women who reported at least one early life
trauma were slightly younger, more often reported growing up in poor or low income
households, and recalled periods when their families did not have enough to eat compared to
women who reported no early life traumas (Table 1). Furthermore, women who reported at least
one category of early life trauma reported earlier menarche and thelarche, more often had at least
one pregnancy, were younger at the birth of their first child, more often consumed alcohol before
age 20, as well as over their lifetime, and more often smoked before age 20, as well as over their
lifetime (Table 1).
Over one third of participants reported early life psychological or emotional trauma, with
17% of women reporting being emotionally or psychologically mistreated by someone close
before age 18. Other commonly reported domains of early life trauma reported included sexual
trauma (16%) and household dysfunction (12%). Prevalence of sexual trauma in which the
perpetrator was someone close and someone not close was similar (9.7 % and 8.4%,
respectively). The most commonly reported source of household dysfunction in early life was
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attributed to experiencing serious family problems related to alcohol, drug, or other substance
abuse, or mental illness before the participant was age 18 (11.8%) or witnessing the attack of a
family member by another family member (7.7%).
Early life trauma types, trauma domains, and cumulative trauma score and incident breast
cancer
The report of different domains of early life trauma were similar among women who
developed breast cancer and those who remained breast cancer free at the end of follow-up/
Approximately 39% (n = 1,052) of women who developed breast cancer reported experiencing at
least one type of emotional or psychological trauma before age 18, with 15% (n = 462) and 12%
(n = 361) of women who developed breast cancer reporting sexual trauma and household
dysfunction in early life, respectively. We found no overall association between number of early
life traumas and incident breast cancer, before and after adjusting for highest level of education
attained in the household, family income while growing up, and childhood food insecurity (HR =
0.98; 95% CI = 0.96, 1.01 vs. HR = 0.98; 95% CI = 0.96, 1.01, respectively, Table 2). Incident
breast cancer was not associated with any of the domains of early life trauma (natural disasters,
major accidents, household dysfunction, sexual trauma, physical trauma, psychological or
emotional trauma, or experiencing a major illness). We did not observe any associations between
individual types of trauma and incident breast cancer (Table 2). There were no statistically
significant associations between any of the domains of early life trauma and risk of ER positive
or ER negative breast cancer.
Co-occurrence of early life trauma types and incident breast cancer risk
Latent class analysis was used to create a measure that better captures the co-occurrence
of early life traumas in The Sister Study cohort. To identify profiles of early life trauma, we
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estimated five LCA models with 2 to 6 latent clusters using the 20 trauma types reported for
early life and four LCA models with 2 to 5 latent clusters using the 7 domains of early life
trauma. Within each model, we assigned substantive classifications to each cluster based on
conditional response probabilities. Entropy values, which represent the level of certainty with
which participants are assigned to the correct clusters, ranged from moderate to high (0.67 to
0.82, ideally greater than 0.8) for models using trauma types and were low (0.53 to 0.63) for
models using trauma domains. Although the estimated models differ in model fit and substantive
clustering, all models using trauma types had clusters that distinguished between high and low
early life trauma. The trauma type models with 4 or more clusters further distinguished between
moderate levels of early life trauma, including unique clusters for moderate early life trauma
overall and moderate early life trauma specifically related to traumas with high levels of
perceived betrayal (sexual, emotional, and physical trauma perpetrated by someone close) and
family drug and/or alcohol use or mental health issues (Table 3). The latent class model with six
clusters had the best model fit of the models tested while still maintaining moderate to high level
certainty that participants were placed in the correct clusters (entropy = 0.72); the six clusters
were classified as 1) Low early life trauma, 2) Moderate early life trauma: Family health issues,
3) Moderate early life trauma: Sexual trauma and family drug/alcohol/mental health issues, 4)
Moderate early life trauma: High betrayal trauma and family drug/alcohol/mental health issues,
5) Moderate early life trauma: Overall, and 6) High early life trauma (Table 4). Latent class
models using the seven trauma domains had poor separation between clusters with entropy less
than 0.65 for all models with 2 to 5 clusters (data not shown).
In latent class models, there were no statistically significant associations between clusters
of early life trauma and incident breast cancer overall or by ER status after adjusting for age,
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race/ethnicity, and early life SEP. However, women classified as reporting moderate early life
trauma consisting of sexual trauma and family drug, alcohol, and/or mental health issues had
higher risk of breast cancer, albeit not statistically significant, overall (HR=1.11; 95% CI: 0.97,
1.29), as well as when stratified by menopausal status (pre-menopausal breast cancer: HR=1.19;
95% CI: 0.89, 1.59; post-menopausal breast cancer: HR=1.09; 95% CI: 0.93, 1.29) when
compared to women classified as low early life trauma, after controlling for early life
socioeconomic position (Table 4). Violations of the proportional hazard assumption were
observed for breast cancer risk models and in post-menopausal breast cancer models in our latent
class analysis. Exploratory analyses indicated that the relationship between early life trauma, as
measured as latent classes, and breast cancer risk varied over time, such that the magnitude of
association increased over time. As a result, we stratified models by menopausal status at
censoring, as pre- and post-menopausal breast cancer are associated with differential risk
patterns, to account for potential time effects. Stratification eliminated the time effect within the
pre-menopausal group, however, the magnitude of risk continued to increase over time within
the post-menopausal group.
Sensitivity analyses
Additional studies looking at pre- and post- menopausal breast cancer risk using
cumulative trauma scores, individual traumas, and trauma domains resulted in similar findings as
noted above for the full cohort.
2.4 Discussion
This is the first study to comprehensively assess the relationship between early life
trauma and risk of incident breast cancer. In addition to evaluating the effects of cumulative
number of traumatic or adverse events, singular traumatic events, or commonly evaluated trauma
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domains (e.g., sexual and physical abuse), we attempted to capture a more nuanced measure of
early life trauma by assessing how individual traumas and trauma domains may work together in
affecting incident breast cancer risk in adulthood. We did not find any statistically significant
associations between early life trauma and incident breast cancer risk using traditional measures
of early life adversity. The present study identified six profiles of early life trauma and observed
patterns that suggest that compared to women who report low early life trauma, women who
reported moderate early life trauma consisting of sexual trauma and family drug, alcohol, and/or
mental health issues were at higher risk of developing pre- and post-menopausal breast cancer.
Women reporting other early life trauma profiles also had a higher risk of developing postmenopausal breast cancer compared to women with low early life trauma, except for those with
the highest profile of early life trauma. These findings suggest that the role of early life trauma
on breast cancer risk may be more nuanced than a cumulative trauma score, a single traumatic
event, or a domain of trauma can capture.
Previous studies of stress and adversity over the life course and incident breast cancer
risk have been inconsistent, with studies reporting positive33, 47, negative48, and null22, 35, 37
associations; the observed variation in results may in part be due to the heterogeneous nature of
the disease, as well as methodological differences in how stress and adversity have been
operationalized and the periods of trauma exposure captured in these studies. A majority of the
previously published literature has not evaluated the potential role of early life adversity outside
of the scope of cumulative adversity over the life course. We found four studies that reported
breast cancer risk associated with childhood and/or adolescence adversity within their
assessments of life course adversity; all of them differ in how early life adversity was captured35,
37, 47, 49

. Our results for cumulative trauma counts, individual traumas, and trauma domains are
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consistent with the findings of Wise et al., who found no significant associations between
childhood sexual or physical abuse victimization and breast cancer risk among the prospective
cohort of Black women enrolled in the Black Women’s Health Study.37 and Surtees et al., who
reported no significant associations between difficulties reported in childhood and incident breast
cancer after adjustment for common breast cancer risk factors in the European Prospective
Investigation into Cancer (EPIC) cohort 35. Conversely, Eskelinen and Ollonen reported a weak
association between losses and deficits in childhood and adolescence and breast cancer risk in a
prospective case-control study of Finnish women47 and Jacobs and Bovasso reported increased
odds of breast cancer associated with maternal death during childhood50, which we did not
observe.
The mechanisms through which trauma and adversity during sensitive periods of breast
development may affect breast cancer risk are poorly understood. One potential biologic
pathway though which early life trauma could affect breast cancer risk are modification of stress
response mechanisms. The hypothalamus-pituitary-adrenal (HPA) axis is one of the primary
stress response mechanisms and functions via a series of biochemical feedback pathways.
Persistent activation of the HPA axis resulting from exposure to chronic stress can decrease its
functionality, contributing to greater allostatic load and disease susceptibility51, 52. Experiences of
early life trauma may predispose women to a chronic dysregulation of stress management
mechanisms including immune function and inflammatory processes53-55. Early life trauma could
also affect breast cancer risk through the alteration of circulating hormone milieus that affect
pubertal changes and early breast development and subsequent reproductive behaviors. Younger
age at menarche56, an indicator of accelerated breast development, has been associated with
increased breast cancer risk, suggesting that the period of breast duct development may serve as
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a sensitive period for carcinogenesis possibly due to rapid cellular differentiation in the breast
ducts. Previous studies have reported an association between childhood sexual abuse and lower
age at menarche24, but less is known about the potential relationship between early life trauma
and other known breast cancer risk factors, including delayed age at first birth, parity, and time
between pregnancies57-59.
Strengths of this study include the prospective design of The Sister Study cohort and the
comprehensive nature in which traumas were collected to reflect periods over the life course.
Trauma in early life was assessed prior to breast cancer diagnosis, limiting potential recall bias.
For this study, experiences of early trauma were collected separately for childhood (before age
12) and adolescence (ages 13-17). Prior studies that have assessed the association between early
life adversity in breast cancer have focused primarily on childhood adversity, however, studies
that limit their scope to childhood may overlook the impact of trauma on pubertal development
and subsequent reproductive pathways associated future breast cancer risk. Furthermore,
although other studies have evaluated different methods of assessing adverse childhood
experiences60, this is the first study to utilize and compare different methods of evaluating breast
cancer risk in a single cohort.
This study also presents some limitations. First, although we capture the number and type
of early life traumas reported during either childhood or adolescence, we do not know the
duration or the magnitude of these exposures over these two periods. Some trauma types tend to
have shorter exposure periods (e.g., natural disasters) whereas other trauma types may be more
persistent (e.g., emotional or psychological mistreatment). The duration and repetition of trauma
over potentially sensitive time periods over the life course may play an important role in the
association between early life trauma and breast cancer risk. Furthermore, although The Sister
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Study collected information on a comprehensive list of traumas, we cannot exclude the
possibility that there may be other types of stress that may be more likely to be biologically
embedded and subsequently play a larger role in the risk of developing breast cancer.
Second, due to the low frequency of reported early life traumas before age 13 when
assessed by breast cancer status, we combined reporting during childhood and adolescence
(younger than 18 years of age) to represent the window of risk during which trauma-related
hazards could influence biological pathways associated with pubertal changes and early breast
development. This may not be ideal as childhood and adolescence may represent potentially
distinct periods of breast cancer risk due do unique developmental processes that occur during
each period. Additional sensitivity analyses should be completed to potentially elucidate the
unique effects of traumatic events experienced during childhood versus adulthood.
Third, The Sister Study does not capture adverse childhood experiences as presented by
the ACE study, instead uses a trauma framework to collect information on early life adversity; as
a result, we cannot not directly compare our results to other studies that have used the traditional
categories for ACEs. However, Bethell et al. demonstrated that although variability exists among
measures of adverse childhood experiences, most measures remain similar and cumulative scores
from these measures reflect consistent association with poor health outcomes60.
Fourth, The Sister Study used an enriched sample of women who had at least one
biological sister diagnosed with breast cancer, but was not diagnosed with breast cancer herself
at enrollment, in order to maximize the likelihood of being able to identify potential risk factors
for incident breast cancer as women who have a sister diagnosed with breast cancer are twice as
likely to develop breast cancer themselves61. In addition, the Sister Study population are
generally older, more educated, and more likely to be healthy and economically sound, which

55

may be masking the effects of early life trauma in more vulnerable populations. However, the
distribution of breast cancer risk factors in The Sister Study cohort resembles that of the general
population, which suggests that the results observed in this study may still be generalizable and
internally valid62.
Finally, breast cancer has a relatively long latency period between potential exposures,
triggering events, and clinical manifestation. We do not adjust for intervening factors or
subsequent stressors, which may serve as mediators in the relationship between early life trauma
and incident breast cancer. Furthermore, there were 841 women who were diagnosed with breast
cancer prior to completion of the biennial stress update, approximately 27% of women diagnosed
with breast cancer who completed a stress questionnaire, which could contribute to differential
recall among women diagnosed versus not diagnosed with breast cancer. Sensitivity analyses did
not show significant differences in the results restricted to women who completed the stress
questionnaire before any breast cancer diagnosis (data not shown). Although we can assure
temporality between reported early life trauma and breast cancer diagnosis, non-differential
exposure misclassification may exist as a result of the long period between experienced trauma
and reporting with potential underreporting of early life trauma. Previous studies have reported
between 60 and 81 percent of study participants accurately disclosing previous experiences of
sexual and physical trauma63-65. This underreporting has been attributed to inability to recall, as
well as avoidance of potential stigmas associated with disclosing early life trauma. Concurrent
mental health issues (e.g., psychological distress) can contribute to higher recall of and reporting
of childhood traumatic experiences66.
In conclusion, we did not find any statistically significant associations between early life
trauma and breast cancer risk in this large cohort of U.S. and Puerto Rican women using
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traditional measures of early life adversity, including cumulative traumatic experiences, singular
trauma types, and types of trauma. However, nuanced measures of early life trauma that
incorporate the co-occurrence of different types of trauma may be more meaningful in defining
breast cancer risk.

57

2.5 Tables and Figures
Table 2.1 Characteristics of the 45,973 Sister Study participants based on experience of early life
traumas before age 18
No Early Life Trauma
N = 23,076 (50%)
n
%
56.54 (9.02)

Age at baseline, mean (SD)
Race/Ethnicity, %
Non-Hispanic White
20,662
Non-Hispanic Black
1,830
Hispanic
1,043
Other
495
Highest level of education in the household at age 13, %
Less than high school
4,170
High school graduate
8,574
Some college
4,473
College degree or higher
6,813
Family income while growing up, %
Poor
1,349
Low income
5,601
Middle income

Any Early Life Trauma
N = 22,897 (50%)
n
%
54.93 (8.70)

85.98
7.62
4.34
2.06

18,547
1,821
917
658

84.52
8.3
4.18
3

17.34
35.68
18.61
28.35

4,186
7,856
4,252
5,649

19.08
35.8
19.38
25.73

5.61
23.31

2,148
6,210

9.79
28.3

Past smoker
Current smoker
Age at menarche, mean (SD)
Age at thelarche, mean (SD)
Parity, mean (SD)
Age at first pregnancy, mean (SD)
Menopause status at censoring
Missing
Pre-menopausal
Post-Menopausal
Age at menopause onset, mean (SD)

<.0001
<.0001

<.0001

<.0001

15,477

64.41

12,217
Well off
1,603
6.67
1,368
As a child, were there times when your family did not have enough food to eat?, %
Yes
1,336
5.56
2,781
No
22,694
94.44
19,162
Ever consumed alcohol, %
Missing
3
0.01
3
No
1,033
4.30
689
Yes
22,994
95.69
21,251
Smoking status at baseline, %
Missing
3
0.01
5
Never smoked

p-value

14,330

59.63

8,128
1,569
12.69 (1.50)
12.27 (1.65)
1.99 (1.35)
24.89 (5.12)

33.82
6.53

38
2,130
21,862
53.29 (3.11)

0.16
8.86
90.98
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11,739
8,263
1,936
12.60 (1.55)
12.16 (1.71)
1.88 (1.34)
24.57 (5.36)
49
2,285
19,609
53.16 (3.31)

55.68
6.23
<.0001
12.67
87.33
<.0001
0.01
3.14
96.85
<.0001
0.02
53.50
37.66
8.82
<.0001
<.0001
<.0001
<.0001
<.0001
0.22
10.41
89.36
0.0193

Figure 2.1 Traditional trauma domains (dark blue) and types of early life trauma (light blue)
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Table 2.2 Association between early life traumas and incident breast cancer risk
Cases

Person-years

Age-adjusted HR
(95% CI)
0.98 (0.96, 1.01)
1.00 (ref)
0.96 (0.89, 1.03)
0.94 (0.77, 1.16)
0.91 (0.73, 1.12)
0.98 (0.87, 1.10)

Multivariable HR
(95% CI)a
0.98 (0.95, 1.01)
1.00 (ref)
0.96 (0.89, 1.03)
0.94 (0.77, 1.16)
0.91 (0.73, 1.12)
0.97 (0.87, 1.09)

Number of early life traumas
3082
435,176
No early life trauma
1675
226,972
Any early life trauma
1407
208,204
Natural disaster
85
14,346
Major accident
77
14,200
Household Dysfunction
314
52,947
Witness attack of a family
member by another family
208
33,240
1.10 (0.97, 1.26)
1.10 (0.97, 1.26)
member
Major issue in personal
24
4,440
0.87 (0.59, 1.29)
0.87 (0.59, 1.29)
relationship
Serious financial/legal issues
21
2,795
1.29 (0.86, 1.93)
1.28 (0.86, 1.92)
Serious family
301
51,787
0.97 (0.87, 1.08)
0.97 (0.86, 1.08)
drug/alcohol/mental illness
Sexual Trauma
373
52,947
0.93 (0.84, 1.04)
0.93 (0.84, 1.03)
Unwanted sexual contact by
218
42,288
0.92 (0.81, 1.04)
0.92 (0.81, 1.05)
someone close
Unwanted sexual contact by
201
36,787
0.99 (0.87, 1.13)
0.99 (0.87, 1.13)
someone not close
Physical Trauma
151
52,947
1.05 (0.90, 1.23)
1.05 (0.90, 1.23)
Hit/attacked by someone close
132
21,584
1.05 (0.89, 1.24)
1.05 (0.89, 1.24)
Hit/attacked by someone not close
26
5,667
1.00 (0.72, 1.38)
1.00 (0.72, 1.38)
Psychological Trauma
889
52,947
0.98 (0.90, 1.06)
0.97 (0.90, 1.06)
Emotionally/psychologically
433
74,889
0.98 (0.89, 1.08)
0.98 (0.89, 1.08)
mistreated by someone close
Emotionally/psychologically
56
10,716
0.92 (0.73, 1.17)
0.92 (0.73, 1.17)
mistreated by someone not close
Witness suicide/attack of someone
75
14,621
0.88 (0.71, 1.09)
0.88 (0.71, 1.09)
close
Witness suicide/attack of someone
14
3,851
0.62 (0.38, 1.02)
0.63 (0.38, 1.02)
not close
Death of a sibling
87
13,909
0.99 (0.81, 1.21)
0.99 (0.81, 1.21)
Death of a parent
172
30,004
0.92 (0.80, 1.07)
0.93 (0.80, 1.07)
Death of a close friend
77
16,226
0.81 (0.65, 1.00)
0.81 (0.65, 1.00)
Major illness (not BC) in someone
120
19,578
1.00 (0.84, 1.19)
1.00 (0.84, 1.19)
close
0.91 (0.71, 1.16)
0.91 (0.71, 1.16)
Major illness before age 18
54
9,850
a
Adjusted for race/ethnicity, highest level of education in the household at age 13, family income while growing
up, and food security as a child.
BC: Breast cancer; CI: Confidence interval; HR: Hazard ratio
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Table 2.3 Fit indices, cluster description, and cluster population share for the latent class
analyses of early life trauma types (n = 20)
# of
clusters
2

3

4

Cluster description
Low early life trauma

40090

87.21

High early life trauma

5877

12.79

Low early life trauma
Moderate early life trauma:
Sexual trauma, physical trauma,
and family drug/alcohol/mental
issues
High early life trauma

35832

77.95

7989

17.38

2146

4.67

Low early life trauma
Moderate early life trauma:
Sexual trauma, physical trauma,
and family drug/alcohol/mental
issues
Moderate early life trauma:
Overall
High early life trauma

35550

77.34

7180

15.62

Low early life trauma

2409

5.24

828

1.80

35674

77.61

1943

4.23

5077

11.04

2432

5.29

841

1.83

35292

76.78

Moderate early life trauma:
Family health issues

1234

2.68

Moderate early life trauma:
Sexual trauma

2901

6.31

Moderate early life trauma:
Family health issues
5

Moderate early life trauma:
Sexual trauma, physical trauma,
and family drug/alcohol/mental
issues
Moderate early life trauma:
Overall
High early life trauma
Low early life trauma

6

Estimated cluster
population share
(%)

n

Moderate early life trauma: High
betrayal trauma and family
drug/alcohol/mental health issues
Moderate early life trauma:
Overall
High early life trauma

3357

7.30

2318

5.04

865

1.88

61

BIC

Entropy

308195.1

0.819

306561.8

0.673

305796.7

0.718

305147.3

0.709

304932.1

0.722

Figure 2.2 Latent class plot of early life trauma (6 clusters)
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Table 2.4 Association between latent classes of early life trauma and incident breast cancer risk by pre/post-menopausal breast cancer

Early life trauma
(Latent class model)
Low early life trauma
Moderate early life
trauma: Family health
issues
Moderate early life
trauma: Sexual trauma
and family
drug/alcohol/mental
health issues

63

Moderate early life
trauma: High betrayal
trauma and family
drug/alcohol/mental
health issues
Moderate early life
trauma: Overall
High early life trauma
aAge-adjusted
bAdjusting

Total Breast Cancer
Model 1a
Model 2b
HR (95% CI)
HR (95% CI)

Pre-menopausal Breast Cancer
Model 1a
Model 2b
Cases
HR (95% CI)
HR (95% CI)

Post-menopausal Breast Cancer
Model 1a HR
Model 2b
Cases
(95% CI)
HR (95% CI)

Personyears

Cases

334,144

2374

1.00 (Ref)

1.00 (Ref)

401

1.00 (Ref)

1.00 (Ref)

1973

1.00 (Ref)

1.00 (Ref)

77

0.98
(0.78, 1.23)

0.98
(0.78, 1.23)

14

0.77
(0.45, 1.31)

0.77
(0.45, 1.31)

63

1.03
(0.80, 1.32)

1.04
(0.81, 1.33)

206

1.11
(0.97, 1.28)

1.11
(0.97, 1.29)

51

1.19
(0.89, 1.59)

1.19
(0.89, 1.59)

155

1.09
(0.93, 1.29)

1.09
(0.93, 1.29)

218

0.98
(0.86, 1.13)

0.98
(0.86, 1.13)

30

0.72
(0.49, 1.04)

0.71
(0.49, 1.03)

188

1.04
(0.90, 1.21)

1.04
(0.90, 1.21)

158

1.08
(0.92, 1.26)

1.07
(0.91, 1.26)

25

0.82
(0.55, 1.23)

0.82
(0.54, 1.23)

133

1.13
(0.95, 1.35)

1.13
(0.94, 1.34)

39

0.73
(0.53, 1.00)

0.73
(0.53, 1.01)

8

0.64
(0.32, 1.28)

0.63
(0.31, 1.28)

31

0.76
(0.53, 1.09)

0.76
(0.53, 1.09)

11,791

27,308

31,923

21,936
8,074

(time-scale)

for age (time scale), race, childhood household education, childhood household income, and childhood food security

2.6 Supplemental Materials
Supplemental Table 2.1 Distribution of trauma types by childhood, adolescence, and childhood
and/or adolescence
No Breast Cancer
(n = 42,891)
Missing
No
Yes
n
n
n
Natural Disaster
Childhood
Adolescence
Childhood and/or adolescence
Major Accident
Childhood
Adolescence
Childhood and/or adolescence
Hit or attacked by someone CLOSE
Childhood
Adolescence
Childhood and/or adolescence
Hit or attacked by someone NOT CLOSE
Childhood
Adolescence
Childhood and/or adolescence
Unwanted sexual contact by someone CLOSE
Childhood
Adolescence
Childhood and/or adolescence
Unwanted sexual contact by someone NOT CLOSE
Childhood
Adolescence
Childhood and/or adolescence
Psychologically mistreated by someone CLOSE
Childhood
Adolescence
Childhood and/or adolescence
Psychologically mistreated by someone NOT CLOSE
Childhood
Adolescence
Childhood and/or adolescence
Witness suicide/attack of someone CLOSE
Childhood
Adolescence
Childhood and/or adolescence
Witness suicide/attack of someone NOT CLOSE
Childhood
Adolescence
Childhood and/or adolescence

Breast Cancer
(n = 3,082)
Missing
No
Yes
n
n
n

386
386
386

41,488
42,051
41,077

1,017
454
1,428

36
36
36

2,986
3,007
2,950

60
39
96

525
525
525

41,740
41,559
40,958

626
807
1,408

45
45
45

2,993
2,991
2,948

44
46
89

409
409
409

40,952
41,289
40,330

1,530
1,193
2,152

35
35
35

2,933
2,975
2,893

114
72
154

237
237
237

42,376
42,302
42,076

278
352
578

23
23
23

3,037
3,040
3,022

22
19
37

335
335
335

39,473
41,007
38,344

3,083
1,549
4,212

36
36
36

2,853
2,950
2,779

193
96
267

364
364
364

40,440
40,841
38,912

2,087
1,686
3,615

30
30
30

2,900
2,945
2,799

152
107
253

1,035
1,035
1,035

35,825
36,765
34,478

6,031
5,091
7,378

90
90
90

2,568
2,642
2,480

424
350
512

732
732
732

41,458
41,489
41,094

701
670
1,065

48
48
48

2,993
2,988
2,964

41
46
70

472
472
472

41,325
41,643
40,947

1,094
776
1,472

26
26
26

2,991
3,008
2,969

65
48
87

483
483
483

42,246
42,139
42,013

162
269
395

30
30
30

3,046
3,040
3,036

6
12
16
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Supplemental Table 2.1 (continued)
No Breast Cancer
(n = 42,891)
Missing
No
Yes
n
n
n
Witness family attack by a family member
Childhood
Adolescence
Childhood and/or adolescence
Death of sibling
Childhood
Adolescence
Childhood and/or adolescence
Death of a parent
Childhood
Adolescence
Childhood and/or adolescence
Death of a close friend
Childhood
Adolescence
Childhood and/or adolescence
Major illness
Childhood
Adolescence
Childhood and/or adolescence
Major illness (not BC) in someone CLOSE
Childhood
Adolescence
Childhood and/or adolescence
Major issues in personal relationship
Childhood
Adolescence
Childhood and/or adolescence
Serious financial/legal troubles
Childhood
Adolescence
Childhood and/or adolescence
Serious family drug/alcohol/mental issues
Childhood
Adolescence
Childhood and/or adolescence
Other serious traumatic event
Childhood
Adolescence
Childhood and/or adolescence

Breast Cancer
(n = 3,082)
Missing
No
Yes
n
n
n

548
548
548

39,789
40,731
39,048

2,554
1,612
3,295

43
43
43

2,856
2,912
2,793

183
127
246

1,444
1,444
1,444

40,570
40,906
40,070

877
541
1,377

90
90
90

2,924
2,960
2,894

68
32
98

2,864
2,864
2,864

38,425
38,616
37,059

1,602
1,411
2,968

189
189
189

2,789
2,800
2,696

104
93
197

2,258
2,258
2,258

40,282
39,313
39,026

351
1,320
1,607

164
164
164

2,899
2,845
2,831

19
73
87

915
915
915

41,260
41,651
40,997

716
325
979

82
82
82

2,958
2,972
2,934

42
28
66

1,816
1,816
1,816

40,051
39,800
39,139

1,024
1,275
1,936

120
120
120

2,899
2,871
2,828

63
91
134

1,116
1,116
1,116

41,526
41,477
41,333

249
298
442

54
54
54

3,013
3,013
3,003

15
15
25

880
880
880

41,886
41,808
41,740

125
203
271

56
56
56

3,016
3,006
3,002

10
20
24

1,453
1,453
1,453

37,692
37,559
36,341

3,746
3,879
5,097

86
86
86

2,753
2,727
2,650

243
269
346

751
751
751

41,559
41,656
41,162

581
484
978

47
47
47

2,996
3,011
2,981

39
24
54

65
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CHAPTER 3
Early Life Trauma and Methylation of the Glucocorticoid Receptor Gene (NR3C1)
3.1 Introduction
The hypothalamic-pituitary-adrenal (HPA) axis is one of the main stress response
mechanisms in the body and functions via a series of biochemical feedback pathways between
the hypothalamus, anterior pituitary gland, and adrenal glands. Glucocorticoid receptors play a
dual role in the stress management by binding to circulating cortisol, a stress hormone, and
regulating the negative feedback of the HPA stress response, thus modulating the impact of
socioenvironmental stress on biologic pathways (e.g., growth and development, metabolism,
immune function and inflammatory processes)1, 2. Persistent activation of the HPA axis due to
exposure to chronic stress can decrease the functionality of the glucocorticoid negative feedback
loop contributing to greater allostatic load and disease susceptibility2, 3.
Early life trauma has been shown to have lasting effects on health4, 5, but the mechanisms
by which adverse early life exposures get under the skin are still being elucidated. Studies of the
effect of adversity and trauma over the life course on stress response mechanisms and HPA axis
dysregulation have largely focused on the epigenetic modification, and primarily DNA
methylation, of HPA axis genes6, 7. Epigenetic modifications are durable, but sometimes
reversible, characteristics that alter gene expression by regulating chromatin structure and DNA
accessibility to DNA transcription factors, without changing the underlying genetic code8.
Cytosine-phosphate-guanine (CpG) sites, which are found along a single strand of DNA, serve as
the primary site of DNA methylation during which a methyl group, --CH3, is added to the 5’
position of the cystosine base. Changes in methylation patterns can result in the expression or
silencing of genes responsible for vital biological mechanisms (e.g. immune response,
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inflammatory pathways, DNA repair, cell apoptosis, etc.), contributing to disease risk and
negative health impacts9. Furthermore, methylation of genes within the HPA axis has been
hypothesized to serve as a potential marker of stress embodiment and disease risk10.
One such gene, nuclear receptor subfamily 3, group C, member 1 (NR3C1), is responsible
for glucocorticoid receptor expression across multiple tissues, as well as regulation of genes
associated with development, metabolism, inflammation and immune function11. Much of the
existing literature studying NR3C1 methylation has focused on methylation of CpG sites within
the 3kpb CpG island that houses the proximal promoter, including seven non-coding first exons,
due to its functional role in NR3C1 transcription. Hypermethylation of NR3C1 promoter region
results in decreased glucocorticoid receptor expression and inhibits glucocorticoid receptorregulated pathways related to stress management, development, metabolism, inflammation and
immune function, and cell differentiation, increasing the potential risk for psychopathologies
(e.g., post-traumatic stress disorder, depression, and borderline personality disorder)12-14,
immune dysfunction, and tumorigenesis10, 15.
Early life trauma has been associated with lower NR3C1 expression in leukocytes16;
differential methylation may contribute to this process by altering NR3C1 transcription.
However, reports on the association between early exposure to stressors and traumatic events on
NR3C1 methylation have been mixed due to differences in study design, measures used to assess
stressors and traumatic events, and CpG sites selected for investigation6. Studies that have
evaluated the relationship between early life adversity and NR3C1 methylation have utilized
summative trauma scores17, 18, distinct traumatic events (e.g., loss of a parent)19, or trauma
domains20. Types of trauma may differ in duration and intensity (i.e., experience of a natural
disaster versus chronic physical abuse throughout childhood and adolescence), which may affect
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how they may in turn impact health later in life. Few studies have looked at how different
patterns of concurrent trauma may affect NR3C1 methylation nor have they taken a life course
approach to assess potential mediating pathways in adulthood that may explain the relationship
between early life trauma and adult levels of NR3C1 methylation.
Using data collected from women enrolled in the Sister Study, the current analysis aims
to investigate the relationship between early life (i.e., during childhood and adolescence)
exposure to traumatic events and methylation of NR3C1 in adulthood.
3.2 Methods
Study population
The Sister Study is a prospective cohort study designed to assess environmental and
genetic risk factors for breast cancer and other conditions21. Participants are women residing in
the U.S. and Puerto Rico (ages 35 to 74 years old; N = 50,884) who have a biological sister
previously diagnosed with breast cancer but had not been diagnosed with breast cancer
themselves at time of enrollment (2003-2009). During the baseline visit, participants completed a
telephone interview, as well as anthropometric measurements and blood sample collection.
Health updates are completed annually, and detailed follow-up questionnaires have been
completed every 2-3 years since baseline. Requests for Sister Study data can be submitted by
following the directions at http://sisterstudy.niehs.nih.gov/English/coll-data.htm.
All participants provided written informed consent. The study was approved by the
Institutional Review Boards of the National Institute of Environmental Health Sciences and the
Copernicus Group. The current analysis using coded data was considered exempt from human
subject research by the Institutional Review Board at the University of Wisconsin-Milwaukee.
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Women eligible for this analysis were included in a previously described case-cohort
study of methylation and breast cancer risk22. A random sample of 1,336 non-Hispanic White
women in the Sister Study cohort for whom a blood sample had been collected at time of study
enrollment was selected. Cases included the 1,542 non-Hispanic White women who were
diagnosed with incident invasive breast cancer or ductal carcinoma in situ (DCIS) between study
enrollment and time of sampling in March 2015, (100 of whom had been selected as part of the
random cohort sample)23 (data release 7.0).
We excluded 102 participants whose sample did not meet methylation-related quality
control thresholds22 and 175 participants who did not complete the stress and trauma
questionnaire at the first biennial follow-up interview. A total of 2,678 participants were
included in the present study.
Trauma measurement
Data on traumatic experiences were collected during the first follow-up interview (two to
three years after enrollment when the blood sample used for these analyses were collected).
Questions were based on the revised 14-item Brief Betrayal Trauma Survey24 and included an
additional 13 questions developed for the Sister Study, for a total of 26 items. Of these, 20 items
were retained to assess early life traumatic experiences. Participants were asked whether they
had ever experienced each type of trauma in their lifetime (Possible responses: Yes, No, Don’t
know, Refuse to answer). Participants who answered affirmatively, were asked if they
experienced the trauma before age 13 (childhood), between the ages of 13 and 17 (adolescence),
from age 18 to one year prior to survey completion (adult), and/or in the past 12 months (recent
adulthood). Traumatic experiences in the past 12 months were excluded from these analyses as
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they would have occurred after NR3C1 methylation was measured in the blood sample collected
at baseline.
Early life trauma
Women were dichotomized based on experience of early life trauma and were considered
to have exposure to traumatic events in early life if they reported experiencing at least one event
in childhood or adolescence. In addition, a latent class variable was created to group women
according to the co-occurrence of early life traumas among all Sister Study participants who
completed the trauma questionnaire (n = 45,973) in order to capture the distribution of trauma
profiles in the underlying Sister Study cohort. We estimated five latent class models with 2 to 6
latent clusters using the 20 types of early life trauma as indicators. Within each model, we
assigned substantive labels to each latent class based on the pattern of conditional response
probabilities within each cluster. The latent class model with six clusters had the best model fit
of the models tested while still maintaining moderate to high level certainty that participants
were placed in the correct clusters, which is evaluated using entropy on a scale of 0 to 1 (entropy
= 0.72). We identified six latent classes based on the proportion of women who reported each
early life trauma within each cluster: 1) low early life trauma (average probability of reporting
any type of early life trauma was less than 2% across all possible traumatic events; referent), 2)
family health issues (highest proportions for death of a parent and major illness (not breast
cancer) in someone close, 40% and 49%, respectively. Average across all other traumas = 6%),
3) sexual trauma and family drug/alcohol/mental health issues (highest proportions for unwanted
sexual contact by someone close (22%) or someone not close (22%) and family drug, alcohol,
and/or mental health issues (17%). Average across all other traumas = 4%), 4) high betrayal
trauma and family drug/alcohol/mental health issues (highest proportions for traumas perpetrated
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by someone close – unwanted sexual contact (22%), hit or attached (16%), emotionally or
psychologically mistreated (99%) and family drug, alcohol, and/or mental health issues (28%).
Average across all other traumas = 5%), 5) moderate early life trauma: overall (average
probability of reporting each early life traumatic event = 17%), and 6) high early life trauma
(average probability of reporting each early life traumatic event = 32%).
Adult trauma
Adult trauma (occurring between age 18 and 12 months before completion of the stress
and trauma questionnaire) was evaluated as a potential mediator of the relationship between
early life trauma and NR3C1 methylation. A continuous latent variable representing trauma
experienced in adulthood was created using indicators for the same 20 traumatic events in
adulthood that were used in the early life trauma latent class model (RMSEA = 0.025, CFI =
0.919).
DNA methylation of NR3C1
Blood samples were obtained at baseline prior to any diagnoses of breast cancer. DNA
extraction and processing are described elsewhere22. Briefly, genomic DNA was extracted from
whole blood samples using an automated system (Autopure LS, Gentra Systems) housed at the
Molecular Genetics Core Facility at the National Institute of Environmental Health Sciences or
using DNAQuick at BioServe Biotechnologies LTD (Beltsville, MD). DNA was analyzed using
the Illumina Infinium HumanMethylation450 BeadChip following the manufacturer’s protocol.
Preprocessing and quality control of methylation data were previously described25. Methylation
results included 40 CpG sites located on NR3C1 and were included in the present study (Figure
3.1).
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Methylation values were originally reported on the Beta-value scale (i.e., the ratio of the
methylated probe intensity compared to the sum of the methylated and unmethylated probe
intensities), which represents the percentage of methylated copies of a CpG site ranging from 0%
(no copies methylated) to 100% (all copies methylated)26. These values were logit-transformed
to calculate M values (i.e., the natural log ratio of methylated probe intensity and unmethylated
probe intensity), with positive values indicating more methylated copies than unmethylated
copies and vice versa for negative values. M values were used for statistical analyses in order to
address homoscedastic assumptions of data for linear models. In addition, we calculated the
mean M value across all 40 NR3C1 CpG sites as well as subsets of CpG sites based on genomic
function, either promoter-associated (n = 24) or within the gene body (n = 7).
Covariates
Covariates including age at blood draw (continuous); measures of early life
socioeconomic position (SEP): highest level of education in the household at age 13 (Less than
high school, High school graduate, Some college, College degree or higher), family income
while growing up (Poor, Low income, Middle income, Well off), and as a child, whether there
were times when the family did not have enough food to eat (Yes, No); adult educational
attainment (continuous) as a measure of adult SEP; body mass index (continuous; kg/m2); and
smoking history - number of pack years smoked (continuous) were adjusted for in our analyses,
as well as proportions of white blood cell types (CD8 T cells, CD4 T cells, natural killer cells, B
cells, monocytes, or granulocytes versus other), which were estimated using the methods
outlined by Houseman et al.27. Although no participants were diagnosed with breast cancer at
time of blood draw, all models were adjusted for breast cancer case status at end of follow-up
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(dichotomous; case vs. non-case) to account for potential pre-clinical effects of breast cancer on
NR3C1 methylation.
Statistical analysis
Descriptive characteristics were evaluated using means and standard deviations for
continuous variables and frequency counts for categorical variables. Multivariable robust linear
regression analysis was conducted to evaluate the association between measures of early life
trauma and M values for 40 individual CpG sites located on NR3C1, as well as overall
methylation and methylation based on CpG location. Models were adjusted for age, breast cancer
status, smoking history, body mass index, and blood cell types. Although smoking history and
body mass index are potential mediators of the early life trauma and NR3C1 methylation
pathway, they are often included as covariates in the literature as strong predictors of DNA
methylation. They were included as confounders in robust linear regression models to contribute
to the robustness of NR3C1 methylation measures despite the potential to attenuate effect sizes as
mediating factors. To correct for multiple testing across the 40 NR3C1 CpG sites, a false
discovery rate (FDR) was applied using the Q-value method28 and CpG sites with FDR Q < 0.05
were considered differentially methylated in relation to early life trauma. Analyses were
conducted using SAS version 9.4 (SAS Institute Inc., Cary, NC)29.
We carried out structural equation modeling (SEM) in Mplus version 8.330 to assess the
relationship between early life exposure to traumatic events and different measures of NR3C1
methylation in adulthood and to evaluate potential mediation through adult trauma. Figure 3.2
outlines the three models used to assess this relationship: model 1 adjusted for age, breast cancer
status, smoking history, body mass index, and blood cell types (black); model 2 additionally
adjusted for early life and adult SEP, with adult SEP acting as a potential intermediate
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confounder (blue); and model 3 allowed for mediating pathways via adult health and lifestyle
factors (smoking and BMI), which were previously included as covariates in models 1 and 2
(green).Path coefficients were estimated using full information maximum likelihood estimation
to calculate the total effect, the direct effect (pathway A) between early life trauma and adult
NR3C1 methylation, the total indirect effect, and the indirect effect mediated specifically by
adult trauma (model 1: B-C; model 2: additionally D-E-C; model 3: additionally D-E-F-G and BF-G). Goodness of fit was evaluated using root mean square error of approximation (RMSEA)
and the Comparative Fit Index (CFI), with RMSEA < 0.02 and CFI > 0.95 as indicators of good
fit31.
Change in percent methylation was calculated on the β-value scale from M value robust
linear regression estimates or SEM pathway coefficients and mean M values using the ‘Mmodel-M-mean’ model described by Xie et al.32
3.3 Results
Sample characteristics
Characteristics of Sister Study participants with DNA methylation and early life trauma
data are shown in Table 3.1. Approximately 46% of women included in the sample reported at
least one traumatic experience before age 18, which is slightly lower than the rate of early life
traumas in the full Sister Study cohort (50%). The average age at baseline of women with at least
one early life trauma was 56.5 (standard deviation: 8.5) years and was 57.8 (standard deviation:
8.9) years for women who experienced no early life trauma. Women who experienced one or
greater early life trauma more often reported lower parental educational attainment, growing up
in a poor or low-income household, and periods of food scarcity as a child compared to women
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with no early life trauma. The distribution of body mass index and smoking status among the
study sample was similar for all women.
Percent NR3C1 methylation
The mean DNA methylation across the 40 NR3C1 CpG sites among women in the sample
was 34.8% with approximately 10% methylation of promoter-associated CpG sites and 93%
methylation of CpG sites located in the gene body (Table 3.2). The mean percent methylation for
individual CpG sites ranged from 0.56% (cg26720913, located in exon 1A in the primary
promoter region) to 98.17% (cg23273257, located in the 3’ untranslated region) (Table 3.3).
Early life trauma and overall NR3C1 methylation
We assessed the relationship between latent classes of early life trauma and differential
NR3C1 methylation overall, as well as across promoter-associated CpG sites and CpG sites
located within the gene body. Latent classes of moderate to high early life trauma were not
associated with differential methylation overall or within promoter-associated CpG sites when
compared to the latent class of low early life trauma after adjusting for age, breast cancer status,
and blood cell types (data not shown) or additional adjustment for smoking history and body
mass index (Table 3.4). The latent class of early life trauma consisting of personal sexual trauma
and family drug, alcohol, and/or mental health issues was associated with a 0.08% decrease in
methylation of gene body CpG sites compared to women with low early life trauma, after
adjusting for age, breast cancer status, smoking history, body mass index, and blood cell types (p
= 0.036). We did not observe any associations between other latent classes of early life trauma
and methylation across NR3C1 gene body CpG sites when compared to the low early life trauma
group.
Early life trauma and differential NR3C1 methylation at individual CpG sites
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We examined the association between latent classes of early life trauma and differential
methylation at 40 individual CpG sites across NR3C1 included on the Illumina Infinium
HumanMethylation450 BeadChip. Ten CpG sites were differentially methylated when
comparing latent classes of early life trauma with low early life trauma as the referent after
controlling for age, breast cancer status, smoking history, body mass index, and cell types, but
failed to remain statistically significant following FDR adjustment (Supplemental Table 3.1).
Although the associations between latent classes of early life trauma and methylation at
individual CpG sites were not statistically significant after controlling for age, breast cancer
status, smoking history, body mass index, and cell types, we explored potential trends in
differential methylation based on latent class of early life trauma. Figure 3.3 shows the percent
change in methylation between each latent class of moderate or high early life trauma compared
to low early life trauma for each CpG site included in the study. Whereas most CpG sites hover
around no differential methylation between latent classes of moderate to high early life trauma
and low early life trauma, a few CpG sites suggest a patterning of differential methylation.
Visual trends suggest that the percent methylation change increased with greater severity of
moderate to high early life trauma compared to low early life trauma for a CpG site in the
proximal promoter, cg12466613, and cg03857453, in the gene body. Conversely, for
cg06968181 and cg18019515, both promoter-associated CpG sites, when compared to women
who reported low levels of early life trauma, percent change in methylation appeared greatest
among women who reported moderate levels of early life trauma consisting of either family
health issues or sexual trauma and family drug, alcohol, or mental health issues (Figure 3.3).
Life course models of trauma and NR3C1 methylation of gene body CpG sites
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We further examined whether the observed association between latent classes of early life
trauma and mean hypomethylation of CpG sites in the NR3C1 gene body was mediated by adult
measures of trauma, SEP, or health and lifestyle factors. Table 3.5 presents results from three life
course models that estimated the total, direct, total indirect, and indirect effects mediated by
adult trauma of this association. In all models, we did not see an association between adult
trauma and NR3C1methylation of gene body CpG sites (path C). We did not observe direct
(pathway A) or indirect effects via adult trauma (path B-C) of latent classes of early life trauma
on percent change in methylation of NR3C1 in models that included age, breast cancer status,
smoking history, BMI, and cell types (RMSEA = 0.030, CFI = 0.985); models that additionally
adjusted for early life and adult SEP (RMSEA = 0.021, CFI = 0.889); and models that
additionally allowed for mediating pathways through adult health and lifestyle factors associated
with DNA methylation - BMI and smoking history (RMSEA = 0.017, CFI = 0.919).
Moderate early life trauma consisting of sexual trauma and family drug, alcohol, and/or
mental health issues was associated with hypomethylation of NR3C1 gene body CpG sites when
direct and indirect pathways were considered in the fully adjusted pathway model; moderate
early life trauma consisting of sexual trauma and family drug, alcohol, and/or mental health
issues resulted in a 0.04% decrease in methylation of NR3C1 gene body CpG sites holding all
covariates constant (p = 0.01), which was attenuated from the effect estimated in the robust
linear regression models (Table 3.5). This was primarily driven by the direct effect of moderate
early life trauma consisting of sexual trauma and family drug, alcohol, and/or mental health
issues on methylation of NR3C1 gene body CpG sites (% methylation change = 0.03, p = 0.048).
The indirect effect of early life trauma on NR3C1 methylation, mediated by all pathways that
included adult trauma, was not statistically significant, suggesting that sexual trauma and family
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drug, alcohol, and/or mental health issues is associated with methylation of NR3C1 gene body
CpG sites independent of adult trauma.
3.4 Discussion
This study used a candidate gene approach to assess the relationship between early life
trauma and adult levels of NR3C1 methylation, as a measure of epigenetic modification of HPA
axis genes in response to early life trauma. To our knowledge, it is one of the largest studies to
specifically assess this relationship. We utilized a latent class model of early life trauma, instead
of traditional overall counts or trauma domains, to assess how various combinations of early life
trauma may differentially affect NR3C1 methylation. We found that moderate early life trauma
consisting of sexual trauma and household dysfunction was associated with moderate decrease in
methylation among CpG sites within the gene body. However, we did not observe any additional
associations between other latent classes of trauma and differential NR3C1 methylation overall,
among promoter-associated CpG sites, or within the gene body. Although there were several
CpG sites that were associated with different latent classes of early life trauma after controlling
for age, breast cancer status, smoking history, body mass index, and blood cell types, these
associations did not survive correction for multiple testing. Furthermore, moderate early life
trauma consisting of sexual trauma and family drug, alcohol, and mental health issues was also
associated with hypomethylation of NR3C1 gene body CpG sites compared to low early life
trauma when considering both direct and indirect effects in life course SEM models. We
observed no mediating effects via adult trauma, adult SEP, nor adult smoking or BMI, which
have been associated with differential DNA methylation33, 34.
The glucocorticoid receptor plays a pivotal role in HPA axis functioning and stress
response mechanisms. Most research on NR3C1 methylation has focused on CpG sites within the
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proximal promotor region of NR3C1 due to its prominent role in NR3C1 transcription; less
studied, methylation changes in the bodies of genes have been reported to play a role in
differential promotor usage, transcription elongation, or alternative splicing35, 36.
Hypomethylation of CpG sites along the gene body, as seen with moderate early life trauma
consisting of sexual trauma and family drug, alcohol, or mental health issues, may contribute to
aberrant DNA transcription and may have implications for downstream health outcomes related
to abnormal tissue-specific expression of glucocorticoid receptors and dysfunction of stress
response regulation, however, these impacts have not yet been elucidated.
Findings from previous studies that have investigated the association between childhood
or early life trauma and adult NR3C1 methylation in peripheral blood have been mixed. Whereas
some studies have reported increased levels of NR3C1 methylation overall and within promoter
regions associated with number of traumas17, 18 or specific domains of childhood/adolescent
adversity (e.g., physical abuse and emotional neglect)37, 38, other studies have reported decreased
methylation around promoter regions and at individual CpG sites associated with different
measures early life trauma19, 38, 39. Still other studies report no association between early life
adversity and NR3C1 methylation20, 40, 41. The variation in these results may be in part to the
heterogeneity of measures used to assess childhood and/adolescent trauma, the period during
which trauma data were ascertained, the NR3C1 CpG sites included in the analyses, the method
used to capture NR3C1 methylation data, whether the studies corrected for multiple testing, as
well as the study populations represented in the study, which differed by age, sex, and proportion
of participants selected for known psychiatric and mental health disorders.
The lack of associations between early life adversity and NR3C1 methylation observed in
this study, when previous studies have reported otherwise, may be attributable to several factors.
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Our findings are consistent with two studies by Vangeel et al. that found no association between
childhood trauma and emotional abuse and NR3C1 methylation in women diagnosed with
chronic fatigue syndrome, who had a mean age older than 40 years20, 41. The lack of associations
observed in those studies, as well as the current study, could be attributed to a in part due to the
long period between the reported early life trauma and the measurement of NR3C1 methylation
in adulthood. Although DNA methylation is thought to be a durable epigenetic modification,
methylation levels can be modified over time and may not persist over the lifecourse42, 43. As
such, different risk or protective factors experienced over the life course may mediate the
association between the reported trauma and the observed methylation patterns. A
comprehensive study by Marzi et al. looked at the association between childhood trauma and
NR3C1 methylation at age 18, thus eliminating the long period between exposure and
measurement, and found no associations40. However, Marzi et al. cited a limitation of using
commercial arrays to assess detailed methylation patterns among candidate genes commonly
associated with stress and maltreatment as these regions are not well covered in the Illumina
array6, 40, 44.
The current study has some limitations. First, this study presents a single measure of
DNA methylation of a single stress response gene, NR3C1 captured in later adulthood (after 35
years of age). It is unknown when epigenetic modification becomes stabilized following
exposures of stress and trauma and the degree to which these changes can be modified post
exposure. Although NR3C1 plays a pivotal part in the stress response due to the role of
glucocorticoid receptors in HPA axis signaling, it is a single gene in a complex network of
mechanisms that characterize the stress management process. In order to better assess the role of
epigenetic modification in the association between early life trauma and stress response
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mechanisms and subsequent health outcomes, it would be prudent to gain a more global picture
by assessing additional HPA axis genes.
Second, although it can be assumed that experience of early life trauma occurred prior to
measurement of NR3C1 methylation in adulthood, the stress and trauma questionnaire was
completed at the biennial follow-up interview, approximately two years after the blood sample
was collected at baseline. Although adult trauma was assessed for the period between age 18 and
a year before completion of the stress questionnaire, it is possible that reported adult traumas
could have occurred after the blood sample was collected, thus attenuating the observed effect of
adult trauma on NR3C1 methylation.
Finally, our population was limited to non-Hispanic White women, who, due to the
eligibility criteria of the parent Sister Study population, all have a family history of breast cancer,
and were sampled in a case-cohort fashion. The Sister Study cohort is generally older, more
educated, and more likely to be healthy and economically sound, which may underestimate the
effects of early life trauma in more vulnerable populations. Although this would not affect the
internal validity of our results, it may limit their application to other diverse populations.
This study also has several strengths and innovations. First, this is the first study to look
at the relationship between early life trauma and NR3C1 methylation using a life course
framework within a structural equation model approach. Other studies that control for SEP
measures over the life course, adult trauma, and/or adult health and lifestyle factors may
inappropriately adjust for complex mediating pathways that affect the overall relationship
between early life trauma and NR3C1 methylation in adulthood, thus attenuating the effect of
early life trauma on NR3C1 methylation. Second, whereas previous studies have utilized
summary measures, domains, or distinct events to assess life course trauma, we utilize a latent
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class approach for early life trauma and a latent variable approach for adult trauma to capture
potential substantive differences in the role of concomitant traumas on adult NR3C1 methylation.
In summary, we did not find an association between latent classes of early life trauma and
adult levels of NR3C1 methylation from peripheral blood, either overall, based on functional
location, or at specific CpG sites along the NR3C1 gene. However, the small decrease in
methylation among CpG sites along the gene body associated with a latent class of early life
trauma representing moderate trauma associated with sexual trauma and family drug, alcohol,
and/or mental health issues may suggest that the cooccurrence of these traumas may open the
door for potential alternative transcription of the NR3C1 variants and that various clusters of
concurrent early life traumatic events should be explored to identify more nuanced patterns of
epigenetic modification. Large studies that encompass multiple stress response genes may
provide a better picture of the role epigenetic modification may play in the association between
the experience of early life trauma and poor health outcomes in adulthood.
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3.5 Tables and Figures
Figure 3.1 Cystine-phosphate-guanine (CpG) sites located on NR3C1
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Figure 3.2 Life course model of NR3C1 methylation with annotated pathways of interest
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Table 3.1 Characteristics of a sub-sample of 2,678 Sister Study participants based on experience
of early life traumas before age 18
No Early Life
Trauma
(n = 1,451)
n
%
Breast cancer status
No breast cancer
591
Invasive or in situ breast cancer
860
Age at baseline, mean (SD)
57.81
Highest level of education in the
household at age 13, %
Less than high school
202
High school graduate
533
Some college
288
College degree or higher
428
Family income while growing up, %
Poor
54
Low income
336
Middle income
976
Well off
85
As a child, were there times when your
family did not have enough food to eat, %
Yes
60
No
1391
Body Mass Index
Underweight
19
Normal weight
561
Overweight
469
Obese
401
Smoking Status
Never smoked
789
Past smoker
564
Current smoker
98
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Any Early Life
Trauma
(n = 1,227)
n
%

p-value
0.104

40.73
59.27
8.86

538
689
56.47

43.85
56.15
8.53

13.92
36.73
19.85
29.5

207
441
252
327

16.87
35.94
20.54
26.65

3.72
23.16
67.26
5.86

114
365
676
72

9.29
29.75
55.09
5.87

<.0001
0.113

<.0001

<.0001
4.14
95.86

140
1087

11.41
88.59
0.627

1.31
38.66
32.32
27.64

10
467
401
349

0.81
38.06
32.68
28.44

54.38
38.87
6.75

613
526
88

49.96
42.87
7.17

0.072

Table 3.2 NR3C1 percent methylation by location
Location
Overall
Promotor-associated
Gene body

% Methylated
34.83
10.05
93.34
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Table 3.3 NR3C1 percent methylation by CpG site
CpG Site
Study
number
1
2

%
Methylated

CpG Site

%
Methylated

95

cg12466613 TSS1500
cg07589972 TSS1500

96.04
96.82

Study
number
21
22

3
4
5

cg26720913 1stExon/5'UTR
cg08818984 1stExon/5'UTR
cg07528216 5'UTR

0.56
1.13
97.82

23
24
25

cg00629244 TSS200/5'UTR
cg18146873 1stExon/5'UTR
cg20753294 1stExon/5'UTR

0.61
0.99
5.62

6
7

cg27345592 5'UTR
cg13648501 TSS1500/5'UTR

97.71
2.20

26
27

cg17617527 5'UTR
cg06521673 5'UTR

1.45
0.93

8

cg24026230 5'UTR

1.59

28

cg06952416 5'UTR

5.56

9
10

cg14558428 TSS1500/5'UTR
cg21702128 TSS1500/5'UTR

0.82
2.76

29
30

cg27122725 5'UTR
cg18998365 5'UTR

5.53
65.76

11
12

cg10847032 TSS1500/5'UTR
cg16335926 TSS1500/5'UTR

1.22
1.49

31
32

cg07733851 5'UTR
cg08845721 5'UTR

36.69
96.52

13
14

cg18849621 TSS1500/5'UTR
cg06968181 TSS1500/5'UTR

1.54
4.76

33
34

cg17342132 Body
cg06613263 Body

94.11
93.74

15

cg26464411 TSS1500

2.91

35

cg25535999 Body

96.34

16
17

cg18068240 TSS1500/5'UTR
cg15645634 TSS1500/5'UTR

0.63
0.59

36
37

cg16586394 Body
cg18484679 Body

97.32
95.88

18
19

cg15910486 TSS1500/5'UTR
cg04111177 TSS1500/5'UTR

5.07
1.40

38
39

cg03857453 Body
cg19457823 Body

82.27
94.46

20

cg17860381 TSS1500/5'UTR

1.54

40

cg23273257 3'UTR

98.17

Name

Location

Name

Location

cg18019515 TSS200/5'UTR
cg11152298 TSS200/5'UTR

1.25
1.36

Table 3.4. Associations between early life trauma and mean percent methylation across NR3C1 CpG sites or functional subgroups
with early life trauma
All locations
Early life trauma Latent Classes

Low early life trauma
Moderate early life trauma:
Family health issues

n

Estimatea

1682

Ref

p value

Promoter-Associated

%
Methylation Estimatea
Change

p value

Gene body

%
Methylation
Change

Ref

Estimatea

p value

%
Methylation
Change

Ref

96

54

-0.0061

0.4738

-0.06

-0.0063

0.5524

-0.01

-0.0204

0.2214

-0.07

Moderate early life trauma: Sexual
trauma and family
drug/alcohol/mental health issues

149

0.0005

0.9287

0.01

0.0056

0.3841

0.01

-0.0214

0.0357

-0.08

Moderate early life trauma: High
betrayal trauma and family
drug/alcohol/mental health issues

171

-0.0016

0.7540

-0.02

-0.0036

0.5601

-0.01

-0.0018

0.8501

-0.01

Moderate early life trauma:
Overall

120

0.0071

0.2286

0.07

0.0012

0.8698

0.00

0.0141

0.2184

0.05

High early life trauma
47
-0.0059
0.5404
-0.06
-0.0037
a
Adjusted for age, breast cancer status, smoking history, body mass index, and cell types.

0.7527

-0.01

-0.0137

0.4633

-0.05

Figure 3.3 Percent change in NR3C1 CpG site methylation by latent class of early life trauma (compared to low early life trauma)
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Table 3.5 Estimates of the association between latent classes of early life trauma (compared to low early life trauma) and NR3C1
methylation on the gene body
Model 1a

Model 2b

Model 3c

p-value

Δ%
mDNA

β

SE

p-value

Δ%
mDNA

β

SE

p-value

Δ%
mDNA

0.807

0.01

0.021

0.016

0.194

0.07

-0.021

0.018

0.240

-0.07

0.276
0.277
0.815

-0.06
-0.06
0.00

-0.007
-0.007
0.000

0.006
0.006
0.000

0.286
0.286
0.827

-0.02
-0.02
0.00

-0.009
-0.005
0.004

0.008
0.006
0.002

0.254
0.434
0.063

-0.03
-0.02
0.01

0.815

0.00

0.000

0.000

0.973

0.00

0.000

0.000

0.623

0.00

Moderate early life trauma: Sexual trauma and family drug/alcohol/mental health issues
Direct
-0.022
0.010
0.032
-0.08
-0.011
0.005
Total
-0.021
0.010
0.033
-0.07
-0.010
0.004
Total Indirect
0.000
0.001
0.807
0.00
0.001
0.001

0.014
0.020
0.214

-0.04
-0.04
0.00

-0.009
-0.011
-0.002

0.005
0.004
0.001

0.048
0.011
0.114

-0.03
-0.04
-0.01

0.220

0.00

-0.001

0.001

0.247

0.00

Moderate early life trauma: High betrayal trauma and family drug/alcohol/mental health issues
Direct
-0.004
0.010
0.711
-0.01
-0.002
0.004
0.681
Total
-0.003
0.010
0.740
-0.01
0.000
0.004
0.914
Total Indirect
0.000
0.002
0.807
0.00
0.001
0.001
0.198

-0.01
0.00
0.00

0.001
-0.001
-0.002

0.004
0.004
0.001

0.873
0.762
0.123

0.00
0.00
-0.01

Pathway

β

SE

Adult Trauma
0.004
0.016
Moderate early life trauma: Family health issues
Direct
-0.018
0.016
Total
-0.018
0.016
Total Indirect
0.000
0.000
Indirect - Adult Traumad
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Indirect - Adult Traumad

Indirect - Adult Traumad

0.000

0.000

0.000

0.001

0.807

0.00

0.001

0.001

0.000

0.002

0.807

0.00

0.001

0.001

0.206

0.00

-0.001

0.001

0.248

0.00

Moderate early life trauma: Overall
Direct
0.013
Total
0.014
Total Indirect
0.000

0.011
0.011
0.002

0.243
0.225
0.807

0.05
0.05
0.00

0.008
0.009
0.001

0.005
0.005
0.001

0.163
0.107
0.191

0.03
0.03
0.00

0.01
0.008
-0.002

0.006
0.005
0.001

0.086
0.147
0.126

0.04
0.03
-0.01

0.002

0.807

0.00

0.001

0.001

0.199

0.00

-0.001

0.001

0.264

0.00

Indirect - Adult Traumad

0.000

Table 3.5 (continued)
Model 1a
Pathway
High early life trauma
Direct
Total
Total Indirect
Indirect - Adult Traumad

Model 2b

Model 3c

β

SE

p-value

Δ%
mDNA

β

SE

p-value

Δ%
mDNA

β

SE

p-value

Δ%
mDNA

-0.011
-0.010
0.001

0.019
0.018
0.003

0.553
0.574
0.807

-0.04
-0.04
0.00

-0.005
-0.003
0.002

0.007
0.006
0.001

0.495
0.622
0.209

-0.02
-0.01
0.01

-0.001
-0.005
-0.004

0.008
0.006
0.002

0.915
0.457
0.070

0.00
-0.02
-0.01

0.001

0.003

0.807

0.00

0.002

0.001

0.216

0.01

-0.002

0.001

0.240

-0.01

RMSEA = 0.030; CFI = 0.985
RMSEA = 0.021; CFI = 0.889
RMSEA = 0.017; CFI = 0.919
Adjusted for age, breast cancer status, cell types, smoking history, and BMI
b
Additionally adjusted for early life socioeconomic factors (early life household income, household educational attainment, and food security) and
allowing mediating pathway via adult socioeconomic position (educational attainment)
c
Additionally allow for mediating pathways via adult lifestyle factors (smoking history and body mass index)
d
Pathways from Figure 3.2 - Model 1: B-C; Model 2: Additionally D-E-C; Model 3: Additionally D-E-F-G and B-F-G
CFI: Comparative fit index; mDNA: Methylation; RMSEA: Root mean square error of approximation; SE: Standard error
a
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3.6 Supplemental Materials
Supplemental Table 3.1 Latent classes of early life trauma and adult NR3C1 methylation by CpG site
Moderate early life trauma: Family health issues
CpG site

Estimate

P - value

q value

cg12466613

-0.0235

0.4072

0.9676

cg07589972

-0.0285

0.3188

cg26720913

-0.0228

cg08818984
cg07528216

Δ % mDNA

Moderate early life trauma: Sexual trauma and family
drug/alcohol/mental health issues
Δ % mDNA

100

Estimate

P - value

q value

-0.0618

0.0093

0.5887

0.9889

0.0243

0.9676

-0.0609

-0.0003

0.9873

0.9971

-0.0006

0.4761

0.9889

-0.0086

0.0261

0.1805

0.8870

0.0100

-0.0518

0.1982

0.9008

-0.0385

0.0071

0.7721

0.9971

0.0054

-0.0077

0.7849

0.9971

-0.0113

0.0133

0.4396

0.9846

0.0194

cg27345592

0.0001

0.9952

0.9971

0.0002

-0.0213

0.1332

0.8034

-0.0331

cg13648501

-0.0336

0.3946

0.9676

-0.0486

-0.0002

0.9919

0.9971

-0.0004

cg24026230

0.0172

0.4845

0.9889

0.0186

-0.0224

0.1366

0.8034

-0.0238

cg14558428

0.0147

0.5174

0.9889

0.0083

0.0313

0.0239

0.6836

0.0178

cg21702128

-0.0559

0.2143

0.9237

-0.0992

-0.0247

0.3682

0.9676

-0.0443

cg10847032

-0.0194

0.5879

0.9889

-0.0158

0.0062

0.7776

0.9971

0.0051

cg16335926

0.0154

0.5985

0.9889

0.0156

0.0119

0.5058

0.9889

0.0120

cg18849621

-0.0263

0.4953

0.9889

-0.0270

-0.0151

0.5201

0.9889

-0.0156

cg06968181

0.0439

0.1907

0.8870

0.1378

0.0315

0.1240

0.8034

0.0984

cg26464411

0.0179

0.6603

0.9971

0.0347

-0.0023

0.9249

0.9971

-0.0045

cg18068240

0.0246

0.2954

0.9676

0.0107

0.0403

0.0050

0.3350

0.0176

cg15645634

-0.0201

0.4232

0.9676

-0.0080

0.0132

0.3884

0.9676

0.0053

cg15910486

-0.0716

0.1195

0.8034

-0.2278

0.0023

0.9346

0.9971

0.0075

cg04111177

-0.0392

0.4624

0.9889

-0.0355

-0.0151

0.6436

0.9971

-0.0138

cg17860381

-0.0075

0.8399

0.9971

-0.0077

0.0159

0.4829

0.9889

0.0165

cg18019515

0.0912

0.0004

0.0802

0.0799

0.0407

0.0095

0.3817

0.0351

cg11152298

-0.0537

0.2322

0.9448

-0.0476

-0.0066

0.8107

0.9971

-0.0059

cg00629244

0.0077

0.7371

0.9971

0.0032

0.0240

0.0871

0.8034

0.0100

cg18146873

-0.0138

0.7223

0.9971

-0.0091

-0.0144

0.5423

0.9889

-0.0095

Supplemental Table 3.1 (continued)
Moderate early life trauma: Family health issues
CpG site

Δ % mDNA

Moderate early life trauma: Sexual trauma and family
drug/alcohol/mental health issues
Estimate
P - value
q value
Δ % mDNA
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Estimate

P - value

q value

cg20753294

-0.0337

0.3171

0.9676

-0.1213

0.0366

0.0751

0.8034

0.1345

cg17617527

0.0406

0.2158

0.9237

0.0399

0.0369

0.0651

0.7839

0.0363

cg06521673

-0.0028

0.9544

0.9971

-0.0017

-0.0072

0.8080

0.9971

-0.0045

cg06952416

0.0031

0.9324

0.9971

0.0110

-0.0003

0.9875

0.9971

-0.0012

cg27122725

-0.0002

0.9948

0.9971

-0.0008

0.0122

0.5775

0.9889

0.0438

cg18998365

0.0363

0.4162

0.9676

0.5625

0.0100

0.7140

0.9971

0.1551

cg07733851

0.0095

0.8421

0.9971

0.1529

-0.0233

0.4243

0.9676

-0.3728

cg08845721

-0.0197

0.6968

0.9971

-0.0447

0.0271

0.3812

0.9676

0.0604

cg17342132

-0.0402

0.3393

0.9676

-0.1493

0.0093

0.7167

0.9971

0.0341

cg06613263

-0.0255

0.5466

0.9889

-0.1023

-0.0399

0.1215

0.8034

-0.1610

cg25535999

0.0022

0.9416

0.9971

0.0053

-0.0276

0.1325

0.8034

-0.0671

cg16586394

0.0028

0.9337

0.9971

0.0049

-0.0155

0.4431

0.9846

-0.0277

cg18484679

-0.0197

0.5246

0.9889

-0.0536

0.0049

0.7945

0.9971

0.0133

cg03857453

-0.0350

0.2846

0.9676

-0.3527

-0.0178

0.3735

0.9676

-0.1783

cg19457823

-0.0064

0.8823

0.9971

-0.0224

-0.0710

0.0070

0.3500

-0.2536

cg23273257

0.0024

0.9298

0.9971

0.0029

-0.0214

0.1895

0.8870

-0.0266

Moderate early life trauma: High betrayal trauma and family
drug/alcohol/mental health issues
CpG site

Estimate

P - value

q value

cg12466613

0.0272

0.1013

0.8034

cg07589972

-0.0055

0.7437

0.9971

cg26720913

-0.0370

0.0487

0.7839

cg08818984

-0.0309

0.1899

cg07528216

-0.0177

cg27345592

0.0029

cg13648501
cg24026230

Δ % mDNA

Moderate early life trauma: Overall
Δ % mDNA

Estimate

P - value

q value

0.0704

0.0304

0.1184

0.8034

0.0787

-0.0116

0.0397

0.0439

0.7839

0.0828

-0.0139

-0.0177

0.4225

0.9676

-0.0067

0.8870

-0.0232

0.0056

0.8384

0.9971

0.0043

0.2858

0.9676

-0.0260

-0.0417

0.0318

0.7417

-0.0618

0.8305

0.9971

0.0045

-0.0297

0.0639

0.7839

-0.0462

-0.0269

0.2456

0.9448

-0.0389

-0.0287

0.2902

0.9676

-0.0416

0.0037

0.7956

0.9971

0.0040

-0.0076

0.6549

0.9971

-0.0081

Supplemental Table 3.1 (continued)
CpG site

Moderate early life trauma: High betrayal trauma and
family drug/alcohol/mental health issues
Estimate
P - value
q value
Δ % mDNA

Moderate early life trauma: Overall
Estimate

P - value

q value

Δ % mDNA

cg14558428

-0.0149

0.2616

0.9676

-0.0084

-0.0158

0.3109

0.9676

-0.0089

cg21702128

0.0638

0.0156

0.5211

0.1178

-0.0125

0.6858

0.9971

-0.0226

cg10847032

-0.0076

0.7191

0.9971

-0.0062

0.0411

0.0954

0.8034

0.0342

cg16335926

-0.0168

0.3277

0.9676

-0.0168

-0.0160

0.4257

0.9676

-0.0160

cg18849621

-0.0141

0.5338

0.9889

-0.0145

0.0035

0.8953

0.9971

0.0036

cg06968181

0.0131

0.5070

0.9889

0.0406

0.0002

0.9915

0.9971

0.0008

cg26464411

-0.0116

0.6286

0.9971

-0.0221

0.0054

0.8477

0.9971

0.0104

cg18068240

-0.0080

0.5638

0.9889

-0.0034

-0.0036

0.8223

0.9971

-0.0016

cg15645634

-0.0110

0.4531

0.9889

-0.0044

-0.0027

0.8764

0.9971

-0.0011

cg15910486

0.0507

0.0095

0.7639

0.9971

0.0310

102

0.0155

0.5650

0.9889

cg04111177

0.0576

0.0651

0.7839

0.0540

0.0390

0.2880

0.9676

0.0363

cg17860381

-0.0100

0.6450

0.9971

-0.0103

-0.0298

0.2437

0.9448

-0.0305

cg18019515

0.0178

0.2380

0.9448

0.0152

0.0219

0.2171

0.9237

0.0187

cg11152298

-0.0025

0.9257

0.9971

-0.0022

-0.0251

0.4171

0.9676

-0.0224

cg00629244

-0.0007

0.9584

0.9971

-0.0003

-0.0083

0.5984

0.9889

-0.0034

cg18146873

-0.0402

0.0769

0.8034

-0.0264

0.0272

0.3074

0.9676

0.0183

cg20753294

-0.0068

0.7296

0.9971

-0.0248

0.0116

0.6155

0.9928

0.0425

cg17617527

0.0016

0.0098

0.6633

0.9971

0.0096

0.0016

0.9326

0.9971

cg06521673

0.0081

0.7769

0.9971

0.0051

0.0479

0.1532

0.8284

0.0303

cg06952416

-0.0114

0.5891

0.9889

-0.0409

0.0054

0.8291

0.9971

0.0193

cg27122725

-0.0024

0.9088

0.9971

-0.0086

-0.0003

0.9910

0.9971

-0.0010

cg18998365

-0.0248

0.3427

0.9676

-0.3874

0.0129

0.6740

0.9971

0.2007

cg07733851

-0.0084

0.7649

0.9971

-0.1343

0.0136

0.6790

0.9971

0.2185

cg08845721

-0.0270

0.3631

0.9676

-0.0613

0.0378

0.2784

0.9676

0.0840

cg17342132

-0.0138

0.5768

0.9889

-0.0507

0.0413

0.1533

0.8284

0.1496

cg06613263

-0.0006

0.9813

0.9971

-0.0023

0.0210

0.4703

0.9889

0.0831

cg25535999

-0.0072

0.6835

0.9971

-0.0174

0.0124

0.5497

0.9889

0.0297

Supplemental Table 3.1 (continued)
CpG site

Moderate early life trauma: High betrayal trauma and
family drug/alcohol/mental health issues
Estimate
P - value
q value
Δ % mDNA

Moderate early life trauma: Overall
Estimate

P - value

q value

Δ % mDNA

cg16586394

0.0295

0.1282

0.8034

0.0520

-0.0057

0.8028

0.9971

-0.0101

cg18484679

0.0003

0.9871

0.9971

0.0008

0.0390

0.0666

0.7839

0.1043

cg03857453

-0.0054

0.7788

0.9971

-0.0539

0.0001

0.9965

0.9971

0.0010

cg19457823

-0.0279

0.2709

0.9676

-0.0982

0.0118

0.6909

0.9971

0.0411

cg23273257

-0.0002

0.9916
0.9971
High early life trauma

-0.0002

0.0358

0.0519

0.7839

0.0436

CpG site

Estimate

P - value

q value

Δ % mDNA
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cg12466613

0.0314

0.3224

0.9676

0.0812

cg07589972

-0.0201

0.5317

0.9889

-0.0427

cg26720913

-0.0421

0.2406

0.9448

-0.0158

cg08818984

-0.0152

0.7365

0.9971

-0.0114

cg07528216

-0.0002

0.9951

0.9971

-0.0003

cg27345592

-0.0273

0.2961

0.9676

-0.0424

cg13648501

-0.0602

0.1739

0.8870

-0.0862

cg24026230

0.0038

0.8894

0.9971

0.0041

cg14558428

0.0063

0.8055

0.9971

0.0035

cg21702128

0.0851

0.0913

0.8034

0.1584

cg10847032

0.0057

0.8874

0.9971

0.0047

cg16335926

0.0285

0.3850

0.9676

0.0289

cg18849621

-0.0701

0.1049

0.8034

-0.0708

cg06968181

-0.0207

0.5816

0.9889

-0.0637

cg26464411

0.0419

0.3598

0.9676

0.0816

cg18068240

0.0139

0.5983

0.9889

0.0060

cg15645634

-0.0093

0.7408

0.9971

-0.0037

cg15910486

0.1096

0.0334

0.7417

0.3692

cg04111177

0.0514

0.3901

0.9676

0.0480

cg17860381

-0.0002

0.9971

0.9971

-0.0002

Supplemental Table 3.1 (continued)
High early life trauma
Estimate

P - value

q value

Δ % mDNA

cg18019515

-0.0231

0.4237

0.9676

-0.0195

cg11152298

0.0153

0.7608

0.9971

0.0139

cg00629244

-0.0130

0.6138

0.9928

-0.0054

cg18146873

0.0226

0.6032

0.9889

0.0152

cg20753294

0.0006

0.9872

0.9971

0.0022

cg17617527

0.0071

0.8462

0.9971

0.0069

cg06521673

-0.0868

0.1122

0.8034

-0.0524

cg06952416

-0.0645

0.1108

0.8034

-0.2270

cg27122725

0.0329

0.4150

0.9676

0.1184

cg18998365

-0.0698

0.1628

0.8566

-1.0948

cg07733851

-0.0011

0.9834

0.9971

-0.0179

cg08845721

-0.1087

0.0555

0.7839

-0.2535

cg17342132

-0.0268

0.5699

0.9889

-0.0990

cg06613263

-0.0322

0.4967

0.9889

-0.1295

cg25535999

-0.0311

0.3558

0.9676

-0.0758

cg16586394

0.0537

0.1475

0.8284

0.0940

cg18484679

-0.0991

0.0042

0.3350

-0.2770

cg03857453

0.0173

0.6366

0.9971

0.1725

cg19457823

0.0180

0.7101

0.9971

0.0625

-0.0204
0.4961
mDNA: Methylation; SE: Standard error

0.9889

-0.0254

CpG site
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cg23273257
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CHAPTER 4
Early Life Trauma and Adult Leucocyte Telomere Length
4.1 Introduction
Growing evidence has linked trauma with adverse psychological and physiological health
outcomes1, 2. Furthermore, research suggests children may be particularly vulnerable to the
effects of trauma from its disruptive effect on neurological, physiological, or psychological
development3. Childhood trauma has been associated with high risk behaviors4, 5, cognitive
impairment6, high risk of revictimization6, and adverse mental and physical health outcomes later
in life1, 7. Under life course conceptual models, early life environments may lead to poor
outcomes due to exposures during developmentally sensitive periods or by contributing to
cumulative damage to biological systems. In a sensitive period model, trauma/adversity in early
life has lasting effects on the structure or function of the body and long-term health effects,
independent of subsequent adverse exposures (Figure 4.1A)8. Alternatively, the accumulation of
risk factors over the life course may have an additive effect that results in cumulative biological
damage contributing to poor health later in life or may have a trigger effect in which the final
link in the chain or risk (i.e., the adult exposure) dictates the final health outcome (Figure 4.1B)8,
9

. Evaluating the pathways of early childhood trauma on biological mechanisms of aging and

disease development provides insight into the early life origins and etiology of adverse health
outcomes.
Telomeres are repeating DNA protein complexes at the end of chromosomes that protect
chromosomal stability and integrity10. Telomeres gradually shorten with each subsequent cell
division, which continues until cell cycle arrest or cellular senescence; the state in which
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telomeres reach a critical length and no longer have the capacity to divide, occurs11. Research
suggests telomeres are linked to age-dependent processes12, the development of chronic
diseases13 including cancer14, obesity, diabetes15, 16, cardiovascular disease15, 17, and mortality18.
Therefore, telomeres have been widely investigated in research as a biomarker for cellular aging
and age-related diseases19.
Due to the growing evidence linking telomere length and disease development, telomeres
have been proposed as a pathway to describe how trauma and other adversities are biologically
embodied “under the skin” to influence adverse health outcomes10. In 2010, preliminary research
suggested childhood maltreatment was associated with shorter telomeres20. Since then, research
has supported the association between childhood and adolescent trauma and shorter telomeres2126

and revealed mixed, reversed, and more complex associations related to age and trauma

measurement27, 28. The type of traumatic adversity22, 23, 29, 30, number of traumatic exposures25, 27,
31

, and timing of exposure29, 31 have been shown to have differential or compounding effects on

telomere length with increased trauma severity or chronic exposures contributing to shorter
telomere length. However, few studies have looked at how the cooccurrence of specific traumas
may play a role in telomere attrition.
Recent life course research evaluating cumulative lifetime adversity has further suggested
that exposure during early life may be particularly damaging, revealing cumulative adversity
during early life predicted shorter telomere length in adulthood24 in addition to shorter baseline
telomere length and greater telomere attrition in mid-life31. Willis et al. proposed a social
trajectory or accumulation model in which the association between childhood stressful life events
and adult saliva telomere length was fully mediated through adult stressful life events32. To our
knowledge, no study has evaluated the mediation of the association between early life trauma
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during childhood and adolescence and telomere length by later life experiences in peripheral
blood or evaluated how different patterns of concurrent trauma in early life may differentially
affect adult telomere length. This study aims to elucidate the relationship between early life
trauma and adult leukocyte telomere length, a marker of cellular aging and the potential
mediating role of chronic trauma in adulthood in this relationship. Furthermore, this study uses a
latent class approach to assess the role of cooccurring traumas on telomere attrition. Evaluating
the effect of cooccurring traumatic experiences during specific windows of vulnerability across
the life course allows for life course mechanisms to be tested, filling gaps in current knowledge
about the relationships between early life stress and adult telomere length. It was hypothesized
that childhood traumatic adversities will be associated with shorter telomere length independent
of exposure to traumatic adversities later in life.
4.2 Methods
Study population
The Sister Study is a prospective cohort study designed to assess environmental and
genetic risk factors for breast cancer and other conditions33. Participants are U.S. and Puerto
Rican women (ages 35 to 74 years old; N = 50,884) and have a biological sister previously
diagnosed with breast cancer but had not been diagnosed with breast cancer themselves at
baseline (2003-2009). During the baseline visit, participants completed a telephone interview, as
well as anthropometric measurements and blood sample collection; annual health updates and
detailed follow-up visits are completed every 2-3 years. Requests for Sister Study data can be
submitted by following the directions at http://sisterstudy.niehs.nih.gov/English/coll-data.htm.
All participants provided written informed consent. The study was approved by the
Institutional Review Boards of the National Institute of Environmental Health Sciences and the
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Copernicus Group. The current analysis using coded data was considered exempt from human
subject research by the Institutional Review Board at the University of Wisconsin-Milwaukee.
An initial vanguard sub-sample of 740 women from the first 2086 Sister Study
participants who completed the first annual health update follow-up by June 2005 was selected to
conduct telomere studies. Smokers, nonwhite women, and women with high perceived stress
were oversampled and the remaining women were sampled randomly34.
We excluded 100 participants with insufficient telomere length data and an additional 73
participants who did not complete a stress and trauma questionnaire at the first follow-up visit
(two to three years after enrollment). A total of 602 participants were included in the present
study.
Traumatic events over the life course
Adverse experiences and traumatic events were collected during the detailed follow-up
questionniare33, which was conducted two to three years after baseline and included original
items from the Brief Betrayal Trauma Survey35 as well as items modified for The Sister Study.
Participants were asked whether they had ever experienced each traumatic event in their lifetime
(Possible responses: Yes, No, Don’t know, Refuse to answer). Participants who answered
affirmatively, were asked if they experienced the trauma before age 13 (childhood), between the
ages of 13 and 17 (adolescence), after age 18 until 12 months prior to survey completion
(adulthood), and during the past twelve months (recent adulthood). Traumatic events classified
as occurring in recent adulthood were excluded as they would have occurred after the blood
sample was collected at baseline. The 20 traumatic experiences collected in the stress and trauma
questionnaire and included in this study were classified into 7 domains: 1) natural disasters, 2)
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major accidents, 3) household dysfunction, 4) sexual abuse, 5) physical abuse, 6) emotional or
psychological abuse, and 7) major illness before age 18.
A latent class variable was created to better capture the co-occurrence of early life
traumas among Sister Study participants who completed the trauma questionnaire (n = 45,973) in
order to capture the distribution of trauma profiles in the underlying Sister Study cohort. We
estimated five latent class models with 2 to 6 latent clusters using the 20 types of early life
trauma as indicators. Within each model, we assigned substantive classifications based on
conditional response probabilities of each cluster. The latent class model with six clusters had the
best model fit of the tested models while still maintaining moderate to high level certainty that
participants were placed in the correct clusters, which is evaluated using entropy on a scale of 0
to 1 (entropy = 0.72). We identified six latent classes based on the proportion of women who
reported each early life trauma within each cluster: 1) low early life trauma (average probability
of reporting any type of early life trauma was less than 2% across all possible traumatic events;
referent), 2) family health issues (highest proportions for death of a parent and major illness (not
breast cancer) in someone close, 40% and 49%, respectively. Average across all other traumas =
6%), 3) sexual trauma and family drug/alcohol/mental health issues (highest proportions for
unwanted sexual contact by someone close (22%) or someone not close (22%) and family drug,
alcohol, and/or mental health issues (17%). Average across all other traumas = 4%), 4) high
betrayal trauma and family drug/alcohol/mental health issues (highest proportions for traumas
perpetrated by someone close – unwanted sexual contact (22%), hit or attached (16%),
emotionally or psychologically mistreated (99%) and family drug, alcohol, and/or mental health
issues (28%). Average across all other traumas = 5%), 5) moderate early life trauma: overall
(average probability of reporting each early life traumatic event = 17%), and 6) high early life
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trauma (average probability of reporting each early life traumatic event = 32%). Adult trauma
that occurred between age 18 and 12 months prior to completing the stress and trauma
questionnaire was assessed using a latent variable created from adult responses to the same 20
trauma types used to assess early life trauma (RMSEA = 0.025, CFI = 0.919).
Leukocyte telomere length
Whole blood samples were obtained during the home visit at study baseline prior to any
diagnosis of breast cancer. Samples were then shipped and stored at -80°C until DNA was
extracted. Relative telomere length was assessed using PCR-based assays using methods
described elsewhere 34, 36, 37. In summary, 1µL aliquots of 100 to 200 ng of template DNA was
amplified for telomeric DNA and a single-copy gene. Telomere length is measured as a ratio
(T/S ratio) of the relative amount of telomeric DNA (T) to the relative amount of DNA from the
single-copy control gene (S). Details on how the samples were run and quality control are
previously described34.
Covariates
Covariates were age at baseline (continuous); race/ethnicity (non-Hispanic White, nonHispanic Black, Hispanic, other); measures of early life socioeconomic position (SEP): highest
level of education in the household at age 13 (Less than high school, High school graduate, Some
college, College degree or higher), family income while growing up (Poor, Low income, Middle
income, Well off), and as a child, whether there were times when the family did not have enough
food to eat (Yes, No); adult educational attainment (continuous) as a measure of adult SEP; and
adult health and lifestyle factors: number of pack years (continuous) and adult body mass index
(BMI, continuous).
Statistical analysis
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Descriptive statistics were calculated using means and standard deviations for continuous
variables and frequency counts for categorical variables.
Risk ratios and 95% confidence intervals (CI) were calculated using linear regression
models created to assess the association between latent classes of early life trauma and telomere
length, using unadjusted, age-adjusted, and age and early life SEP-adjusted models. Model
estimates represent the change in telomere length (T/S ratio) when comparing women in each
latent class of early life trauma compared to women who were classified as experiencing low
early life trauma. Descriptive statistics and linear regression models were conducted using SAS
version 9.4 (SAS Institute Inc., Cary, NC)38 and structural equation models.
We constructed structural equation models using Mplus version 8.339 to assess the
relationship between early life trauma and telomere length and to evaluate potential mediation
through adult trauma (Figure 4.1C). Structural equation modeling accommodates time varying
variables (i.e. early life and adult SEP) and can control for confounding along multiple
pathways40. Path coefficients were estimated using full information maximum likelihood
estimation. Goodness of fit was evaluated using root mean square error of approximation
(RMSEA) and the Comparative Fit Index (CFI), with RMSEA < 0.02 and CFI > 0.95 as
indicators of good fit41. We calculated the total effect of early life trauma on telomere length
including the direct effect (blue pathway) of early life trauma on telomere length, the indirect
effect via adult trauma (red pathways) and indirect effects due to all other mediating pathways as
seen in Figure 4.2. Model 1 adjusted for age and race/ethnicity; model 2 additionally adjusted for
early life SEP and allowed adult SEP to act as a mediator; and model 3 also allowed adult health
and lifestyle factors to serve as potential mediators between early life trauma and telomere length
(green pathway; Figure 4.2).
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4.3 Results
Sample characteristics
Characteristics of Sister Study participants included in the vanguard telomere subsample
are reported in Table 4.1. Approximately 47% of women (n = 284) reported experiencing at least
one early life trauma before age 18, which is slightly lower than the rate of reported early life
trauma in the full Sister Study cohort (50%), but is still comparable to national surveys of
childhood and adolescent trauma in which 48 to 51 percent of women report experiencing at
least one trauma over the life course42, 43. Women who reported at least one early life trauma
were slightly younger at 53.3 (standard deviation: 9.3) years compared to 55.6 (standard
deviation: 9.6) years for women who reported no early life trauma. Although both groups were
predominantly non-Hispanic White, a higher percentage of women who reported at least one
early life trauma also reported being Hispanic or some other race/ethnicity (not non-Hispanic
Black). In this subsample, the distribution of parental educational attainment was similar,
however, women who reported at least one early life trauma were more likely to report growing
up in poor or low-income households and to recall periods of food insecurity. Women who
reported at least one early life trauma were more likely to be obese than women without
experiences of early life trauma, but less likely to be past or current smokers.
Early life trauma and telomere length
When we ran individual linear regression models to assess the overall association
between latent classes of early life trauma and adult telomere length, we found that women who
were grouped in the latent class for high early life trauma had telomeres that were 0.112 (95%
CI: -0.221, -0.004) T/S units shorter than women who were classified as having experienced low
early life trauma (Table 4.2). Although we saw a trend of shorter telomere length observed in all
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latent classes of moderate early life trauma, except for moderate early life trauma consisting of
sexual trauma and family drug, alcohol, and/or mental health issues, none of the models were
statistically significant, whether they were unadjusted or adjusted for age, race/ethnicity, and
early life SEP.
Life course models of trauma and telomere length
Table 4.3 presents results from life course models of the association between latent
classes of early life trauma and telomere length. The initial pathway model of early life trauma
and telomere length allowed for both a direct pathway (blue line) and an indirect pathway via
adult trauma (red lines; Figure 4.2-A). The association between moderate early life trauma
consisting primarily of family health issues on adult telomere length persisted when direct and
indirect (via adult trauma (red lines) and adult health and lifestyle factors (green line)) pathways
were considered together after controlling for early life SEP and adult SEP was included as a
potential mediator (model 3 fit indices: RMSEA = 0.021, CFI = 0.903); experience of family
health issues in early life resulted in telomeres that were 0.042 T/S units shorter than the absence
of such experience after holding other covariates constant (p < 0.05). Furthermore, high early life
trauma was associated with shorter telomere length when direct and indirect pathways were
considered in the fully adjusted pathway model; high early life trauma decreased telomere length
by 0.060 T/S units holding all covariates constant (p = 0.008). This was largely driven by the
negative association attributed to the direct effect of high early life trauma on telomere length (β
= -0.118, S.E. 0.057, p = 0.038). The indirect effect of early life trauma on telomere length,
mediated by adult trauma, was not statistically significant, suggesting that high early life trauma
is associated with telomere length independent of adult trauma.
Sensitivity analyses

118

We also conducted analyses using traditional domains of early life trauma. Using
individual linear regression models, we found that women who reported experiencing a natural
disaster before age 18 had longer telomeres than women who did not experience a natural
disaster in early life after controlling for age, race/ethnicity, and factors of early life SEP (β =
0.124, 95% CI = 0.028, 0.220) (Supplemental Table 4.1). Conversely, women who experienced
physical trauma in early life had shorter telomeres than those who did not experience physical
trauma before age 18 (β = -0.083, 95% CI = -0.162, -0.004 in age-, race/ethnicity-, and early life
SEP-adjusted models. We observed statistically significant inverse total and direct effects
between major accidents, physical trauma, and major illness and telomere length, such that
women who experienced each of these domains of early life trauma had shorter telomeres than
women who did not experience that domain of early life trauma after controlling for all
covariates, life course SEP, and allowing mediating pathways via adult smoking history and BMI
(Supplemental Table 4.2).
4.4 Discussion
The association between childhood trauma and telomere length has been well studied,
however, most studies rely on cumulative scales of childhood trauma26 or specific exposures of
child trauma (i.e., trauma domains44, 45 or specific events46, 47) to represent childhood trauma and
often fail to consider adolescent trauma in their measures of early life trauma. Traumas do not
usually occur in isolation and summative measures may not fully capture the nuances of cooccurring traumas. We only found two studies that used latent variables to capture early life
trauma32, 48, however, it is difficult to assign substantive meaning to a unit change in these
variables making them hard to interpret, so we utilized a latent class model of early life trauma to
assess the effects of concomitant traumas. In our latent class model of early life trauma, only
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women who were classified as having high early life trauma had significantly shorter telomeres
than women classified with low early life trauma in adjusted models.
To assess whether adult trauma mediated the association between early life trauma and
telomere length, we used a sensitive period model including later life risk factors assuming early
life trauma affects telomere length both directly and indirectly (Figure 4.1). We found in models
adjusting for late life risk factors, evidence for a sensitive period effect of early life trauma on
leukocyte telomere length. In models with statistically significant direct effects between
measures of early life trauma and telomere length, the direct effect of early life trauma on
telomere length was in the same direction but had a larger magnitude than the total effect. This ,
suggests that models that adjust for potential life course mediating factors may not capture the
true direct effect of early life trauma on telomere length and may instead be reporting attenuated
effects.
In initial regression models, we observed a positive association between natural disasters
in early life and telomere length after controlling for age and early life SEP. Although the direct
effect of early life natural disasters on telomere length was also positive and statistically
significant in sensitive period models that also controlled for age and early life SEP, the
association was no longer statistically significant and in the opposite direction in models that
controlled for SEP over the life course and allowed for additional mediating pathways through
adult health and lifestyle factors. This suggests that the positive association observed with natural
disasters could be attributable to other factors that occur over the life course associated with SEP
or adult health and lifestyle factors, such as resilience and social support, which has been
reported to moderate the association between natural disasters and other health outcomes49, 50.
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Previous studies of the association between early life trauma and telomere length have
reported mixed results with just over half of studies reporting statistically significant negative
associations between recalled early stressful life events measured in adulthood and telomere
length26. In a review by Willis et al., the authors note that the heterogeneity in findings appear to
be unrelated to the type of measure used to assess early life stress and whether the studies also
adjusted for adult health and lifestyle factors or experience of trauma over the life course26.
However, studies that adjust for potential mediators as confounders may result in estimates that
do not fully capture the effect of early life trauma on adult telomere length. We found only one
study that used SEM to evaluate different life course models of childhood stressful life events
before 18 years in saliva telomere length32. Using financial and social/traumatic adversity to
create an adversity score first constructed in Puterman et al.24, Wallis et al. reported that there
was no direct effect of childhood stressful life events on adult telomere length, with all effects
mediated through adult stressful life events. Observed differences between that study and the
current study could be due to 1) the fact that we capture a wider spectrum of early life traumas
that may be internalized differently, 2) the differences in study populations, and 3) the limited
ability to directly compare qPCR measures of telomere length across populations, let alone
measures from different cell types (i.e., saliva vs. leukocytes)51.
This study has several limitations. First, this study presents a cross-sectional measure of
telomere length. Although we know that experience of early life trauma and recalled adult
trauma all occurred prior to measure of telomere length, we do not know how telomere length is
changing over time in response to experiences of trauma over the life course. Longitudinal
studies that capture serial measures of telomere length over the life course would be better suited
to elucidate the timing associated with trauma experience, embodiment, and telomere

121

modification. Second, although we captured a diverse spectrum of early life traumatic experience
in this sample, the duration and magnitude of these experiences during childhood and
adolescence are unknown. Persistent exposure to traumatic experiences may differentially affect
cellular division and subsequent telomere shortening. Finally, this study utilizes a small
subsample of the total Sister Study cohort, and purposefully oversampled women with higher
perceived stress, were current smokers, and were non-Hispanic White, which may limit its
generalizability to other samples. Additional samples that are both larger and more diverse are
needed to confirm the results observed in this study.
In summary, this paper builds upon previous literature by utilizing interpretable latent
measures of early life trauma that extends into adolescence and exploring potential pathways
through which early life trauma may affect leukocyte telomere length in adulthood. Unlike a
previous study that first explored structural life course models of childhood trauma and salivary
telomere length and found that a social trajectory model in which the effect of child stressful life
events was fully mediated by adult stressful life events32, we found that high early life trauma
was directly associated with leukocyte telomere length independent of mediating effects of adult
trauma and other adult health and lifestyle factors. This suggests that early life is a sensitive
period in which trauma is embodied and affects telomere length independent of adult pathways.
As a result, prevention efforts that address early life trauma would be most successful in
mitigating the effect of early life trauma on telomere weathering and associated poor health
outcomes.
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4.5 Tables and Figures
Figure 4.1. Life course models of the relationship between early life trauma and adult telomere
length (A, B) and pathway model (C).
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Table 4.1. Characteristics of a sub-sample of 602 Sister Study participants based on experience
of early life traumas before age 18
No Early Life Trauma Any Early Life Trauma
(n = 318)
(n = 284)
p-value
n
%
n
%
Age at baseline, mean (SD)
55.63
(9.57)
53.28
(9.29)
0.002
Race/Ethnicity
0.211
Non-Hispanic White
274
86.16
237
83.45
Non-Hispanic Black
19
5.97
15
5.28
Hispanic
4
1.26
11
3.87
Other
21
6.6
21
7.39
Highest level of education in the
0.301
household at age 13, %
Missing
1
0.31
6
2.11
Less than high school
63
19.81
52
18.31
High school graduate
123
38.68
114
40.14
Some college
63
19.81
58
20.42
College degree or higher
68
21.38
54
19.01
Family income while growing up,
0.005
%
Missing
1
0.31
0
0
Poor
10
3.14
28
9.86
Low income
71
22.33
74
26.06
Middle income
216
67.92
166
58.45
Well off
20
6.29
16
5.63
As a child, were there times when
your family did not have enough
0.062
food to eat?, %
Yes
22
6.92
32
11.27
No
296
93.08
252
88.73
Body Mass Index
0.025
Missing
1
0.31
0
0
Underweight
5
1.57
5
1.76
Normal weight
139
43.71
99
34.86
Overweight
95
29.87
77
27.11
Obese
78
24.53
103
36.27
Smoking Status
0.125
Never smoked
149
46.86
143
50.35
Past smoker
104
32.7
72
25.35
Current smoker
65
20.44
69
24.3
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Table 4.2. Telomere length by latent class of early life trauma
Trauma Latent Class
N
Low early life trauma
468
Moderate early life trauma: Family
13
health issues
Moderate early life trauma: Sexual
trauma and family drug/alcohol/mental
40
health issues
Moderate early life trauma: High betrayal
trauma and family drug/alcohol/mental
36
health issues
Moderate early life trauma: Overall

25

Model 1a
β (95% CI)
Ref

Model 2b
β (95% CI)
Ref

Model 3c
β (95% CI)
Ref

-0.043 (-0.179, 0.094)

-0.078 (-0.210, 0.055)

-0.068 (-0.206, 0.070)

0.056 (-0.024, 0.136)

0.028 (-0.049, 0.106)

0.027 (-0.052, 0.105)

-0.032 (-0.116, 0.052)

-0.046 (-0.128, 0.035)

-0.040 (-0.122, 0.042)

-0.043 (-0.143, 0.057)

-0.072 (-0.169, 0.025)

-0.058 (-0.157, 0.040)
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High early life trauma
20
-0.117 (-0.227, -0.006)
-0.139 (-0.247, -0.031)
-0.112 (-0.221, -0.004)
a
unadjusted
b
Adjusted for age
c
Additionally adjusted for early life socioeconomic factors (early life household income, household educational attainment, and
food security)

Figure 4.2 Structural equation model diagrams of the relationship between early life trauma and
adult leukocyte telomere length
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Table 4.3. Estimates for the association between latent classes of early life trauma (compared to
low early life trauma) and adult leukocyte telomere length.
Model 1a
β
(T/S
units)

SE

Model 2b
pvalue

β
(T/S
units)

SE

Model 3c
pvalue

β
(T/S
units)

0.096
0.051
0.327

-0.099
-0.042
0.057

SE

pvalue

Moderate early life trauma: Family health issues
Direct
Total

-0.046
-0.029
0.017

0.036
0.025
0.017

0.200
0.253
0.313

-0.065
-0.043
0.023

0.039
0.022
0.023

Total Indirect
Indirect - Adult
0.017
0.017
0.313
0.023
0.021
0.281
0.033
Traumad
Moderate early life trauma: Sexual trauma and family drug/alcohol/mental health issues
Direct
Total

0.000
0.021
0.021

0.030
0.021
0.018

0.997
0.316
0.247

-0.007
0.024
0.031

0.034
0.018
0.025

0.846
0.181
0.215

-0.024
0.025
0.050

Total Indirect
Indirect - Adult
0.021
0.018
0.247
0.031
0.024
0.199
0.042
Traumad
Moderate early life trauma: High betrayal trauma and family drug/alcohol/mental health issues
Direct
Total

-0.036
-0.019
0.017

0.025
0.019
0.015

Total Indirect
Indirect - Adult
0.017
0.015
Traumad
Moderate early life trauma: Overall
Direct
Total
Total Indirect
Indirect - Adult
Traumad
High early life trauma
Direct
Total
Total Indirect
Indirect - Adult
Traumad

0.058
0.021
0.044

0.087
0.046
0.193

0.029

0.255

0.044
0.018
0.037

0.582
0.165
0.179

0.032

0.187

0.150
0.305
0.266

-0.037
-0.017
0.020

0.024
0.017
0.016

0.120
0.322
0.212

-0.040
-0.018
0.022

0.029
0.017
0.023

0.163
0.307
0.324

0.266

0.020

0.016

0.223

0.027

0.022

0.207

-0.040
-0.028
0.012

0.024
0.019
0.012

0.096
0.147
0.306

-0.035
-0.018
0.017

0.024
0.016
0.015

0.132
0.264
0.258

-0.046
-0.019
0.027

0.027
0.017
0.021

0.096
0.249
0.203

0.012

0.012

0.306

0.017

0.015

0.251

0.023

0.019

0.243

-0.086
-0.061
0.025

0.040
0.024
0.024

0.029
0.012
0.285

-0.093
-0.060
0.033

0.042
0.023
0.028

0.026
0.008
0.238

-0.118
-0.060
0.058

0.057
0.023
0.045

0.038
0.008
0.200

0.025

0.024

0.285

0.033

0.028

0.242

0.046

0.038

0.223

RMSEA = 0.024;
RMSEA = 0.022;
RMSEA = 0.021;
CFI = 0.907
CFI = 0.905
CFI = 0.903
a
Adjusted for race/ethnicity and age
b
Additionally adjusted for early life socioeconomic factors (early life household income, household educational
attainment, and food security) and adult socioeconomic position (educational attainment)
c
Additionally adjusted for adult lifestyle factors (smoking history and body mass index)
d

Pathways from Figure 4.2 - Model 1: a; Model 2: Additionally b; Model 3: Additionally c
CFI: Comparative fit index; RMSEA: Root mean square error of approximation; SE: Standard error
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4.6 Supplemental materials
Supplemental Table 4.1 Telomere length (T/S ratio) by early life trauma domains
Model 1a
β (95% CI)
0.101 (0.001, 0.200)
-0.013 (-0.152, 0.127)
0.008 (-0.045, 0.062)
0.007 (-0.047, 0.060)
-0.079 (-0.158, 0.000)
-0.017 (-0.060, 0.027)
-0.074 (-0.256, 0.108)

Model 2b
β (95% CI)
0.097 (0.000, 0.194)
-0.049 (-0.187, 0.088)
-0.010 (-0.062, 0.043)
-0.008 (-0.061, 0.044)
-0.091 (-0.169, -0.014)
-0.027 (-0.070, 0.015)
-0.092 (-0.270, 0.086)

Model 3c
β (95% CI)
0.124 (0.028, 0.220)
-0.052 (-0.187, 0.083)
-0.011 (-0.063, 0.042)
-0.005 (-0.058, 0.047)
-0.083 (-0.162, -0.004)
-0.019 (-0.062, 0.024)
-0.068 (-0.243, 0.108)
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Trauma Domain
N
Natural Disasters
25
Major Accidents
15
Household Dysfunction
102
Sexual Trauma
101
Physical Trauma
44
Psychological Trauma
183
Major Illness
9
a
Unadjusted
b
Adjusted for age
c
Additionally adjusted for early life socioeconomic factors (early life household income, household educational attainment, and
food security)

Supplemental Table 4.2 Standardized estimates for the association between domains of early life trauma and adult leukocyte
telomere length (Telomere length/Single copy gene (T/S) ratio)
Model 1a
β
(T/S
units)

Trauma Domain
Direct Effect
Natural Disasters

Total Effect

SE

Model 2b
p-value

β
(T/S
units)

SE

p-value

0.045

-0.004

0.079

0.957

-0.017

0.085

0.838

0.037

0.020

0.056

-0.015

0.074

0.845

-0.042

0.073

0.571

Total Indirect Effect

-0.003

0.002

0.212

-0.010

0.011

0.353

-0.024

0.022

0.275

Indirect Effect via Adult Trauma

-0.003

0.002

0.212

-0.006

0.010

0.559

-0.004

0.009

0.666

RMSEA = 0.063; CFI = 0.692

RMSEA = 0.064; CFI = 0.619

Direct Effect

-0.168

0.087

0.054

-0.251

0.075

0.001

-0.318

0.101

0.002

Total Effect

-0.169

0.082

0.040

-0.239

0.064

<0.001

-0.247

0.065

<0.001

Total Indirect Effect

-0.001

0.011

0.962

0.012

0.018

0.492

0.071

0.048

0.143

Indirect Effect via Adult Trauma

-0.001

0.011

0.962

0.013

0.017

0.427

0.015

0.019

0.429
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RMSEA = 0.050; CFI = 0.809

RMSEA = 0.050; CFI = 0.760

Direct Effect

-0.009

0.062

0.884

-0.024

0.063

0.699

-0.028

0.066

0.667

Total Effect

-0.022

0.058

0.706

-0.027

0.058

0.641

-0.001

0.021

0.956

Total Indirect Effect

-0.013

0.013

0.331

-0.003

0.015

0.855

-0.029

0.058

0.609

-0.013

0.013

0.331

-0.006

0.014

0.673

-0.002

0.018

0.913

Indirect Effect via Adult Trauma

RMSEA = 0.086; CFI = 0.875

Sexual Trauma

p-value

0.020

RMSEA = 0.039; CFI = 0.959

Household
Dysfunction

SE

0.040

RMSEA = 0.000; CFI = 1.00

Major Accidents

β
(T/S
units)

Model 3c

RMSEA = 0.071; CFI = 0.754

RMSEA = 0.070; CFI = 0.595

Direct Effect

-0.014

0.070

0.839

-0.056

0.071

0.434

-0.053

0.072

0.463

Total Effect

-0.027

0.063

0.667

-0.055

0.063

0.381

-0.063

0.063

0.319

Total Indirect Effect

-0.013

0.015

0.385

0.001

0.017

0.968

-0.010

0.018

0.570

Indirect Effect via Adult Trauma

-0.013

0.015

0.385

-0.002

0.016

0.881

-0.001

0.016

0.970

RMSEA = 0.070; CFI = 0.920

RMSEA = 0.063; CFI = 0.810

RMSEA = 0.067; CFI = 0.644

Supplemental Table 1 (Continued)
Model 1a

0.071

0.007

0.070

0.001

β
(T/S
units)
-0.261

0.073

<0.001

-0.190

0.065

0.004

-0.231

0.062

0.000

-0.244

0.063

<0.001

Total Indirect Effect

0.002

0.012

0.857

0.013

0.015

0.415

0.017

0.021

0.418

Indirect Effect via Adult Trauma

0.002

0.012

0.857

0.013

0.015

0.387

0.012

0.014

0.411

Direct Effect
Physical Trauma

Total Effect

SE

p-value

RMSEA = 0.017; CFI = 0.994

Psychological or
Emotional Trauma

SE

p-value

RMSEA = 0.056; CFI = 0.827

SE

p-value

RMSEA = 0.064; CFI = 0.629

Direct Effect

-0.076

0.053

0.154

-0.089

0.054

0.102

-0.089

0.054

0.103

Total Effect

-0.082

0.051

0.108

-0.088

0.052

0.087

-0.091

0.052

0.079

Total Indirect Effect

-0.006

0.010

0.536

0.001

0.011

0.954

-0.002

0.013

0.878

Indirect Effect via Adult Trauma

-0.006

0.010

0.536

-0.001

0.011

0.940

0.002

0.012

0.884

RMSEA = 0.047; CFI = 0.954
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Major Illness

Model 3c

β
(T/S
units)
-0.244

Trauma Domain

β
(T/S
units)
0.192

Model 2b

RMSEA = 0.063; CFI = 0.789

RMSEA = 0.067; CFI = 0.609

Direct Effect

-0.099

0.089

0.266

-0.250

0.084

0.003

-0.317

0.117

0.007

Total Effect

-0.103

0.081

0.204

-0.238

0.076

0.002

-0.250

0.073

0.001

Total Indirect Effect

-0.004

0.014

0.760

0.012

0.017

0.507

0.067

0.055

0.217

Indirect Effect via Adult Trauma

-0.004

0.014

0.760

0.013

0.016

0.429

0.014

0.019

0.437

RMSEA = 0.000; CFI = 1.000
aAdjusted

RMSEA = 0.039; CFI = 0.872

RMSEA = 0.045; CFI = 0.788

for race/ethnicity and age
adjusted for early life socioeconomic factors (early life household income, household educational attainment, and food security) and adult socioeconomic position
(educational attainment)
cAdditionally adjusted for adult lifestyle factors (smoking history and body mass index)
bAdditionally

d

Pathways from Figure 4.2 - Model 1: a; Model 2: Additionally b; Model 3: Additionally c

CFI: Comparative fit index; RMSEA: Root mean square error of approximation; SE: Standard Error
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CHAPTER 5
Conclusion
5.1 Conclusion
This dissertation examined the potential effects of biological embedding of early life
trauma on adult health outcomes, specifically breast cancer incidence, DNA methylation of the
hypothalamus-pituitary-adrenal (HPA) axis gene – NR3C1, and leukocyte telomere length,
within a cohort of women residing in the U.S. or Puerto Rico with a first degree family history of
breast cancer. As early life traumatic events do not commonly occur in isolation, this dissertation
uses a latent class approach to evaluate the effect of different early life trauma profiles on the
three target measures of adult health and biological embedding of trauma. A latent class variable
was created to capture the potential clustering of 20 different early life traumatic experiences. I
observed patterns that suggest women who reported moderate early life trauma consisting jointly
of sexual trauma and household dysfunction (i.e., family drug, alcohol, and/or mental health
issues) were at higher risk for developing pre- and post-menopausal breast cancer, as well as a
moderate decrease in DNA methylation among cytosine-phosphate-guanine (CpG) sites within
the NR3C1 gene body compared to women classified as low early life trauma. There was no
association between moderate early life trauma consisting jointly of sexual trauma and household
dysfunction and leukocyte telomere shortening compared to low early life trauma. However,
women who were classified as having high early life trauma had significantly shorter telomeres
than women classified with low early life trauma but did not show any statistically significant
differences in incident breast cancer risk nor NR3C1 methylation. Although there was a trend in
the positive direction between most latent classes of early life trauma and elevated risk for postmenopausal breast cancer as well as shorter telomere length, I did not observe any additional
statistically significant associations between the latent classes of early life trauma not previously
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mentioned and differential NR3C1 methylation overall, among promoter-associated CpG sites, or
within the gene body.
The experience of early life trauma is highly predictive of future revictimization in
adulthood1-3, contributing to the accumulation of trauma over the life course and subsequent
negative impacts on health. However, this dissertation attempted to elucidate whether early life
trauma may impact adult health independent of subsequent trauma by serving as a sensitive
period during which the biological embedding of trauma may have a stronger effect on
developing systems. Moderate early life trauma consisting of sexual trauma and family drug,
alcohol, and/or mental health issues was the only latent class of early life trauma to exhibit a
statistically significant overall effect on NR3C1 methylation, which was observed as
hypomethylation of CpG sites located within the gene body, compared to low early life trauma.
This association was driven by the direct effect of moderate early life trauma consisting of sexual
trauma and family drug, alcohol, and/or mental health issues as no statistically significant
indirect effects were observed via pathways mediated by adult trauma. A similar pattern emerged
for the relationship between early life trauma and leukocyte telomere shortening, featuring the
high early life trauma latent class. Early life trauma was associated with significantly shorter
leukocyte telomeres among women classified as high early life trauma compare to women
classified as experiencing low early life trauma. Again, this association was driven by the direct
effect between high early life trauma and telomere length, with no statistically significant
indirect effects or indirect effects specifically mediated by adult trauma. These results suggest
that early life may serve as a sensitive period for during which the effects of specific clusters of
traumatic experiences may differentially impact future health outcomes independent of
subsequent trauma trajectories.

138

Prior studies investigating the relationship between early life trauma and incident breast
cancer, NR3C1 methylation, or leukocyte telomere length has been highly mixed due to
heterogeneity in the definitions used to classify early life adversity (namely trauma, stress or
stressful life events, and adverse childhood experiences – ACEs), methods used to quantify early
life trauma, and the timing of exposure (i.e., childhood, adolescence, or both). The findings from
this dissertation improve upon the current literature by utilizing comprehensive models of early
life trauma and its impact on adult health to build a more robust picture of these associations.
Future research will need to work towards addressing these discrepancies before a unified picture
of the association between early life trauma and these health outcomes can be elucidated.
This dissertation found that early life represents a sensitive period during which trauma
can be biologically embedded and affect telomere length independent of adult pathways. As a
result, prevention efforts that address early life trauma would be most successful in mitigating
the effect of early life trauma on telomere weathering and associated poor health outcomes.
Furthermore, this work supports the use of comprehensive measures, rather than summative
scores, individual events, or trauma domains that have been used traditionally to elucidate the
effects of early life trauma on measures of stress embodiment and adult health. Our work also
supports the use of life course models to evaluate various pathways that may ultimately influence
the observed associations between measures of early life trauma and adult health.
5.2 Aim 1 – Early Life Trauma and Incident Breast Cancer
The first aim of this dissertation investigated the association between early life trauma
and incident breast cancer risk, using traditional measures, as well as a latent class model, of
early life trauma. There were no statistically significant associations between early life trauma
and incident breast cancer risk using traditional measures of early life trauma. A latent class
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model identified six unique early life trauma profiles that reflected not only overall severity (i.e.,
low and high overall early life trauma), but also combinations of traumatic events (e.g., sexual
trauma and family drug, alcohol, and/or mental health issues). Model results suggested that
women who reported moderate early life trauma consisting of sexual trauma and family drug,
alcohol, and/or mental health issues had potentially higher risk of developing pre- and postmenopausal breast cancer compared to women who reported low early life trauma (premenopausal breast cancer HR 1.19, 95% CI 0.89, 1.59; post-menopausal breast cancer HR 1.09;
95% CI: 0.93, 1.29) after adjusting for race/ethnicity and childhood socioeconomic position
(SEP), which was captured as highest level of education in the household at age 13, family
income while growing up, and food security as a child. Estimated effects were also in the
positive direction for other early life trauma profiles, except for high early life trauma, and postmenopausal breast cancer when compared to the low early life trauma profile. Therefore, the role
of early life trauma on breast cancer risk may be more nuanced than what may be captured by a
cumulative trauma score, a single traumatic event, or traditional trauma domains.
Aim 1 builds upon previous literature on the relationship between early life trauma and
breast cancer incidence, which continues to be inconsistent. The observed variation in results
from previous studies and the current dissertation may in part be due to the heterogeneous nature
of breast cancer (i.e., differences in class, stage, and molecular subtypes), as well as
methodological differences in the operationalization of stress, adversity, and trauma (e.g.,
summative scores, singular traumatic events, and trauma domains) and exposure periods (i.e.,
childhood, adolescence, or both) in these studies. Similar to prior research that has utilized
summative trauma scores and/or trauma domains, there was no statistically significant
association between early life trauma and incident breast cancer. Prior studies have not assessed
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the relationship between early life trauma and breast cancer molecular subtype. To my
knowledge, only one study has looked at the association between chronic psychological stress
and breast cancer tumor subtype, which reported that women with breast cancer who reported a
history of chronic stress also had a high percentage of human epidermal growth factor receptor 2
(HER2) amplified tumors—a form of aggressive breast cancer—compared to women with breast
cancer and no history of chronic distress4. In this dissertation, the direction of effects varied
slightly between risk for estrogen receptor (ER) positive and negative breast cancer, with slightly
higher risk observed for ER positive breast cancer for most early life trauma domains and latent
classes of early life trauma. The hazard ratios for ER negative breast cancer were higher than
those for ER positive breast cancer for women reporting early life sexual trauma (domain) or
classified as experiencing moderate early life trauma consisting of sexual trauma and family
drug, alcohol, and/or mental health issues when compared to women who did not experience of
sexual trauma or women classified as low early life trauma, respectively; however, these
associations did not reach statistical significance.
The mechanisms through which traumatic experiences that occur during sensitive periods
of breast development and may subsequently affect breast cancer risk are complex and poorly
understood. One potential biologic pathway though which early life trauma could affect breast
cancer risk is modification of stress response mechanisms. The HPA axis is one of the primary
stress response mechanisms and functions via a series of biochemical feedback pathways.
Persistent activation of the HPA axis resulting from exposure to chronic stress can decrease the
its functionality, contributing to greater allostatic load and disease susceptibility5, 6. Experiences
of early life trauma may predispose women to a chronic dysregulation of stress management
mechanisms including immune function and inflammatory processes7-9. Early life trauma could
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also affect breast cancer risk through the alteration of circulating hormones that affect pubertal
changes and early breast development and subsequent reproductive behaviors. Younger age at
menarche10, an indicator of accelerated breast development, has been associated with increased
breast cancer risk. Previous studies have reported an association between childhood sexual abuse
and lower age at menarche11, but less is known about the potential relationship between early life
trauma and other known breast cancer risk factors, including delayed age at first birth, parity, and
time between pregnancies12-14. Other life course factors that may be affected by early life trauma
and subsequently modify breast cancer risk include adult health and lifestyle factors (e.g.,
alcohol use15-17 and body mass18-21) or adult stress and coping mechanisms. In these analyses of
early life trauma and incident breast cancer risk, I did not adjust for these factors due to their role
as potential mediators. Future studies should assess these pathways to discover if environmental
hazards, social factors, or health and behaviors in adulthood may differentially affect the
association between early life trauma and incident breast cancer risk.
5.3 Aim 2 – Early life trauma and circulating NR3C1 methylation
The second aim of this dissertation examined the relationship between early life trauma
and patterns of DNA methylation of the HPA axis gene, nuclear receptor subfamily 3, group C,
member 1 (NR3C1) in peripheral blood, using the latent class model of early life stress
developed in Aim 1 (Chapter 2). Only the latent class consisting of early life sexual trauma and
family drug, alcohol, and/or mental health issues was associated with moderate decrease in
methylation of CpG sites within the NR3C1 gene body (β = -0.021, p = 0.036, % methylation
change = -0.08) after controlling for age, breast cancer status, body mass index (BMI), smoking
history, and proportions of white blood cell types. In similar models, there were no statistically
significant associations between latent classes of early life trauma and NR3C1 methylation
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overall, among promoter-associated CpG sites, or within the gene body. Various CpG sites were
associated with differential methylation at several CpG sites, however, these associations did not
survive correction for multiple testing. In life course structural equation models, potential
mediating effects via adult trauma and other adult SEP and health and lifestyle factors were
assessed and no direct nor indirect effects between latent classes of early life trauma and adult
NR3C1 methylation were identified.
Aim 2 builds upon previous literature investigating the association between early life
trauma and DNA methylation of HPA axis genes, specifically the glucocorticoid receptor gene –
NR3C1. Whereas previous studies have relied on summative trauma scores and traditional
trauma domains, to our knowledge, this is one of the few studies to utilize a latent class approach
to assess the co-occurrence of traumatic events in early life and the first to evaluate the
relationship between early life trauma and adult NR3C1 methylation using structural equation
models and a life course approach to observe potential mediating effects through adult SEP,
trauma, and health and behavioral factors. Other studies that control for SEP measures over the
life course, adult trauma, and/or adult health and lifestyle factors may mask complex mediating
pathways of the observed relationship between early life trauma and NR3C1 methylation in
adulthood. Using traditional measures of early life adversity and trauma, findings from previous
studies have been mixed with some studies reporting hypermethylation22-25, hypomethylation2527

, and no changes28-30 in NR3C1 methylation overall, in promotor-specific regions, and at

individual CpG sites. The variation in these results may in part be due to the heterogeneity in the
measurement of early life trauma—both the measures used and the exposure period assessed, the
targeted NR3C1 CpG sites, the method used to capture NR3C1 methylation, whether the studies
corrected for multiple testing, as well as the study populations represented, which differed by
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age, sex, and proportion of participants selected for known psychiatric and mental health
disorders.
The latent class of moderate early life trauma consisting of sexual trauma and family
drug, alcohol, and/or mental health issues was associated with hypomethylation of CpG sites
located in the NR3C1 gene body. This association was replicated, albeit attenuated, in life course
SEM models when both direct and indirect effects were considered and was largely driven by the
direct effect of moderate early life trauma consisting of sexual trauma and family drug, alcohol,
and/or mental health issues. Although most research in this field has focused on the methylation
of CpG sites within the proximal promotor region of NR3C1 due to its prominent role in NR3C1
transcription, methylation changes in the bodies of genes have been reported to play a role in
differential promotor usage, transcription elongation, or alternative splicing31, 32. Structural
equation models did not identify direct or indirect effects via adult SEP, trauma, smoking, or
BMI in the relationship between latent classes of early life trauma and NR3C1 methylation
overall. Compared to other toxic exposures, such as smoking and tobacco use, methylation
associated with the embedding of early life psychological stress and trauma tend to be less
pervasive and associated with smaller changes in methylation, which may make them hard to
disentangle from subsequent behavioral and environmental exposures associated with a history
of trauma28.
The lack of associations between early life trauma and NR3C1 methylation overall and at
individual CpG sites that have been observed in previous studies, as well as this dissertation,
could be attributed in part to the long period between the experience of early life trauma and the
measurement of adult NR3C1 methylation. Although DNA methylation is thought to be a durable
epigenetic modification, methylation levels can be modified over time and may not persist over
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the life course33, 34. As such, different risk or protective factors (e.g., coping and support)
experienced over the life course that were not explored in the current models may further
mediate the association between the reported trauma and the observed methylation patterns. A
comprehensive study by Marzi et al. looked at the relationship between childhood trauma and
NR3C1 methylation at age 18, thus eliminating the long period between exposure and
measurement, and found no associations28. This suggests that biological embedding of early life
trauma may not occur immediately but may result from the chronic psychological stress
associated with reliving the trauma over time or may contribute to behaviors later in life that
have a stronger impact on DNA methylation. Future research should assess why the combination
of early life sexual trauma and household dysfunction may differentially affect methylation of
NR3C1, and potentially other HPA axis genes, compared to other clusters of early life trauma
and whether alternative pathways through adult behaviors may exist that may mediate or modify
the association between early life trauma and NR3C1 methylation as no direct association
between early life trauma and NR3C1 methylation was observed.
5.4 Aim 3 – Early life trauma and leukocyte telomere length
The third aim of this dissertation assessed the relationship between early life trauma and
leukocyte telomere length, a biomarker of cellular aging, using the latent six class model of early
life trauma developed in Aim 1 (Chapter 2). Women who were classified as experiencing high
early life trauma had significantly shorter telomeres than women who were classified as
experiencing low early life trauma after controlling for age and early life SEP (β = -0.112; 95%
CI = -0.221, -0.004). This association was maintained in life course structural equation models
when direct and indirect pathways were considered after adjusting for age, race/ethnicity, and
early life and adult SEP, and allowing for mediating pathways through adult smoking history and
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BMI; high early life trauma decreased telomere length by 0.060 T/S units holding all covariates
constant (p = 0.008). This was largely driven by the negative direct effect of high early life
trauma on telomere length (β = -0.118, S.E. 0.057, p = 0.038). The indirect effect of early life
trauma on telomere length that was mediated by adult trauma was not statistically significant,
suggesting that high early life trauma was associated with telomere length independent of adult
trauma.
Aim 3 fills several gaps in the previous literature on early life trauma and adult leukocyte
telomere length. To our knowledge, this is the first analysis to use structural equation modeling
and a life course approach to assess the relationship between early life trauma and leukocyte
telomere length. A previous study used SEM to evaluate different life course models of
childhood stressful life events before age 18 years in saliva telomere length and reported an
association between childhood stressful life events and shorter saliva telomere length, which was
fully mediated by the experience of stressful life events in adulthood35. Experience of high early
life trauma was associated with shorter telomere length, albeit in leukocytes, the observed
association was due to the significant direct effect of early life trauma on telomere length and
was not mediated by adult trauma, SEP, nor indicators of adult health or health behavior.
Observed differences between that study and the current dissertation could be due to how a wider
spectrum of early life traumas were captured in the Sister Study and the degree to which they
may be internalized differently, variations in study populations, and the limited ability to directly
compare qPCR measures of telomere length across populations, let alone measures from
different cell types (i.e., saliva vs. leukocytes)36. Our findings suggest that childhood and
adolescence represent a sensitive period in which trauma is embodied and affects telomere length
independent of adult pathways. As a result, prevention efforts that address early life trauma
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would be most successful in mitigating the effect of early life trauma on telomere weathering and
associated poor health outcomes (e.g., cancer37, obesity, diabetes38, 39, and cardiovascular
disease38, 40, and mortality41).
Previous studies of the association between early life trauma and telomere length have
reported mixed results with just over half of studies reporting statistically significant negative
associations between recalled early stressful life events measured in adulthood and telomere
length42. In a review by Willis et al., the authors note that the heterogeneity in findings appear to
be unrelated to the type of measure used to assess early life stress and whether the studies also
adjusted for adult health and lifestyle factors or experience of trauma over the life course42.
However, studies that inappropriately adjust for potential mediators may result in estimates that
do not fully capture the effect of early life trauma on adult telomere length. Furthermore, in our
models with statistically significant direct effects between measures of early life trauma and
telomere length, the direct effects suggested a stronger negative association with telomere length
than measured total effects, suggesting that models that do not address life course mediating
factors may not capture the true direct effect of early life trauma on telomere length and may
instead report attenuated effects. Our results suggested that clusters of traumatic experiences in
early life may have differential effects on adult leukocyte telomere length, but the greatest effect
was observed when comparing the extreme latent classes of early life trauma (i.e., high early life
trauma vs. low early life trauma).
Future research on the relationship between early life trauma and leukocyte telomere
length should consider how duration of clustered early life traumatic experiences may affect
leukocyte telomere length and how positive and negative coping behaviors over the life course
may contribute to the observed effects. As such, due to the myriad of pathways that early life
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trauma can alter telomere length (e.g., directly as well as via socioeconomic factors, health
behaviors, and coping mechanisms), life course models will be necessary in teasing out potential
points of intervention to lessen the impact of early life trauma on telomere weathering.
5.5 Strengths and Limitations
This is the first study to comprehensively assess the relationship between early life
trauma and risk of incident breast cancer overall and by breast cancer tumor subtype and to
utilize this latent measure of early life trauma in life course structural equation models to
evaluate the association between early life trauma and adult circulating NR3C1 methylation and
leukocyte telomere length. I used data from participants of the Sister Study, a large prospective
cohort of U.S. and Puerto Rican women with a sister diagnosed with breast cancer. Due to the
prospective design of the Sister Study and the nature of the exposure, I can ensure temporality
between the experience of early life trauma and breast cancer diagnosis, adult NR3C1
methylation, and adult leukocyte telomere length. Our outcomes of interest had high validity,
with breast cancer diagnosis verified with medical records for approximately 86% of women
with breast cancer and a 99% agreement between medical records and self-report for breast
cancer; NR3C1 methylation and leukocyte telomere length were measured and checked for
quality using standard practices. Experiences of early trauma were combined for childhood
(before age 12) and adolescence (ages 13-17). Prior studies that have assessed the association
between early life adversity in breast cancer have focused primarily on childhood adversity,
however, studies that limit their scope to childhood may overlook the impact of trauma on
pubertal development and subsequent reproductive pathways associated future breast cancer risk.
Furthermore, although other studies have evaluated different methods of assessing adverse

148

childhood experiences43, this is the first study to utilize and compare different methods of
evaluating breast cancer risk in a single cohort.
Whereas previous studies have utilized summary measures, domains, or distinct events to
assess early life trauma, this dissertation utilized a latent class approach for early life trauma and
a latent variable approach for adult trauma to capture potential nuanced roles of concomitant
traumas on incident breast cancer risk, adult NR3C1 methylation, and adult telomere length. In
addition, this is the first study to look at the relationship between early life trauma and NR3C1
methylation and adult leukocyte telomere length using a life course framework and structural
equation model approach. These models were able to control for covariates of interest including
age, race/ethnicity (except for NR3C1 methylation analyses, which were limited to non-Hispanic
White women), early life and adult SEP, and adult health and lifestyle factors—smoking status
and BMI—based on their potential relationships to our exposure and outcomes. Other studies
that directly control for life course SEP measures, adult trauma, and/or adult health and lifestyle
factors may hide complex mediating pathways that affect the overall relationship between early
life trauma and our outcomes of interest.
This dissertation has several limitations. First, the Sister Study consists of an enriched sample
of women who did not have breast cancer but had at least one biological sister diagnosed with
breast cancer at baseline. In addition, the Sister Study population are generally older, more
educated, and more likely to be healthy and economically sound, which may mask the effects of
early life trauma in more vulnerable populations. However, the distribution of breast cancer risk
factors in the Sister Study cohort resembles that of the general population, which suggests that
the results observed in this study may still be generalizable and remain internally valid44.
Furthermore, the participants included in the NR3C1 methylation and leukocyte telomere
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analyses were small samples of the total Sister Study cohort. The NR3C1 methylation sample
were strictly non-Hispanic White women who were sampled in a case-cohort fashion while the
leukocyte telomere sample purposefully oversampled women with high perceived stress, were
current smokers, and were not non-Hispanic White, which may limit the generalizability of these
samples to larger populations. Additional samples that are both larger and more diverse are
needed to confirm the results observed in Aims 2 and 3. Furthermore, previous studies have
demonstrated sex and gender differences in the associations between early life adversity/trauma
and adult health outcomes (e.g., cancer45 and pulmonary disease46). As such, the results reported
in this dissertation may not be generalizable to men. Future studies in more diverse populations
could help to strengthen the findings observed in this dissertation.
Second, although the number and type of early life traumatic experiences that occurred in
childhood or adolescence were captured, the duration nor the magnitude of these exposures over
these two periods remain unknown. Some trauma types tend to have shorter exposure periods
(e.g., natural disasters) whereas other trauma types may be more persistent (e.g., emotional or
psychological mistreatment). The duration and repetition of trauma over potentially sensitive
time periods over the life course may play an important role in the association between early life
trauma and adult indicators of biological embedding of early life trauma. The Sister Study
collected information on a comprehensive list of traumas, however, the possibility that there may
be other types of stress and adversity with higher likelihood to be biologically embedded and
subsequently play a larger role in the risk of breast cancer, DNA methylation, and leukocyte
telomere length remains unknown. In addition, although temporality between reported early life
trauma and breast cancer diagnosis can be assured, non-differential exposure misclassification
may exist as a result of the long period between experienced trauma and accurate reporting.

150

Previous studies have reported between 60 and 81 percent of study participants accurately
disclosing previous experiences of sexual and physical trauma47-49. This underreporting has been
attributed to the inability to recall the traumatic experience, as well as avoidance of potential
stigmas associated with disclosing early life trauma. Concurrent mental health issues (e.g.,
psychological distress) can contribute to higher recall and reporting of childhood traumatic
experiences50. Furthermore, the Sister Study does not capture adverse childhood experiences as
presented by the ACE study, instead uses a trauma framework; as a result, the observed results
cannot be directly compared with other studies that have used the traditional categories for
ACEs. However, Bethell et al. demonstrated that although variability exists among measures of
adverse childhood experiences, most measures remain similar and cumulative scores from these
measures reflect consistent association with poor health outcomes43.
Finally, this study presents single measures of DNA methylation of a single stress
response gene, NR3C1, and of leukocyte telomere length in later adulthood. Although NR3C1 is
pivotal in the stress response, attributable to the role of glucocorticoid receptors in HPA axis
signaling, it is a single gene in a complex network of mechanisms that characterize the stress
management process. The study of DNA methylation of additional HPA axis genes would
provide a more global picture of the role of early life trauma on methylation of these genes.
Furthermore, it is unknown when epigenetic modification becomes stabilized following
experiences of psychological stress and trauma and the degree to which these changes can be
modified post exposure. Persistent exposure to traumatic experiences may differentially affect
DNA methylation or cellular division and subsequent telomere shortening. Longitudinal studies
that capture serial measures of DNA methylation and telomere length over the life course would
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be better suited to elucidate timing associated with trauma experience, embodiment, and
epigenetic modification.
5.6 Future Directions
This dissertation builds upon the current literature on the relationship between early life
trauma and three indicators of adult health, incident breast cancer, NR3C1 methylation, and
leukocyte telomere length. Future studies should focus on refining measures to assess early life
trauma and their impact on health and future elucidate additional pathways through which early
life trauma may affect adult health.
Prior studies in this field have depended on summative trauma scores, individual
traumatic events, and trauma domains, and fail to consider the effects that may result from the
cooccurrence of different traumatic experiences in early life, resulting in mixed findings on the
relationship between early life trauma and the outcome studied in this dissertation. I utilized a
latent class approach to identify substantive classes of early life trauma in order to assess how the
cooccurrence of different early life traumatic experiences may affect the embodiment of
psychosocial stress and subsequent health in adulthood. The latent class variable created in this
dissertation is likely not the final measure to be used to evaluate early life trauma since latent
classes are specific to the study population and may differ from study to study depending on the
underlying distribution of reported early life trauma. However, one of the primary goals of the
latent class measure was to capture the cooccurrence of different early life traumas. Results from
future studies that utilize similar approaches can be used to elucidate patterns of cooccurring
early life trauma that impact adult health. Identifying clusters of early life traumatic experiences
can inform effective public health policies and programs to prevent trauma profiles that have the
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largest impact on health or to help mitigate the effect of high-risk trauma profiles in vulnerable
populations.
The life course models used in this dissertation include potential mediating roles of adult
trauma, socioeconomic position, and health and lifestyle factors. However, measures of stress
management, such as coping, social support, and depression, may also serve as mediating factors
between early life trauma and the indicators of adult health featured in this dissertation. Future
studies should consider these factors to gain a greater understanding of the relationship between
early life trauma and adult health.
Finally, early life trauma and SEP are highly correlated with higher rates of reported
early life trauma and child maltreatment associated with low childhood SEP51, 52, including
receipt of public assistance53, poverty54, homelessness55, and neighborhood disadvantage56.
Studies have evaluated the association between neighborhood and socio-structural barriers and
breast cancer57, 58, DNA methylation of stress management-related genes59, and telomere
length60, 61, however, there is a paucity of research on the effect of early neighborhood on these
indicators of adult health. Future studies that utilize similar life course models as used in this
dissertation can start to disentangle the effects of early life trauma, SEP, and neighborhood
effects on incident breast cancer, DNA methylation of stress management genes, and telomere
shortening.
5.7 Dissertation Summary
Using data from participants in the Sister Study, a large prospective cohort of women,
this dissertation attempted to capture a nuanced measure of early life trauma by assessing how
clusters of different types of trauma may work together to affect three indicators of adult health
that are vulnerable to the biological embedding of psychosocial stress: 1) breast cancer
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tumorigenesis, 2) epigenetic modification of the stress management gene, NR3C1, and 3)
leukocyte telomere length, a measure cellular aging. Despite representing different physiological
mechanisms, these measures represent various aspects of the stress response. Methylation of
HPA axis genes, such as NR3C1, contributes to modified expression of genes related to immune
response, inflammatory pathways, and cell apoptosis, contributing to disease risk and negative
health impacts62. Furthermore, leukocyte migration is a key feature of the stress response and
inflammatory processes, which is partially regulated by glucocorticoid signaling63 and
characterized by telomere shortening64. In addition, breast cancer tumorigenesis, DNA
methylation of HPA axis genes, and telomere weathering are all ongoing biological processes
that start in early life and proceed over the life course, potentially making them more vulnerable
to the effects of chronic stress. Childhood and adolescence represent potentially vulnerable
periods for breast cancer development due to the rapid proliferation of undifferentiated
mammary cells and heightened susceptibility to tumorigenic changes65, 66. Since this dissertation
was unable to evaluate the process of breast cancer tumorigenesis, incident breast cancer risk
was used to assess whether the effects of early life trauma are observable not only in relatively
durable biological mechanisms of stress embodiment but also remain detectable in downstream
health outcomes, such as breast cancer incidence.
In order to build upon previous literature that have relied heavily on summative scores of
trauma and adversity, traditional trauma domains, and individual events to represent early life
trauma, a latent class model of early life trauma was used to assess the potentially nuanced
effects of concomitant traumatic experiences. This dissertation also used a life course approach
using structural equation modeling to evaluate how adult trauma, SEP, and health behaviors may
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mediate the relationship between early life trauma and adult measures of biological embedding
of psychosocial stress and overall health.
The relationship between early life trauma and these indicators of adult health are
complex. Results from this dissertation suggest higher incident pre- and post-menopausal breast
cancer risk and hypomethylation of CpG sites located in the NR3C1 gene body among women
classified as experiencing moderate early life trauma consisting of sexual trauma and family
drug, alcohol, and/or mental health issues in early life compared to women classified as
experiencing low early life trauma. However, there was no association between the latent class
for high early life trauma and incident breast cancer risk nor differential NR3C1 methylation,
compared to low early life trauma. This would suggest that early life trauma consisting primarily
of sexual trauma and family drug, alcohol, and/or mental health issues may contribute to
different social, behavioral, and/or biological trajectories that can subsequently affect incident
breast cancer risk and adult NR3C1 methylation, unique from other clusters of varying traumatic
experiences.
Conversely, the strongest association between early life trauma and shorter telomere
length was observed for women who experienced high early life trauma compared to women
who experienced low early life trauma. In life course structural equation models, the latent class
for high early life trauma was associated with shorter leukocyte telomere length compared to the
latent class for low early life trauma when direct and indirect pathways were considered after
adjusting for age, race/ethnicity, and early life and adult SEP, and allowing for mediating
pathways through adult smoking history and BMI. This association was largely driven by the
direct effect between high early life trauma and adult leukocyte telomere length, which hinted at
a stronger inverse association than measured total effects, suggesting that early life trauma
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models that do not address life course mediating factors may not capture the true direct effect of
early life trauma on specific health outcomes and may instead be reporting attenuated effects..
These associations were not observed between latent classes of early life trauma and differential
adult NR3C1 methylation in similar life course structural equation models. These findings
suggest that the process of biological embedding of early life trauma may differ for various
indicators of adult health depending on how proximal they are to key stress response
mechanisms. Experience of clustered traumatic experiences or overall high levels of early life
trauma may have differential effects on health by directly impacting biological mechanisms,
exposing individuals to negative socioeconomic or environmental hazards in adulthood, or
contributing to adaptive or maladaptive behaviors that subsequently influence of adult health.
Breast cancer, DNA methylation of NR3C1, and leukocyte telomere length have all
previously been associated with traditional measures of psychosocial stress and early life trauma.
However, they represent fundamentally different biologic mechanisms and there were no
apparent sweeping trends across these three outcomes associated with specific patterns of early
life trauma. These differences may be due to the long period between exposure of early life
trauma and our outcomes of interest and the durability and magnitude of the effect of the
biological embedding of early life trauma on these outcomes compared to more proximal risk
(e.g., hormonal and reproductive factors for breast cancer or health behaviors such as smoking
that may contribute to increased DNA methylation or telomere shortening) and protective (e.g.,
coping mechanisms and social support) factors.
In conclusion, these findings suggest that the role of early life trauma on breast cancer
risk, NR3C1 methylation, and leukocyte telomere length may be more nuanced than a cumulative
trauma score, a single traumatic event, or a trauma domain can capture. This dissertation benefits
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public health by setting a precedence of using comprehensive measures of early life trauma and
utilizing life course models to fully understand the relationship between the experience of early
life trauma and adult manifestations of the biological embedding of stress and trauma. Our
findings contribute to the current understanding of the relationship between latent measures of
early life trauma and incident breast cancer risk, adult circulating NR3C1 methylation, and adult
leukocyte telomere length and support the need to identify potential windows for interventions
targeted at minimizing these negative health outcomes.
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TEACHING
University of Wisconsin-Milwaukee
Spring 2019, 2020
Guest Lecturer, Joseph J. Zilber School of Public Health, PH763:
Field Epidemiology, Topic: Working with SAS
Spring/Fall 2017 – 2019

Guest Lecturer, Joseph J. Zilber School of Public Health, PH101:
Introduction to Public Health, Topic: Disease Detectives: Public
Health in Action (Field Epidemiology)

Fall 2018

Student Instructor, PhD Statistics Workshop, Joseph J. Zilber School
of Public Health (Enrollment: 5)

Fall 2017

Guest Lecturer, Joseph J. Zilber School of Public Health, PH768:
Cancer Epidemiology, Topic: Cancer Epidemiology Statistics

Summer 2017

Guest Lecturer, SOCWORK794: Evaluation of Programs, Topic:
Show me the money: How to make a budget

Spring 2017

Guest Lecturer, Joseph J. Zilber School of Public Health, PH759:
Applied Quantitative Methods for Studying Population Health and
Health Disparities, Topic: Data Analysis as a Grad Student

Spring 2016

Guest Lecturer, Joseph J. Zilber School of Public Health, PH759:
Applied Quantitative Methods for Studying Population Health and
Health Disparities, Topic: Qualitative Response Regression Models
(Parts 1-3)

COMMITTEE MEMBERSHIP
University of Wisconsin-Milwaukee Joseph J. Zilber School of Public Health, Milwaukee, WI
2019 – current
Co-president, Public Health Graduate Student Association
2018 – current
Member, Health Research Symposium Planning Committee
2017 – current
Member, Evaluation Workgroup
2015 – current
Member, Seminars Committee
2015 – 2018
PhD Student Representative, Graduate Program Committee
2015
Member, Values Accreditation Workgroup
2015
Member, Practice and Community Engagement Ad Hoc Committee
2015
Member, Mission and Goals Accreditation Workgroup
2014 – 2017
Blood Drive Organizer, Public Health Graduate Student Association
University Wisconsin-Milwaukee, Milwaukee, WI
2018 – current
Member, Subcommittee on Graduate Courses & Curriculum
2018 – current
Member, Scholastic Affairs Committee
Society for Epidemiologic Research
2019 – current
Lead, Twitter Initiative Group
2018 – current
Member, Twitter Initiative Group
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Childhood Arthritis & Rheumatology Research Alliance
2014 – 2019
Chair, Research Coordinator Advisory Committee
2012 – 2014
Member, Research Coordinator Advisory Committee
Pediatric Arthritis and Lupus (PAL) Foundation
2012 – 2014
Founding Board Member
PROFESSIONAL SERVICE
2019, 2020
Mock Interviewer, Zilber School of Public Health MPH Mock Interview Day
2018 – 2019
Abstract and film reviewer, American Public Health Association
COMMUNITY SERVICE
2014 – current
Volunteer, Milwaukee Habitat for Humanity, Milwaukee, WI
2014 – 2020
Volunteer, UCLA Mattel Children’s Hospital, Department of Rheumatology, Los
Angeles, CA
2014 – 2020
Volunteer, Children’s Hospital of Wisconsin, Milwaukee, WI
2013 – 2020
Volunteer, Down Syndrome Association of Wisconsin, Milwaukee, WI
2016
Volunteer, Southeast Asian Literacy Program, Milwaukee, WI
PROFESSIONAL MEMBERSHIPS
2017 – current
Wisconsin Public Health Association (WPHA)
2016 – current
Society for Epidemiologic Research (SER)
2015 – current
American Public Health Association (APHA)
2012 – current
Childhood Arthritis & Rheumatology Research Alliance (CARRA)
2009 – current
Association of Rheumatology Health Professionals (ARHP)
2012 – 2013
Delta Omega Honor Society (Kappa Chapter)
SKILLS
Analytic Programs: ArcGIS, MPlus, SAS, STATA
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